Sentence,class,file
"Nat Neurosci (2007); 10:161-8;PMID:17237777; http://dx.doi.org/10.1038/nn1835 [22] Watari-Goshima N, Ogura K, Wolf FW, Goshima Y, Garriga GC.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Nat Neurosci (2007); 10:169-76; PMID:17237778;http://dx.doi.org/10.1038/nn1834 [23] Levy-Strumpf N, Culotti JG.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"PLoS Genet (2014); 10:e1004381; PMID:24901837; http://dx.doi.org/10.1371/journal.pgen.1004381 [24] Wong M-C, Schwarzbauer JE.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Development (2011); 138:2915-24;PMID:21653614; http://dx.doi.org/10.1242/dev.064733 [26] Su M, Merz DC, Killeen MT, Zhou Y, Zheng H, Kramer JM, Hedgecock EM, Culotti JG.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"PLoS Biol (2010); 8:e1000297; PMID:20126385; http://dx.doi.org/10.1371/journal.pbio.1000297 [29] Yang P-T, Lorenowicz MJ, Silhankova M, Coudreuse DY, Betist MC, Korswagen HC.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Cell(2008); 134:646-56; PMID:18724937; http://dx.doi.org/10.1016/j.cell.2008.06.026 [31] Levy-Strumpf N, Krizus M, Zheng H, Brown L, Culotti JG.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"PLOS Genet (2015); 11:e1005446; PMID:26292279; http://dx.doi.org/10.1371/journal.pgen.1005446 [32] Jaworski A, Tom I, Tong RK, Gildea HK, Koch AW, Gonzalez LC, Tessier-Lavigne M. Operational redun-dancy in axon guidance through the multifunctionalreceptor Robo3 and its ligand NELL2.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Science (2015);350:961-965; PMID:26586761; http://dx.doi.org/10.1126/science.aad2615 [33] Kulkarni G, Xu Z, Mohamed AM, Li H, Tang X, Limerick G, Wadsworth WG.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Nature (1993); 364:327-30; PMID:8332188; http://dx.doi.org/ 10.1038/364327a0 [35] Leung-Hagesteijn C, Spence AM, Stern BD, Zhou Y, Su MW, Hedgecock EM, Culotti JG.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Cell (1992); 71:289-99; PMID:1384987;http://dx.doi.org/10.1016/0092-8674(92)90357-I [36] Sawa H, Korswagen HC.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Cell MolLife Sci (2005); 62:2599-616; PMID:16158190; http://dx.doi.org/10.1007/s00018-005-5191-3 [38] Baker KA, Moore SW, Jarjour AA, Kennedy TE.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Curr Opin Neu- robiol (2006); 16:529-34; PMID:16935486; http://dx.doi.org/10.1016/j.conb.2006.08.002 [39] Cirulli V, Yebra M. Netrins: beyond the brain.",Non-OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Nat Rev Mol Cell Biol (2007); 8:296-306; PMID:17356579; http://dx.doi.org/10.1038/nrm2142 [40] Poon VY, Klassen MP, Shen K. UNC-6/netrin and its r ecep- tor UNC-5 locally exclude presynaptic components from dendrites.",Non-OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
Nature (2008); 455:669-73; PMID:18776887; http://dx.doi.org/10.1038/nature07291e1146857-6 N. LEVY-STRUMPF,Non-OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Nat Cell Biol (2009);11:183-9; PMID:19098902; http://dx.doi.org/10.1038/ ncb1825 [43] Col /C19on-Ramos DA, Margeta MA, Shen K. Glia promote local synaptogenesis through UNC-6 (netrin) signalingin C. elegans.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"Science (2007); 318:103-6; PMID:Can ’t; http://dx.doi.org/10.1126/science.1143762 [44] Ciani L, Salinas PC.",Non-OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"JNeurosci (2005); 25:10376-8; PMID:16280576; http://dx.doi.org/10.1523/JNEUROSCI.3429-05.2005[46] Park M, Shen K. WNTs in synapse formation and neuro- nal circuitry.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"EMBO J (2012); 31:2697-704; PMID:22617419; http://dx.doi.org/10.1038/emboj.2012.145 [47] Herr P, Hausmann G, Basler K. WNT secretion and sig- nalling in human disease.",Non-OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
Trends Mol Med (2012);18:483-93; PMID:22796206; http://dx.doi.org/10.1016/j.molmed.2012.06.008 [48] Polakis P. Wnt signaling in cancer.,OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
Cold Spring Harb Per- spect Biol (2012); 4(5):4:pii: a008052; PMID:22438566;http://dx.doi.org/10.1101/cshperspect.a008052.,OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
"J Cell Biochem (2007);102:1519-28; PMID:17471511; http://dx.doi.org/10.1002/jcb.21372 [50] Coudreuse DYM, Ro €el G, Betist MC, Destr /C19ee O, Kors- wagen HC.",OADS,/arxiv_data1/oa_pdf/1c/b5/kwrm-05-01-1146857.PMC4805361.pdf
PLoS Ge net 2015; 11: e1005285; PMID:26061275; http://dx.doi.org/10.1371/journal.pgen.1005285 © 2016 Zao Li and Zheng Zhou.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"1, e1120400 (10 pages)http://dx.doi.org/10.1080/21624054.2015.1120400",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Trends Biochem Sci 2007; 32:37 – 43; PMID:17141506; http://dx.doi.org/10.1016/j.tibs.2006.11.001 [2] Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell Death Differ 2009; 16:3 –11; PMID:18846107; http://dx.doi.org/10.1038/cdd.2008.150 [3] Jacobson MD, Bergeron L. Cell death in the nervous sys- tem, in Apoptosis, the molecular biology of programmedcell death.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell Calcium 2004; 36:285 – 93; PMID:15261484; http://dx.doi.org/10.1016/j.ceca.2004.03.001 [5] Noch E, Khalili K. Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
CancerBiol Ther 2009; 8:1791 –7; PMID:19770591; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell Mol Life Sci 2010; 67:3241 –53; PMID:20532807; http://dx.doi.org/10.1007/ s00018-010-0413-8 [7] Whelan RS, Kaplinskiy V, Kitsis RN.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Annu Rev Physiol 2010; 72:19 –44; PMID: 20148665; http://dx.doi.org/10.1146/annurev.physiol.,Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Curr Opin Cell Biol 2010;22:882 –8; PMID:20889324; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Trends Biochem Sci 2010; 35:434 –41; PMID:20346680; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Dev Dyn 2010; 239:1337 –51; PMID:20108319; http://dx.doi.org/10.1002/dvdy.22230 [11] Zhou W, Yuan J. Necroptosis in health and diseases.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Apoptosis 2006; 11:1709 –26; PMID: 16951923; http://dx.doi.org/10.1007/s10495-006-9527-8 [15] Poon IK, Hulett MD, Parish CR.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell Death Differ2010; 17:381 –97; PMID:20019744; http://dx.doi.org/ 10.1038/cdd.2009.195 [16] Metzstein MM, Stan ﬁeld GM, Horvitz HR.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Trends Genet 1998; 14:410 –416; PMID:9820030; http://dx.doi.org/10.1016/S0168-9525(98)01573-X [17] Driscoll M, Gerstbrein B.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Nat RevGenet 2003; 4:181 –94; PMID:12610523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Dev Biol 1981; 82:358 –70; PMID:7227647; http://dx.doi.org/ 10.1016/0012-1606(81)90459-0 [19] Driscoll M, Chal ﬁe M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutateto induce neuronal degeneration.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nature 1991; 349:588 – 93; PMID:1672038; http://dx.doi.org/10.1038/349588a0 [20] Treinin M, Chal ﬁe M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Neu- ron 1995; 14:871 –7; PMID:7718248; http://dx.doi.org/ 10.1016/0896-6273(95)90231-7 [21] Ellis HM, Horvitz HR.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell 1986; 44:817 – 29; PMID:3955651; http://dx.doi.org/10.1016/0092-8674(86)90004-8 [22] Bianchi L, Gerstbrein B, Frokjaer-Jensen C, Royal DC, Mukherjee G, Royal MA, Xue J, Schafer WR, Driscoll M. The neurotoxic MEC-4(d) DEG/ENaC sodium channelconducts calcium: implications for necrosis initiation.Nat Neurosci 2004; 7:1337 –44; PMID:15543143; http:// dx.doi.org/10.1038/nn1347 [23] Chung S, Gumienny TL, Hengartner MO, Driscoll M. A common set of engulfment genes mediates removal ofboth apoptotic and necrotic cell corpses in C. elegans.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell Death Differ 2006; 13:2011 –22; PMID:16628234; http://dx.doi.org/10.1038/sj.cdd.4401900 [25] Zhou Z, Hartwieg E, Horvitz HR.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Exp Med2010; 207:1807 –17; PMID:20805564; http://dx.doi.org/ 10.1084/jem.20101157 [29] Tung TT, Nagaosa K, Fujita Y, Kita A, Mori H, Okada R, Nonaka S, Nakanishi Y. Phosphatidylserine recognition and induction of apoptotic cell clearance by Drosophilaengulfment receptor Draper.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Biochem 2013; 153:483 – 91; PMID:23420848; http://dx.doi.org/10.1093/jb/mvt014 [30] Balasubramanian K, Schroit AJ.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Annu Rev Physiol2003; 65:701 –34; PMID:12471163; http://dx.doi.org/ 10.1146/annurev.physiol.65.092101.142459 [31] Vance JE, Steenbergen R. Metabolism and functions of phosphatidylserine.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Prog Lipid Res 2005; 44:207 –34; PMID:15979148; http://dx.doi.org/10.1016/j.plipres.2005.05.001 [32] Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F, Nagata S. Caspase-mediated cleavage ofphospholipid ﬂippase for apoptotic phosphatidylserine exposure.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Science 2014; 344:1164 –8; PMID:24904167; http://dx.doi.org/10.1126/science.1252809 [33] Sims PJ, Wiedmer T. Unraveling the mysteries of phos- pholipid scrambling.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Science 2013; 341:403 – 6; PMID:23845944; http://dx.doi.org/10.1126/science.1236758 [36] Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-depen- dent phospholipid scrambling by TMEM16F.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nature2010; 468:834 –8; PMID:21107324; http://dx.doi.org/ 10.1038/nature09583 [37] Suzuki J, Fujii T, Imao T, Ishihara K, Kuba H, Nagata S. Calcium-dependent phospholipid scramblase activity ofTMEM16 protein family members.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Biol Chem 2013;288:13305 –16; PMID:23532839; http://dx.doi.org/ 10.1074/jbc.M113.457937 [38] Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, et al.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nat Cell Biol 2000; 2:399 –406; PMID:10878804; http://dx.doi.org/10.1038/35017029 [39] Alder-Baerens N, Muller P, Pohl A, Korte T, Hamon Y, Chimini G, Pomorski T, Herrmann A. Headgroup-spe-ciﬁc exposure of phospholipids in ABCA1-expressing cells.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Biol Chem 2005; 280:26321 –9; PMID:15905177; http://dx.doi.org/10.1074/jbc.M413993200[40] Williamson P, Halleck MS, Malowitz J, Ng S, Fan X, Krahling S, Remaley AT, Schlegel RA.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"PLoS One 2007; 2:e729; PMID:17710129; http://dx.doi.org/10.1371/journal.pone.0000729 [41] Venegas V, Zhou Z.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Mol Biol Cell 2007; 18:3180 –92; PMID:17567952; http://dx.doi.org/10.1091/ mbc.E07-02-0138 [42] Li Z, Venegas V, Nagaoka Y, Morino E, Raghavan P, Audhya A, Nakanishi Y, Zhou Z. Necrotic cells activelyattract phagocytes through the collaborative action oftwo distinct PS-Exposure mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"PLoS Genet 2015;11:e1005285; PMID:26061275; http://dx.doi.org/10.1371/ journal.pgen.1005285 [43] Callebaut I, Mignotte V, Souchet M, Mornon JP.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"BiochemBiophys Res Commun 2003; 300:619 –23; PMID:12507493; http://dx.doi.org/10.1016/S0006-291X(02)02904-2 [44] Wu HH, Bellmunt E, Scheib JL, Venegas V, Burkert C, Reichardt LF, Zhou Z, Farinas I, Carter BD.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nat Neurosci 2009;12:1534 –41; PMID:19915564; http://dx.doi.org/10.1038/ nn.2446 [45] Kay JN, Chu MW, Sanes JR. MEGF10 and MEGF11 mediate homotypic interactions required for mosaicspacing of retinal neurons.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nature 2012; 483:465 –9; PMID:22407321; http://dx.doi.org/10.1038/nature10877 [46] Fullard JF, Kale A, Baker NE.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Apoptosis 2009; 14:1029 –37; PMID:19291407; http://dx.doi.org/10.1007/s10495-009-0335-9 [47] Hamon Y, Trompier D, Ma Z, Venegas V, Pophillat M, Mignotte V, Zhou Z, Chimini G. Cooperation betweenengulfment receptors: the case of ABCA1 and MEGF10.PLoS One 2006; 1:e120; PMID:17205124; http://dx.doi.org/10.1371/journal.pone.0000120 [48] Scheib JL, Sullivan CS, Carter BD.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Neurosci 2012; 32:13022 –31; PMID:22993420; http://dx.doi.org/10.1523/JNEUROSCI.6350-11.2012 [49] Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwa- matsu A, Nagata S. Identi ﬁcation of a factor that links apoptotic cells to phagocytes.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nature 2002; 417:182 –7; PMID:12000961; http://dx.doi.org/10.1038/417182a [50] Wang X, Li W, Zhao D, Liu B, Shi Y, Chen B, Yang H, Guo P, Geng X, Shang Z, et al.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
NatCell Biol 2010; 12:655 –64; PMID:20526330; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Cell DeathDiffer 2001; 8:829 –40; PMID:11526436; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Morphol 2003; 258:336 –45; PMID:14584035; http://dx.doi.org/10.1002/jmor.10161 [53] Zong WX, Thompson CB.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Genes Dev 2006; 20:1 –15; PMID:16391229; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Neuroscience 1986; 18:417 –36; PMID:3526173; http://dx.doi.org/10.1016/ 0306-4522(86)90163-6 [55] Wu Y, Horvitz HR.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Am J Physiol Regul Integr Comp Physiol2013; 305: R1376 –89; PMID:24049119; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Physiol Rev 2014; 94:419 –59; PMID:24692353; http://dx.doi.org/10.1152/ physrev.00039.2011 [60] Segawa K, Suzuki J, Nagata S. Constitutive exposure of phosphatidylserine on viable cells.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Proc Natl Acad Sci US A 2011; 108: 19246 –51; PMID:22084121; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Cell2012; 151: 111 –22; PMID:23021219; http://dx.doi.org/ 10.1016/j.cell.2012.07.036 [62] Malvezzi M, Chalat M, Janjusevic R, Picollo A, Tera- shima H, Menon AK, Accardi A. Ca2 C-dependent phos- pholipid scrambling by a reconstituted TMEM16 ionchannel.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Nat Commun 2013; 4:2367; PMID:23996062; http://dx.doi.org/10.1038/ncomms3367 [63] Scudieri P, Caci E, Venturini A, Sondo E, Pianigiani G, Marchetti C, Ravazzolo R, Pagani F, Galietta LJ.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"J Physiol2015; 593:3829 –48; PMID:26108457; http://dx.doi.org/ 10.1113/JP270691 [64] Yu K, Whitlock JM, Lee K, Ortlund EA, Cui YY, Hartzell HC.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Neuron 2001; 31:957 –71; PMID:11580896; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"IUBMB Life 2008; 60:575 –90; PMID:18478527; http://dx.doi.org/10.1002/iub.91 [67] Mano I, Driscoll M. Caenorhabditis elegans glutamate transporter deletion induces AMPA-receptor/adenylylcyclase 9-dependent excitotoxicity.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
J Neurochem 2009;108:1373 –84; PMID:19054279; http://dx.doi.org/10.1111/ j.1471-4159.2008.05804.x [68] Paschen W. Dependence of vital cell function on endo- plasmic reticulum calcium levels: implications for themechanisms underlying neuronal cell injury in differentpathological states.,Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Cell Calcium 2001; 29:1 –11; PMID: 11133351; http://dx.doi.org/10.1054/ceca.2000.0162 [69] Mattson MP.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Aging Cell 2007; 6:337 –50; PMID:17328689; http://dx.doi.org/ 10.1111/j.1474-9726.2007.00275.x [70] Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Calcium signaling in the ER: its role inneuronal plasticity and neurodegenerative disorders.Trends Neurosci 2000; 23:222 –9; PMID:10782128; http://dx.doi.org/10.1016/S0166-2236(00)01548-4 [71] Verkhratsky A. Endoplasmic reticulum calcium signaling in nerve cells.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Biol Res 2004; 37:693 –9; PMID:15709699; http://dx.doi.org/10.4067/S0716-97602004000400027 [72] Huang M, Chal ﬁe M. Gene interactions affecting mecha- nosensory transduction in Caenorhabditis elegans.Nature 1994; 367:467 –70; PMID:7509039; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Proc Natl Acad Sci U S A 1998; 95:15492 –5; PMID:9860996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Genes Dev 1997;11:1493 –503; PMID:9203577; http://dx.doi.org/10.1101/ gad.11.12.1493[77] Nikoletopoulou V, Tavernarakis N. Necrotic cell death in Caenorhabditis elegans.",Non-OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"Methods Enzymol 2014;545:127 –55; PMID:25065889; http://dx.doi.org/10.1016/ B978-0-12-801430-1.00006-8 [78] Kourtis N, Nikoletopoulou V, Tavernarakis N. Small heat-shock proteins protect from heat-stroke-associatedneurodegeneration.",OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
Nature 2012; 490:213 –8; PMID:22972192; http://dx.doi.org/10.1038/nature11417e1120400-10 Z. LI AND Z. ZHOU,OADS,/arxiv_data1/oa_pdf/af/3a/kwrm-05-01-1120400.PMC4805362.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-375620160001000012016 – a second step Rogério Souza1,2 1.",Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(1):1-2. http://dx.doi.org/10.1590/S1806- 37132015000100001 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(5):403.  http://dx.doi.org/10.1590/S1806-37132015000500007 3.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(5):397. http://dx.doi.org/10.1590/S1806- 37132015000500001 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2013;39(1):5-15. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2014;40(6):609-16.  http://dx.doi.org/10.1590/S1806-37132014000600004 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2014;40(5):528-34. http://dx.doi.org/10.1590/S1806-37132014000500009 7.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(5):454-66. http://dx.doi.org/10.1590/S1806- 37132015000000152 8.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(3):264-74. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(6):547-53. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(4):388. http://dx.doi.org/10.1590/S1806- 37132015000000076 11.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
2015;41(5):485. http://dx.doi.org/10.1590/S1806- 37132015000000215 6 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/a4/4d/1806-3713-jbpneu-42-01-00005.PMC4805379.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000100002Ischemia/reperfusion-induced lung injury  prevention: many options, no choices Pedro Caruso1,2, Susimeire Gomes1 1.",Non-OADS,/arxiv_data1/oa_pdf/68/70/1806-3713-jbpneu-42-01-00007.PMC4805380.pdf
2004;30(1):51-61. http://dx.doi.org/10.1007/s00134-003-2022-6 2.,Non-OADS,/arxiv_data1/oa_pdf/68/70/1806-3713-jbpneu-42-01-00007.PMC4805380.pdf
2008;359(5):473-81. http://dx.doi.org/10.1056/ NEJMoa071142 4.,Non-OADS,/arxiv_data1/oa_pdf/68/70/1806-3713-jbpneu-42-01-00007.PMC4805380.pdf
2011;70(3):717-23. http://dx.doi.org/10.1097/ TA.0b013e3181f30fb0J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/68/70/1806-3713-jbpneu-42-01-00007.PMC4805380.pdf
2010;25(7):2328-33. http://dx.doi.org/10.1093/ndt/ gfq077 7.,Non-OADS,/arxiv_data1/oa_pdf/68/70/1806-3713-jbpneu-42-01-00007.PMC4805380.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000183ABSTRACT Objective:  To investigate the effects of N-acetylcysteine (NAC) and pentoxifylline in  a model of remote organ injury after hind-limb ischemia/reperfusion (I/R) in rats, the  lungs being the remote organ system.",Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
http://dx.doi.org/10.1152/ajpcell.00112.2001 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2002;26(1):115-21. http://dx.doi.org/10.1007/s00268-001-0169-2 3.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1997;14(5):351-9. http://dx.doi.org/10.1016/ S1078-5884(97)80284-5 4.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1989;209(2):231-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2015;21(1):30-5. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2013;39(4):434-9. http://dx.doi.org/10.1590/S1806- 37132013000400006 9.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2012;27(2):168-71. http://dx.doi.org/10.1590/ S0102-86502012000200012 10.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2006;21(5):1240-7. http://dx.doi.org/10.1093/ndt/gfk032 11.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2008;52(3):464-74. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2006;40(1):27-33. http://dx.doi.org/10.1111/j.1600- 079X.2005.00272.x 14.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1959;82(1):70-7. http://dx.doi.org/10.1016/0003-9861(59)90090-6 17.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2005;51(5):453-62. http://dx.doi.org/10.1016/j.phrs.2004.11.007 18.,OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1993;21(9):1376-86. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1999;26(1-2):202-26.  http://dx.doi.org/10.1016/S0891-5849(98)00196-8 22.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1991;20(2):123-134. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2013;64(3):204-9. http://dx.doi.org/10.5114/ pjp.2013.38140 24.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
1989;6(6):593-7. http://dx.doi.org/10.1016/0891-5849(89)90066-X 25.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2000;47(3):537-48. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2008;23(10):3067-73. http://dx.doi.org/10.1093/ndt/gfn237 30.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2005;9(1):65-76. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2004;5(4):245-51. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2004;26(6):597- 605. http://dx.doi.org/10.1081/JDI-200038329 34.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2002;40(5):224-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
2011;662(1-3):70-7.  http://dx.doi.org/10.1016/j.ejphar.2011.04.049 14 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/1e/0f/1806-3713-jbpneu-42-01-00009.PMC4805381.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000029ABSTRACT Objective:  To translate The Manchester Respiratory Activities of Daily Living (MRADL)  questionnaire into Portuguese and to create a version of the MRADL that is cross- culturally adapted for use in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2006;61(9):772-8. http://dx.doi.org/10.1136/thx.2006.060145 3.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
1996;110(5):1255-63. http://dx.doi.org/10.1378/chest.110.5.1255 4.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2005;171(9):972-7.  http://dx.doi.org/10.1164/rccm.200407-855OC 5.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
1998;12(2):363-9. http://dx.doi.or g/10.1183/09031936.98.12020363 7.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2002;31(5):355-8. http://dx.doi.org/10.1093/ageing/31.5.355 9.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2005;34(5):491-6. http://dx.doi.org/10.1093/ageing/afi163 10.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2000;26(3):119-28. http://dx.doi.org/10.1590/S0102- 35862000000300004 11.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
1994;3(6):403-12. http://dx.doi.org/10.1007/BF00435392 12.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2003;29(1):28-35. http://dx.doi.org/10.1590/s0102- 35862003000100007 14.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2008;34(12):1008-18. http://dx.doi.org/10.1590/S1806-37132008001200005 16.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2005;8(2):94-104. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2014;40(3):213-21. http://dx.doi.org/10.1590/S1806-37132014000300003 19.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2008;34(3):143-51. http://dx.doi.org/10.1590/S1806- 37132008000300004 22.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2002;31(2):137-40. http://dx.doi.org/10.1093/ ageing/31.2.137 25.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
Available from: http://www.who.int/respiratory/copd/burden/en/ 27. International Labour Office – ILO [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2008;31(4):466-75 http://dx.doi.org/10.1002/uog.5256 29.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
2000;30(1):1-15. http://dx.doi.org/10.2165/00007256- 200030010-00001 21 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/94/11/1806-3713-jbpneu-42-01-00015.PMC4805382.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000030ABSTRACT Objective:  To determine whether a restrictive pattern on spirometry is associated with  the level of physical activity in daily life (PADL), as well as with cardiovascular disease  (CVD) risk factors, in asymptomatic adults.",Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2010;65(6):499-504.  http://dx.doi.org/10.1136/thx.2009.126052 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2011;34(10):2306-13. http://dx.doi.org/10.2337/dc11-0682 4.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2003;167(6):911-6. http://dx.doi.org/10.1164/rccm.2203022 5.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2009;179(6):509- 16. http://dx.doi.org/10.1164/rccm.200807-1195OC 6.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2013;17(11):1507-14. http://dx.doi.org/10.5588/ ijtld.12.0906 7.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2003;37(6):521-8. http://dx.doi.org/10.1136/ bjsm.37.6.521 9.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2002;89(2):191-7. http://dx.doi.org/10.1016/S0002-9149(01)02199-310.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2005;26(5):948-68. http://dx.doi.org/10.1183/09031936.05.00035205  11.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2013;107(1):98-106.  http://dx.doi.org/10.1016/j.rmed.2012.09.011 12.,OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2003;114(9):758-62.  http://dx.doi.org/10.1016/S0002-9343(03)00185-2 13.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
Available from: http://www.goldcopd.org/other-resources-gold- spirometry-guide.html  14.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2007;33(4):397- 406. http://dx.doi.org/10.1590/S1806-37132007000400008 15.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
Curr Sports Med Rep. 2013;12(4):215-7.  http://dx.doi.org/10.1249/JSR.0b013e31829a68cf 18.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2005;26(2):319-38.  http://dx.doi.org/10.1183/09031936.05.00034805 19.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2004;23(6):1430-53. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2001;17(3):248-53. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2011;37(5):607-14. http://dx.doi.org/10.1590/S1806- 37132011000500007 23.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2006;38(2):380-7. http://dx.doi.org/10.1249/01.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
1998;30(5):777-81. http://dx.doi.org/10.1097/00005768-199805000- 00021 25.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2012;21(2):187-93. http://dx.doi.org/10.4104/ pcrj.2012.00027 27.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2005;21(5):1565-73 http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2006;100(1):115-22. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2008;23(2):96-103. http://dx.doi.org/10.1007/s00380-007-1018-5 31.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
1998;12(3):627-34. http://dx.doi.org/10.1 183/09031936.98.12030627 32.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2007;44(1):3-11. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2002;19(2):167-70. http://dx.doi.org/10.1046/j.1464- 5491.2002.00652.x 37.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
2012;13:10.  http://dx.doi.org/10.1186/1465-9921-13-10 28 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/6d/33/1806-3713-jbpneu-42-01-00022.PMC4805383.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000105ABSTRACT Objective:  To determine the prevalence of alternative diagnoses based on chest CT  angiography (CTA) in patients with suspected pulmonary thromboembolism (PTE)  who tested negative for PTE, as well as whether those alternative diagnoses had been  considered prior to the CTA.",Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2007;98(4):756-64. http://dx.doi.org/10.1160/th07-03- 0212 3.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2006;166(2):169-75. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2012;130(6):847-52. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2008;29(18):2276-315.  http://dx.doi.org/10.1093/eurheartj/ehn310 8.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2013;13:9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
"2002;360(9349):1914-20. http://dx.doi.org/10.1016/S0140- 6736(02)11914-3 11. van Strijen MJ, de Monyé W, Schiereck J, Kieft GJ, Prins MH,  Huisman MV, et al.",OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
"2003;138(4):307-14. http://dx.doi.org/10.7326/0003-4819-138- 4-200302180-00009 12. de Monyé W, Pattynama PM.",Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2001;27(1):33-9. http://dx.doi.org/10.1055/s-2001-12845 13.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2000;160(3):293-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2000;132(3):227- 32. http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00009 15.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2012;5:104. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2009;169(21):1961-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2015;12(5):689-95. http://dx.doi.org/10.1513/AnnalsATS.201404- 144OC 19.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
"2010;64(1):26-32.  http://dx.doi.org/10.4103/0019-5359.92484 20. van Es J, Douma RA, Schreuder SM, Middeldorp S, Kamphuisen  PW, Gerdes VE, et al.",OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
J Thromb Haemost 2005;3(11):2449-56. http://dx.doi.org/10.1111/ j.1538-7836.2005.01596.x 22.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2009;169(21):1966-8.  http://dx.doi.org/10.1001/archinternmed.2009.400 23.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2008; 113(3):373-84. http://dx.doi.org/10.1007/ s11547-008-0262-9 25.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2006;354(22):2317-27. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2012;18(2):201-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2011;57(6):700-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/b3/1806-3713-jbpneu-42-01-00035.PMC4805385.pdf
2016;42(1):42-47 http://dx.doi.org/10.1590/S1806-37562016000004480 ORIGINAL ARTICLE,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
Available from http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2005;6(1):8-13. http://dx.doi.org/10.1016/j.prrv.2004.11.002 3.,OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
Available from: http://tabnet.datasus.gov.br 5.,OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
1995;8(3):483-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2010;3(3):48-52. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2015;41(1):3-15. http://dx.doi.org/10.1590/S1806- 37132015000100002 10.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2004;24(3):406-12. http://dx.doi.org/10.1183/09031936.04.00090 303 12.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
J Pediatr (Rio J) 2014;90(1):78-84. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
1998;53(4):353-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2000;162(4 Pt 1):1403-6.  http://dx.doi.org/10.1164/ajrccm.162.4.9912111 17.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2004;114(6):1282-7. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2012;130(5):1049-62. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2005;172(11):1463-71.  http://dx.doi.org/10.1164/rccm.200408-1141ST 21.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
revised 2012. http://www.brit-thoracic.org.uk/ 25.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2013;22(2):188-94. http://dx.doi.org/10.4104/pcrj.2013.00040 27.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2013;6(Suppl 1):43. http://dx.doi.org/10.1186/1939-4551-6- S1-P43 28.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2008;63(1):5-34. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2014;69(9):789-90. http://dx.doi.org/10.1136/ thoraxjnl-2014-205401 30.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2012;129(4):735-44. http://dx.doi.org/10.1542/peds.2011-2196 31.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2013;11:27. http://dx.doi.org/10.1186/1741- 7015-11-27 32.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2012;67(8):976-97. http://dx.doi.org/10.1111/j.1398- 9995.2012.02865.x 36.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2012;39(5):1220-9. http://dx.doi.org/10.1183/09031936.00184511 39.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2014;32(1):114-25. http://dx.doi.org/10.1590/S0103- 05822014000100018 40.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
2008;34(2):103- 6. http://dx.doi.org/10.1590/S1806-37132008000200007 47 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/53/69/1806-3713-jbpneu-42-01-00042.PMC4805386.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000012ABSTRACT Objective:  To determine whether there are significant differences between rapid-eye- movement (REM)-related obstructive sleep apnea (OSA) and non-REM (NREM)-related  OSA, in terms of the demographic, anthropometric, and polysomnographic characteristics  of the subjects.",Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2012;16(2):519-26. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1985;87(4):432-6. http://dx.doi.org/10.1378/chest.87.4.432 4.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2005;128(5):3350-7. http://dx.doi.org/10.1378/ chest.128.5.3350 6.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2008;12(3):259-64. http://dx.doi.org/10.1007/s11325-007-0161-7 8.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2008;134(6):1156-61. http://dx.doi.org/10.1378/chest.08-1311 9.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2005;99(1):91-6.  http://dx.doi.org/10.1016/j.rmed.2004.05.014 10.,OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2009;45(7):330-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2013;61(4):283-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2011;15(3):463-70. http://dx.doi.org/10.1007/s11325-010-0358-z 17.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2008;36(5):906-13. http://dx.doi.org/10.1177/147323000803600506 18.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1997;112(3):629-39. http://dx.doi.org/10.1378/ chest.112.3.629 20.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2010;90(1):47-112. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1996;63(5):283-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2013;2013:670381. http://dx.doi.org/10.1155/2013/670381 23.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
http://dx.doi.org/10.5664/ jcsm.2258 24.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2013;17(1):173-9. http://dx.doi.org/10.1007/s11325-012- 0666-6 25.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1995;152(1):179- 85. http://dx.doi.org/10.1164/ajrccm.152.1.7599821 26.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2000;161(5):1465-72. http://dx.doi.org/10.1164/ ajrccm.161.5.9904121 28.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2000;118(4):1018-24.  http://dx.doi.org/10.1378/chest.118.4.1018 30.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1990;141(6):1522-6. http://dx.doi.org/10.1164/ajrccm/141.6.1522 31.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2012;2012:324635. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2009;180(8):788-93. http://dx.doi.org/10.1164/rccm.200905- 0773OC 53 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2010;182(3):325-31. http://dx.doi.org/10.1164/rccm.200912-1869OC 34.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2005;72(2):142-9. http://dx.doi.org/10.1159/000084044 35.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
1986;89(4):533-9. http://dx.doi.org/10.1378/chest.89.4.533 36.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2013;36(6):819-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2009;35(6):507-14. http://dx.doi.org/10.1590/ S1806-37132009000600003 38.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
2012;8(3):243-7. http://dx.doi.org/10.5664/jcsm.1902 39.,Non-OADS,/arxiv_data1/oa_pdf/86/b6/1806-3713-jbpneu-42-01-00048.PMC4805387.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000092ABSTRACT Objective:  Obstructive sleep apnea syndrome (OSAS) has a high prevalence and carries  significant cardiovascular risks.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2010;11(5):441-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2001;19(12):2271-7.  http://dx.doi.org/10.1097/00004872-200112000-00022 5.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2014;6:137-47. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2015;73(6):1133- 42. http://dx.doi.org/10.1016/j.joms.2014.11.020 8.,OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2014;52(5):445-51. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
http://dx.doi.org/10.1164/ ajrccm-conference.2011.183.1_meetingabstracts.a2732 10.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2014;18(5):405-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2013;71(8):1397- 405. http://dx.doi.org/10.1016/j.joms.2013.02.022 17.,OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
1996;154(4 Pt  1):1106-16. http://dx.doi.org/10.1164/ajrccm.154.4.8887615 19.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
1991;144(4):939-44. http://dx.doi.org/10.1164/ ajrccm/144.4.939 20.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2012;27(6):1078-82. http://dx.doi.org/10.1111/j.1440- 1746.2011.06968.x 21.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
1991;151(3):448-54. http://dx.doi.org/10.1001/ archinte.1991.00400030018004 22.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
1977;15(2):104-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2006;166(9):965-71.  http://dx.doi.org/10.1001/archinte.166.9.965 24.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2004;8(4):193-200. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2010;113(4):812-8. http://dx.doi.org/10.1097/ ALN.0b013e3181f1b834 27.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2009;179(3):241-6. http://dx.doi.org/10.1164/rccm.200807- 1076OC 28.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2011;115(2):273-81. http://dx.doi.org/10.1097/ ALN.0b013e318223ba6d 30.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
1998;2(3):139-62. http://dx.doi.org/10.1016/S1087- 0792(98)90018-131.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
2005;103(3):484- 8. http://dx.doi.org/10.1097/00000542-200509000-00009 60 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/42/5e/1806-3713-jbpneu-42-01-00055.PMC4805388.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000101ABSTRACT Among all causes of preventable deaths, smoking is responsible for the greatest  number of deaths worldwide and predisposes to fatal, noncommunicable diseases,  especially cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
Available  from: http://www.cesjf.br/revistas/cesrevista/edicoes/2011/21_ PSICOLOGIA_Tabagismo.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2014;19(2):499-510. http://dx.doi.org/10.1590/1413- 81232014192.13482012 4.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
Available  from: http://www.hc-sc.gc.ca/hl-vs/pubs/tobac-tabac/swk-dat/ intro01-eng.php 5.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2009;101(8):554-9. http://dx.doi.org/10.1093/jnci/djp023 7.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2013;35(3):212-20.  http://dx.doi.org/10.1590/S2237-60892013000300008 12.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2014;12:22. http://dx.doi.org/10.1186/1477-7525-12-22 15.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2006;59(1):82-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
1999;82(5):543-4. http://dx.doi.org/10.1136/hrt.82.5.543 18.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2010;36(1):67-74. http://dx.doi.org/10.1590/S1806- 37132010000100012 19.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2004;99(1):29-38.  http://dx.doi.org/10.1111/j.1360-0443.2004.00540.x 20.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2003;5(6):961-2. http://dx.doi.org/10.1080/1462220031000161 5330 21.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2005;30(2):375- 381. http://dx.doi.org/10.1016/j.addbeh.2004.05.009 22.,OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2004;110(3):195-200. http://dx.doi.org/10.1111/ j.1600-0447.2004.00342.x 23.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
1987;10(1):1-11. http://dx.doi.org/10.1002/nur.4770100103 24.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2011;11:256. http://dx.doi.org/10.1186/1471-2458-11-256 25.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2013;48(8):1261-71. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2014;44(12):2523- 35. http://dx.doi.org/10.1017/S0033291713003206 31.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2009;15(2):179-97. http://dx.doi.org/10.1016/ S0873-2159(15)30126-4 32.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
1995;49(6):583-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2009;11(4):433-43. http://dx.doi.org/10.1093/ntr/ ntp002 34.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
1990;322(4):213-7. http://dx.doi.org/10.1056/ NEJM199001253220401 35.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2004;30(Suppl 2):1-76. http://dx.doi.org/10.1590/S1806- 37132004000800002 36.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2010;32(2):267-76. http://dx.doi.org/10.1093/pubmed/fdp107 40.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2008;34(12):1090.  http://dx.doi.org/10.1590/S1806-37132008001000014 42.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2009;35(10):980-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2015;41(5):433-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
"Interação  em Psicologia, 2006,10(1):91-9. http://dx.doi.org/10.5380/psi.",Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2000;157(3):368-74. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
2005;32(5):267-75. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/1806-3713-jbpneu-42-01-00061.PMC4805389.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000193ABSTRACT Angiosarcoma is a rare malignant vascular tumor.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2010;11(10):983-91. http://dx.doi.org/10.1016/S1470- 2045(10)70023-1 2.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2011;80(2):257- 63. http://dx.doi.org/10.1016/j.critrevonc.2010.10.007 3.,OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
1993;103(5):1531- 5. http://dx.doi.org/10.1378/chest.103.5.1531 4.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2010;70(3):352-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2015;237(4):273-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2006;14(1):69-71. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2014;39(5):450-2. http://dx.doi.org/10.1097/ RLU.0b013e318292f3b3 9.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2008;61(1):131-6.  http://dx.doi.org/10.1016/j.lungcan.2007.12.006 10.,OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
2003;124(6):2397-2400. http://dx.doi.org/10.1378/chest.124.6.2397 70 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/66/2e/1806-3713-jbpneu-42-01-00068.PMC4805390.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000280Tumor seeding along the needle track after  percutaneous lung biopsy Leonardo Guedes Moreira Valle1, Rafael Dahmer Rocha1,   Guilherme Falleiros Mendes1, José Ernesto Succi2, Juliano Ribeiro de Andrade1 1.",Non-OADS,/arxiv_data1/oa_pdf/9d/cf/1806-3713-jbpneu-42-01-00071.PMC4805391.pdf
2003;23(5):828-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/cf/1806-3713-jbpneu-42-01-00071.PMC4805391.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000217Tracheal lobular capillary hemangioma  treated with laser photocoagulation Hans Dabó1, Rita Gomes2, Nelson Teixeira1, Gilberto Teixeira3,   Gabriela Fernandes1, Adriana Magalhães1 1.",Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2014;14:41. http://dx.doi.org/10.1186/1471-2466-14-41 2.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2008;14(4):527-34. http://dx.doi.org/10.1016/S0873-2159(15)30257- 9 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2011;82(2):125-33. http://dx.doi.org/10.1007/ s00104-010-1974-7 4.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2003;123(6):2148-9. http://dx.doi.org/10.1378/chest.123.6.21486.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
Available from: http://www.uptodate.com/home/index.html  7.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2007;134(5):1366-7. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2009;4(5):635- 8. http://dx.doi.org/10.1097/JTO.0b013e31819d18f9 9.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2013;75(1):36-9. http://dx.doi.org/10.4046/ trd.2013.75.1.36 10.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
1999;5(3):233-4. http://dx.doi.org/10.1053/ paor.1999.0194 73 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/a2/bf/1806-3713-jbpneu-42-01-00072.PMC4805392.pdf
2011;183(6):788-824. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2015;41(5):454-66. http://dx.doi.org/10.1590/S1806- 37132015000000152 3.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2015;41(6):560- 1. http://dx.doi.org/10.1590/S1806-37562015000000165 4.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2014;23(133):308-19. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2013;66(10):896-903. http://dx.doi.org/10.1136/ jclinpath-2013-201442 6.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2014;93(24):340- 9. http://dx.doi.org/10.1097/MD.0000000000000217 7.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2014;370(22):2083-92.  http://dx.doi.org/10.1056/NEJMoa1402582 9.,Non-OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
2014;370(22):2071-82. http://dx.doi.org/10.1056/ NEJMoa1402584 75 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/01/4e/1806-3713-jbpneu-42-01-00074.PMC4805393.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000275Crazy-paving pattern Bruno Hochhegger1,2, Roberto Schumacher Neto1, Edson Marchiori3,4 1.",Non-OADS,/arxiv_data1/oa_pdf/9a/50/1806-3713-jbpneu-42-01-00076.PMC4805394.pdf
2003;23(6):1509-19. http://dx.doi.org/10.1148/rg.236035101  Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/50/1806-3713-jbpneu-42-01-00076.PMC4805394.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000013 p < 0.001 Log-rank test 0 25 50 75 100 125 150 175 Months100% 75% 50%25% 0%SurvivalTwo  yearsFive  yearsWhat is survival analysis, and when should I  use it?",Non-OADS,/arxiv_data1/oa_pdf/56/3b/1806-3713-jbpneu-42-01-00077.PMC4805395.pdf
2008;177(5):516-23. http://dx.doi.org/10.1164/rccm.200706-815OC 2.,Non-OADS,/arxiv_data1/oa_pdf/56/3b/1806-3713-jbpneu-42-01-00077.PMC4805395.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000165errataManuscript: How many patients with idiopathic pulmonary fibrosis are there in Brazil?,Non-OADS,/arxiv_data1/oa_pdf/e5/5e/1806-3713-jbpneu-42-01-00078.PMC4805396.pdf
"DOI: http://dx.doi.org/10.1590/S1806-37562015000000165 On page 561 of the original publication, right column, first paragraph, lines two to nine, where it is written  “From Table 1, we might assume that the annual incidence of IPF cases is between 6,841 and 9,997 cases/100,000  population, whereas its prevalence ranges between 13,945 and 18,305 cases/100,000 population.",Non-OADS,/arxiv_data1/oa_pdf/e5/5e/1806-3713-jbpneu-42-01-00078.PMC4805396.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000004524errataManuscript:  Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context  of the Brazilian Unified Health Care System Publication: J Bras Pneumol.",Non-OADS,/arxiv_data1/oa_pdf/47/dd/1806-3713-jbpneu-42-01-00079.PMC4805397.pdf
"DOI: http://dx.doi.org/10.1590/S1806-37562015000004524 On page 536 of the original publication, where it is written Márcia Pinto, Anete Trajman, Ricardo Steffen, Aline Piovezan Entringer, it should read Márcia Pinto, Aline Piovezan Entringer, Ricardo Steffen, Anete Trajman.J Bras Pneumol.",Non-OADS,/arxiv_data1/oa_pdf/47/dd/1806-3713-jbpneu-42-01-00079.PMC4805397.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000095errataManuscript:  Bronchiectasis caused by common variable immunodeficiency Publication: J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/17/50/1806-3713-jbpneu-42-01-00080.PMC4805398.pdf
"DOI: http://dx.doi.org/10.1590/S1806-37132015000000095 On page 482 of the original publication, where it is written  Paulo Henrique do Amor Divino, José Henrique de Carvalho Basilio, Renato Moraes Alves Fabbri, Igor Polônio Bastos,  Wilma Carvalho Neves Forte, it should read  Paulo Henrique do Amor Divino, José Henrique de Carvalho Basilio, Renato Moraes Alves Fabbri, Igor Bastos Polonio,  Wilma Carvalho Neves Forte.",Non-OADS,/arxiv_data1/oa_pdf/17/50/1806-3713-jbpneu-42-01-00080.PMC4805398.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/3/e1501835/DC1 Movie S1.,Non-OADS,/arxiv_data1/oa_pdf/2b/a0/1501835.PMC4805431.pdf
0 ST) from a BXD mouse genetic reference population(26) were analyzed for transcript expression correlationsbetween NAD 1regulating and b-oxidation genes using the GeneNetwork program ( http://www.genenetwork.,OADS,/arxiv_data1/oa_pdf/46/f9/HEP-63-1190.PMC4805450.pdf
Raw microarray data are also publicly available on Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/46/f9/HEP-63-1190.PMC4805450.pdf
"Method Data for this review were identified by investigating the  archives of MEDLINE, Current Contents, Springerlink, Wiley, EBSCO, Ovid, and Web of science by applying a sensitive search strategy using combinations of the following search terms: “myopathy”, “muscle disease”, “muscular dystrophy”, “transmission”, “myasthenia”, “neuromuscular”, “nerve”, “neuropathy”, “motor neuron disease”, “plexopathy”, “radiculitis”, “anterior horn cell”, in combination with “heart”, “cardiac”, “cardiologic”, “myocardium”, “cardiomyopathy”, “noncompaction”, “hypertrabeculation”, “Takotsubo”, “echocardiography”, “electrocardiography”, “cardiac magnetic resonance imaging”, “late gadolinium enhancement”, “heart failure”, “left ventricular dysfunction”, Review Article http://dx.doi.org/10.4070/kcj.2016.46.2.117 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Heart Disease in Disorders of Muscle, Neuromuscular Transmission,  and the Nerves Josef Finsterer, MD1, and Claudia St öllberger, MD2 1Krankenanstalt Rudolfstiftung, Vienna, 22nd Medical Department with Cardiology and Intensive Care Medicine, Krankenanstalt Rudolfstiftung, Vienna, Austria Little is known regarding cardiac involvement (CI) by neuromuscular disorders (NMDs).",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"118  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org “right ventricular dysfunction”, “arrhythmias”, “ventricular tachycardia”, and  “sudden cardiac death”.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org (rCMP), arrhythmogenic right ventricular dysplasia, histiocytoid  cardiomyopathy (CMP), left ventricular hypertrabeculation/noncompaction (LVHT) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"120  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org Disorders of the peripheral nerves with cardiac involvement  Disorders of the nerves are classified as neuronopathies (also: anterior horn cell disorders), radiculopathies, plexopathies, or  neuropathies.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org Neuronopathies:  CI in neuronopathies is uncommon but occasional  case reports exist in the literature.5) CI in neuronopathies includes  dilation of the left ventricle,5) dCMP,6) or arrhythmias7) in patients  with spinal muscular atrophy (SMA).",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
122  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org dCMP in association with life-threatening ventricular arrhythmias  has also been reported.38) A subset of patients with X-EDMD due to  FHL1 mutations can present with pulmonary artery hypoplasia or SCD (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org manifest with dCMP requiring HTX before the onset of muscular  manifestations.83) Patients with myofibrillar myopathy and a  limb-girdle phenotype due to MYOT mutations may develop CMP only in the late stages of the disease.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"124  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org involvement may also progress to myocardial fibrosis, thereby  manifesting as LGE on cMRI.125) In a study of 129 MD1 patients, CI  was found in 55%.126) In this cohort, first degree AV-block was found  in 23.6%, second-degree AV-block in 5.6%, right bundle branch block in 5.5%, LBBB in 3.2%, and QTc-prolongation in 7.2%, whereas atrial fibrillation occurred in 4.1%, other supraventricular tachyarrhythmias in 7.3%, and non-sustained ventricular tachycardia in 4.1%.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org potentially treatable and may significantly improve outcome with  timely, appropriate management.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"126  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org Cardiac drugsIn case of heart failure, conservative heart failure therapy with  angiotensin-converting enzyme inhibitors, AT-1-blockers, beta- blockers, diuretics, aldosterone-antagonists, must be initiated according to established guidelines.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org Preclinical options Several preclinical therapies are undergoing development,  including utrophin up-regulation, stop codon read-through  therapy, viral gene therapy, cell-based therapy, or exon skipping.176)  Some of these therapies are undergoing clinical trials, but these have predominantly focused on correction of skeletal muscle compromise.",Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
128  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org and its treatment with continuous positive airway pressure.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org 36.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
130  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org nonsense mutation in delta-sarcoglycan exon 3 in a case of  LGMD2F.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org 96.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
132  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org 1999;80:267-70.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org Neuromuscul Disord  2014;24:648-50.,OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
Available from http://www.ncbi.nlm.nih.gov/books/NBK115333/.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
134  Heart Disease in Neuromuscular Disorders http://dx.doi.org/10.4070/kcj.2016.46.2.117 www.e-kcj.org myocardial noncompaction: results from the pediatric  cardiomyopathy registry.,Non-OADS,/arxiv_data1/oa_pdf/e9/ba/kcj-46-117.PMC4805555.pdf
"In Asians, such as Koreans, Chinese, and Japanese, the prevalence of hypertriglyceridemia is greater than hypercholesterolemia within the Korean population, 6-8) Chinese National Survey,9) and Japanese men  (http://www.mhlw.go.jp/bunya/kenkou/eiyou/h25-houkoku.html).",Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
"Review Article http://dx.doi.org/10.4070/kcj.2016.46.2.135 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Hypertriglyceridemia and Cardiovascular Diseases: Revisited Seung Hwan Han, MD1, Stephen J Nicholls, MD2, Ichiro Sakuma, MD3, Dong Zhao, MD4, and Kwang Kon Koh, MD1 1Department of Cardiology, Gachon University Gil Medical Center, Incheon, Korea, 2Department of Cardiology, South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia, 3Department of Cardiovascular Medinine, Hokko Memorial Clinic, Sapporo, Japan, 4Department of Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing An Zhen Hospital, Capital Medical University, Beijing, China Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting  hypertriglyceridemia.",Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
136  Hypertriglyceridemia and Cardiovascular Diseases http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org Recent Evidence of the Role of Hypertriglyceride - mia and Triglyceride-Rich Lipoproteins as Cardio - vascular Risk Factors Experimental evidence  TRLs are too large to enter into the arterial intima and therefore cannot lead to development of atherosclerosis at greatly elevated  triglycerides (TG) concentrations (>4450 mg/dL).,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org and intermediate density lipoprotein (IDL).,OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
"138  Hypertriglyceridemia and Cardiovascular Diseases http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org smaller remnants of chylomicrons and large VLDL, as well as LDL  and lipoprotein (a) enter the arterial wall and therefore enhance cholesterol accumulation directly.",Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org Genetic evidence The genetic basis of mild to moderate hypertriglyceridemia with  or without elevated LDL cholesterol in most individuals is polygenic.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
140  Hypertriglyceridemia and Cardiovascular Diseases http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org Treatment options for hypertriglyceridemia and remnant  cholesterol Fibrates and omega-3 fatty acids  Fibric acid is a synthetic ligand of the nuclear receptor PPAR α that  is highly expressed in skeletal muscle and the heart where it promotes  ß-oxidation of fatty acids to mediate hypolipidemic actions.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org Lipid-modification (NCT01252953) and A Study of Evacetrapib in  High-Risk Vascular Disease (ACCELERATE, NCT01687998).82)  Antisense inhibition of apolipoprotein C-III  ISIS 304801 is a second generation antisense inhibitor of  APOC3 synthesis.",Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
142  Hypertriglyceridemia and Cardiovascular Diseases http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org 4.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org atherosclerotic cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
144  Hypertriglyceridemia and Cardiovascular Diseases http://dx.doi.org/10.4070/kcj.2016.46.2.135 www.e-kcj.org 61.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/kcj-46-135.PMC4805556.pdf
"145 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Editorial http://dx.doi.org/10.4070/kcj.2016.46.2.145 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Unsolved Favorable Effect of Statin on Blood Viscosity  Sehyun Shin, PhD School of Mechanical Engineering, College of Engineering, Korea University, Seoul, Korea Refer to the page 147-153  In an interesting study, Jung et al.1) found an effective reduction  of whole blood viscosity in statin naïve acute coronary syndrome  (ACS) patients with early statin administration.",Non-OADS,/arxiv_data1/oa_pdf/07/d0/kcj-46-145.PMC4805557.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/d0/kcj-46-145.PMC4805557.pdf
146  Favorable Effect of Statin on Blood Viscosity http://dx.doi.org/10.4070/kcj.2016.46.2.145 www.e-kcj.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/07/d0/kcj-46-145.PMC4805557.pdf
"Beyond their lipid-lowering effects, statins also have a different  potential mechanism, a rheological effect.14) However, there have Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.147 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Rosuvastatin Reduces Blood Viscosity in Patients  with Acute Coronary Syndrome Lae-Young Jung, MD1, Sang-Rok Lee, MD1, Jin-Mu Jung, PhD2, Yi-Shik Kim, MD1, Sun-Hwa Lee, MD1, Kyoung-Suk Rhee, MD1,  Jei-Keon Chae, MD1, Dong-Hwan Lee, PhD2, Dal-Sik Kim, MD3, Won-Ho Kim, MD1, and Jae-Ki Ko, MD1 1Division of Cardiology, Chonbuk National University Hospital and Chonbuk National University Medical School, Jeonju, 2Division of Mechanical Design Engineering, Chonbuk National University, Jeonju, 3Department of Laboratory Medicine, Chonbuk National University Hospital and Chonbuk National University Medical School, Jeonju, Korea Background and Objectives: Wall shear stress contributes to atherosclerosis progression and plaque rupture.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
"This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
"148  Statin and Blood Viscosity in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org been limited reports on the effect of statins on blood viscosity.15-17)  Moreover, there are no studies of statin effects on patients with  ACS in terms of WBV.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org on a z score using Fisher’s z transformation.,OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
150  Statin and Blood Viscosity in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org ACS patients.,Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
"152  Statin and Blood Viscosity in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org change in WBV may be more variable in patients with ACS, so it  is very important to consider the hemorheological status of the patient and early blood sampling before administration of usual cardiovascular drugs (such as anticoagulants or antiplatelet agents) or fluids.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.147 www.e-kcj.org characteristics and cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/ed/b8/kcj-46-147.PMC4805558.pdf
"1) Therefore, Hcy level may be influenced  by factors such as nutrition, genetics, lifestyle, ethnicity, age, Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.154 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Prognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease: A Propensity Score Matched Analysis Sung Woo Kwon, MD1, 2, Jong-Youn Kim, MD3,  Young Ju Suh, PhD4, Dae Hyung Lee, MS5, Young Won Yoon, MD3,   Byoung Kwon Lee, MD3, Young-Hak Jung, MD3, Eui-Young Choi, MD3, Bum-Kee Hong, MD3, Se-Joong Rim, MD3,   and Hyuck Moon Kwon, MD3 1 Department of Cardiology, Inha University Hospital, Incheon,  2 Department of Medicine, Yonsei University Graduate School, Seoul,  3Department of Cardiology and Cardiovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul,  4 Clinical Research Institute, Inha University School of Medicine, Incheon,  5 Future Strategy, Inha University Hospital, Incheon, Korea Background and Objectives: We sought to determine whether an elevated homocysteine (Hcy) level is associated with a worse prognosis  in Korean patients with coronary artery disease (CAD) .",Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org and gender.1)2) Epidemiological studies have demonstrated that  progression of atherosclerosis plaques is correlated with elevated  circulating Hcy due to increased thrombogenicity, oxidative stress status and endothelial dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
156  Prognostic Value of Hyperhomocysteinemia  http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org and clinical outcome in both the entire cohort and the propensity  score-matched cohort.,Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
158  Prognostic Value of Hyperhomocysteinemia  http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org significantly worse outcomes than the normal Hcy group in the  matched cohort (p=0.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org cells, lipoprotein oxidation, vascular inflammation, smooth muscle  proliferation, platelet activation, and abnormalities in the clotting cascade.",Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
160  Prognostic Value of Hyperhomocysteinemia  http://dx.doi.org/10.4070/kcj.2016.46.2.154 www.e-kcj.org G; Novara Atherosclerosis Study Group (NAS).,Non-OADS,/arxiv_data1/oa_pdf/07/75/kcj-46-154.PMC4805559.pdf
"2) Since bleeding  complications is one of the major predictors of post procedure mortality and morbidity in patients having coronary disease, a TRC may be a safer method of approach compared to the transfemoral approach 3)4); however, several other rarer complications were  reported in inconsiderable amounts.5) Particularly, hand numbness Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.161 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Numbness after Transradial Cardiac Catheterization: the Results  from a Nerve Conduction Study of the Superficial Radial Nerve Ho-Jun Jang, MD1*, Ji-Young Kim, MD2*, Jae Deok Han, MD3, Hyun Jong Lee, MD1, Je Sang Kim, MD1, Jin Sik Park, MD1,  Rak Kyeong Choi, MD1, Young Jin Choi, MD1, Won-Heum Shim, MD1, Sung Woo Kwon, MD4, and Tae-Hoon Kim, MD1 1Division of Cardiology, Department of Internal Medicine, Sejong General Hospital, Bucheon,  2Department of Neurology, Inje University Seoul Paik Hospital,  Seoul,  3Department of Rehabilitation, Sejong General Hospital, Bucheon,  4Division of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Korea  Background and Objectives: Numbness on the hand occurs infrequently after a transradial cardiac catheterization (TRC).",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"162  Numbness after Transradial Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org after the TRC, often a disabling complication, occurs infrequently,  but this fact is not generally known.6) Superficial radial neuropathy,  or Cheiralgia paraesthetica, is a neuropathy of the hand caused by the compression or trauma of the superficial branch of the radial nerve.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org were marked at the onset of the first negative peak and the  amplitudes were determined from peak to peak.,OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
164  Numbness after Transradial Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org Mann-Whitney U test for the continuous variables.,Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org after the coronary artery bypass graft surgery, through to the  last OPD visit (2 out of 10 on the symptom scale; required no medication; symptom sustained 475 days after TRC; patient #9).",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"166  Numbness after Transradial Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org 7 French sheaths (odds ratio: 5.50, 95% confidence interval: 1.06- 28.58, p=0.042) was significantly associated with post-procedural numbness.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org artery occlusion, prolonged compression of the puncture site and  hematoma formation.14) Our study demonstrated that the number of  punctures was not a predictor of neuropathy.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
168  Numbness after Transradial Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.161 www.e-kcj.org 22.,Non-OADS,/arxiv_data1/oa_pdf/63/f6/kcj-46-161.PMC4805560.pdf
"4) Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.169 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain Jea-Geun Lee, MD, Joon Hyouk Choi, MD, Song-Yi Kim, MD, Ki-Seok Kim, MD, and Seung-Jae Joo, MD Division of Cardiology, Department of Internal Medicine, School of Medicine, Jeju National University, Jeju, Korea Background and Objective: A cardiologist’s evaluation of psychiatric symptoms in patients with chest pain is rare.",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"170  Psychiatric Characteristics of Patients with Chest Pain http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org In many previous studies, the effect and necessity of psychiatric  intervention or medications have been demonstrated in patients  with chest pain with or without CAD.9-14) However, the psychiatric  evaluation of patients with chest pain by a cardiologist is very rare in Korea.",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org variables or as frequencies for categorical variables.,OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
172  Psychiatric Characteristics of Patients with Chest Pain http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org Table 3-1.,Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org Table 3-2.,OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"174  Psychiatric Characteristics of Patients with Chest Pain http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org “easily mentally fatigued” (item 8, neurasthenia, 2 [1-3], 83%).",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org characteristics between the groups with and without CAD,  though some psychiatric items were different between the groups; (2) a correlation between the intensity of chest pain and somatization without chest pain in the non-CAD group; and (3) an inverse correlation between the intensity of chest pain and hypochondriasis in the CAD group.",OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"176  Psychiatric Characteristics of Patients with Chest Pain http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org and life stress are associated with cardiovascular risk factors.20)  For instance, hypertension is related to anxiety,21)22) and the  association of metabolic syndrome with depression has been well  documented.23) These relationships have been explained based on  sympathetic nervous system hyperresponsivity, hypercortisolism, and unhealthy lifestyle behaviors.",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org low (5%), because we recruited patients from the outpatient  department.",Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
178  Psychiatric Characteristics of Patients with Chest Pain http://dx.doi.org/10.4070/kcj.2016.46.2.169 www.e-kcj.org 1984;14:51-61.,Non-OADS,/arxiv_data1/oa_pdf/ff/bd/kcj-46-169.PMC4805561.pdf
"6-8) ICD shocks negatively impact the quality of life and  are associated with anxiety and depression, in addition to cardiac Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.179 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Tachyarrhythmia Cycle Length in Appropriate versus Inappropriate  Defibrillator Shocks in Brugada Syndrome, Early Repolarization  Syndrome, or Idiopathic Ventricular Fibrillation Woo Seok Lee, MD, Jun Kim, MD, Chang-Hee Kwon, MD, Jin Hee Choi, MD, Uk Jo, MD, Yoo Ri Kim, MD, Gi-Byoung Nam, MD, Kee-Joon Choi, MD, and You-Ho Kim, MD Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background and Objectives: Implantable cardioverter–defibrillators (ICDs) are indicated in patients with Brugada syndrome (BS), early  repolarization syndrome (ERS), or idiopathic ventricular fibrillation (IVF) who are at high risk for sudden cardiac death.",Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"180  Optimal Defibrillator  Programming for Reducing Inappropriate Shock http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org and cerebral ischemic injury.9-12) Although strategic programming  of ICDs intended to reduce inappropriate shocks is associated with  improved survival in patients with structural heart disease and left ventricular dysfunction, 13)14) there are few data on the optimal  programming required to reduce inappropriate shocks in patients with BS, ERS, or IVF.",Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org Results Patient characteristics A total of 90 patients (79 men; 11 women) with BS, ERS, or IVF (39,  22, and 29 patients, respectively) had undergone ICD implantation  at our center between April 1996 and April 2014.",Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
182  Optimal Defibrillator  Programming for Reducing Inappropriate Shock http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org implanted in 35 patients and dual-chamber ICDs in 6.,Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org noise oversensing (4 episodes), and T-wave oversensing (1 episode).",Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"184  Optimal Defibrillator  Programming for Reducing Inappropriate Shock http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org of the tachyarrhythmias that activated inappropriate shocks was  284.8±24.4 ms, which was significantly longer than the mean VFCL.",OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.179 www.e-kcj.org 9.,Non-OADS,/arxiv_data1/oa_pdf/50/01/kcj-46-179.PMC4805562.pdf
"The aim of the present study was to report our experience of  the indications, success rates, and complications of transvenous extraction of pacemaker and defibrillator leads via an inferior Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.186 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Transvenous Lead Extraction via the Inferior Approach   Using a Gooseneck Snare versus Simple Manual Traction Uk Jo, MD1, Jun Kim, MD1, You-Mi Hwang, MD1, Ji-Hyun Lee, MD1, Min-Su Kim, MD1, Hyung-Oh Choi, MD2,   Woo-Seok Lee, MD1, Chang-Hee Kwon, MD1, Gi-Young Ko, MD3, Hyun-Ki Yoon, MD3, Gi-Byoung Nam, MD1,   Kee-Joon Choi, MD1, and You-Ho Kim, MD1 1Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2Division of Cardiology, Department of Internal Medicine, Soonchunhyang University  Hospital, Soonchunhyang University College of Medicine, Bucheon, 3Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background and Objectives: The number of patients with cardiac implantable electronic devices needing lead extraction is increasing for  various reasons, including infections, vascular obstruction, and lead failure.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org approach using a gooseneck snare with or without an ablation  catheter as first-line therapy and compare extraction using a gooseneck snare with extraction using simple manual traction.,Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
"188  Transfemoral Lead Extraction http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org 9 were performed in a dedicated electrophysiology laboratory  under local anesthesia and conscious sedation, with on-site cardiac surgery back-up available to intervene in the event of an emergency, and 2 were performed in an operation room under general anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org (Figs.,OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
190  Transfemoral Lead Extraction http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org B (p=0.51).,Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
192  Transfemoral Lead Extraction http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org the residual coil restored blood flow.,Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
"194  Transfemoral Lead Extraction http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org 20 and 21, a free-floating pacing lead inside the tricuspid valve  and a defibrillator lead, which was fractured during traction via the inferior approach, could not be grasped using the snare (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org success rate was obtained with transfemoral lead extraction, and  there were no major complications, including cardiac tamponade, hemothorax, emergency operation, or mortality, directly related to the procedure.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
196  Transfemoral Lead Extraction http://dx.doi.org/10.4070/kcj.2016.46.2.186 www.e-kcj.org contemporary setting: the LExICon study: an observational  retrospective study of consecutive laser lead extractions.,Non-OADS,/arxiv_data1/oa_pdf/c3/78/kcj-46-186.PMC4805563.pdf
"Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.197 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Early Parasympathetic Reinnervation Is Not Related to Reconnection of Major Branches of the Vagus Nerve after Heart Transplantation So-Ryoung Lee, MD, Do-Yoon Kang, MD, Youngjin Cho, MD, Hyun-Jai Cho, MD, Hae-Young Lee, MD, Eue-Keun Choi, MD, and Seil Oh, MD Department of Internal Medicine, Division of Cardiology, Seoul National University Hospital, Seoul, Korea Background and Objectives: Bicaval heart transplantation (HTx) may promote parasympathetic reinnervation.",Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
"198  Early Parasympathetic Reinnervation after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org Although the study of parasympathetic reinnervation has been  difficult because of the lack of an accurate, definite method to  evaluate reinnervation, HRV has been widely used in previous studies for the noninvasive assessment of parasympathetic reinnervation.",Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org value immediately after the electrical stimulation.,OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
"200  Early Parasympathetic Reinnervation after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org into the early (<1 year), intermediate (1 to 2 years), or late (>2  years) group for analysis.",Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org is known about the clinical implication of parasympathetic  reinnervation in HTx recipients.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
202  Early Parasympathetic Reinnervation after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
"204  Early Parasympathetic Reinnervation after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org histological evidence of myocardial reinnervation in humans until  long after HTx (i.e., 10 years).23) The results of physiologic and  pharmacologic studies have also suggested that parasympathetic reinnervation might not occur until 8 years after HTx.",Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org We could observe the progressive nature of parasympathetic  reinnervation by examining the correlation between parasympathetic  activity and time after HTx.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.2.197.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
206  Early Parasympathetic Reinnervation after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.2.197 www.e-kcj.org transplanted human heart as evidenced from heart rate variability  studies.,Non-OADS,/arxiv_data1/oa_pdf/7c/40/kcj-46-197.PMC4805564.pdf
"In such Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.207 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Right Cardiac Catheterization Using the Antecubital Fossa Vein  in Korean Patients Sang Hyun Lee, MD, Kook Jin Chun, MD, Dae Sung Lee, MD, Soo Yong Lee, MD, Jongmin Hwang, MD,  Min Ku Chon, MD, Ki Won Hwang, MD, Jeong Su Kim, MD, Yong Huyn Park, MD, and June Hong Kim, MD Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea Background and Objectives: Right heart catheterization is traditionally performed using a femoral vein approach that involves admission,  bed rest, and risks of bleeding and hematoma.",Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
"208  Right Cardiac Catheterization Using the Antecubital Fossa Vein http://dx.doi.org/10.4070/kcj.2016.46.2.207 www.e-kcj.org cases, it is difficult to choose the access sites for the right cardiac  catheterization when considering the radial artery approach for the left cardiac catheterization.",Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.207 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
210  Right Cardiac Catheterization Using the Antecubital Fossa Vein http://dx.doi.org/10.4070/kcj.2016.46.2.207 www.e-kcj.org the puncture site with gauze and elastic plaster.,Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.207 www.e-kcj.org femoral vein group (0.0 min vs. 201.2±48.1 min, p<0.01).",Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
212  Right Cardiac Catheterization Using the Antecubital Fossa Vein http://dx.doi.org/10.4070/kcj.2016.46.2.207 www.e-kcj.org relatively small numbers of patients.,Non-OADS,/arxiv_data1/oa_pdf/80/ac/kcj-46-207.PMC4805565.pdf
"A significant decline in LV function Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.213 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Predicting Left Ventricular Dysfunction after Surgery in Patients  with Chronic Mitral Regurgitation: Assessment of Myocardial Deformation by 2-Dimensional Multilayer Speckle Tracking Echocardiography Eun Jeong Cho, MD1,3, Sung-Ji Park, MD1, Hye Rim Yun, RDCS1, Dong Seop Jeong, MD2, Sang-Chol Lee, MD1,   Seung Woo Park, MD1 and Pyo Won Park, MD2 1Division of Cardiology, Department of Internal Medicine, Cardiovascular Imaging Center, 2Department of Thorax Surgery, Heart Vascular Stroke Institute, Samsung  Medical Center, Sungkyunkwan University School of Medicine, Seoul,  3Division of Cardiology, Department of Internal Medicine, Cardiology Clinic, National Cancer Center,  Goyang, Korea Background and Objectives: The development of postoperative left ventricular (LV) dysfunction is a frequent complication in patients with  chronic severe mitral valve regurgitation (MR) and portends a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
"214  Preoperative Prediction of Left Ventricular Dysfunction in Mitral Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org is defined, in these recommendations, echocardiographically as  an LV ejection fraction (LVEF)<60% or an LV end-systolic diameter (LVESD)>40 mm.",Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org the average of three consecutive Doppler signals to perform these  measurements.,OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
216  Preoperative Prediction of Left Ventricular Dysfunction in Mitral Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org relative wall thickness (RWT) and E/e’ ratio were not significantly  different (Table 2).,OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org Discussion  The main finding of our study in patients with degenerative  severe MR and preserved LV systolic function, was that, (1) in the  postoperative echocardiography at 7 days follow-up, patients with LV remodeling had larger LVEDD, LVESD, and left atrial dimensions than patients within the non-remodeling group.",Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
218  Preoperative Prediction of Left Ventricular Dysfunction in Mitral Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org than patients within the non-remodeling group.,Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org (strain) parameters as assessed with different imaging techniques  have been proposed to predict LV dysfunction after mitral valve surgery.,Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
220  Preoperative Prediction of Left Ventricular Dysfunction in Mitral Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org LVEF were correlated with preoperative mid-layer GLS.,OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.213 www.e-kcj.org its determinants in the general population: contribution of age,  gender, and cardiac and extra-cardiac factors .",Non-OADS,/arxiv_data1/oa_pdf/d3/7b/kcj-46-213.PMC4805566.pdf
"A number of studies have been conducted to evaluate the effectiveness of combination therapy of a calcium channel blocker and an angiotensin receptor blocker versus monotherapy of either of Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.222 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Valsartan 160 mg/Amlodipine 5 mg Combination Therapy  versus Amlodipine 10 mg in Hypertensive Patients  with Inadequate Response to Amlodipine 5 mg Monotherapy Jidong Sung, MD1, Jin-Ok Jeong, MD2, Sung Uk Kwon, MD3, Kyung Heon Won, MD4, Byung Jin Kim, MD5,   Byung Ryul Cho, MD6, Myeong-Kon Kim, MD7, Sahng Lee, MD8, Hak Jin Kim, MD9, Seong-Hoon Lim, MD10,   Seung Woo Park, MD1 and Jeong Euy Park, MD1 1Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  2Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, 3Department  of Internal Medicine, Vision 21 Cardiac and Vascular Center, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, 4Department of Cardiology, Cardiovascular  Center, Seoul Medical Center, Seoul, 5Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  Seoul, 6Division of Interventional Cardiology, Department of Internal Medicine, Kangwon National University Hospital, Chooncheon, 7Department of Cardiovascular  Medicine, Kyung Hee University Medical Center, Seoul, 8Cardiology Division, Internal medicine, Eulji University Hospital, Daejeon, 9Department of Cardiology, Center for  Clinical Specialty, National Cancer Center, Goyang,  10Division of Cardiology, Department of Internal Medicine, Dankook University Hospital, Cheonan, Korea Background and Objectives: When monotherapy is inadequate for blood pressure control, the next step is either to continue monotherapy  in increased doses or to add another antihypertensive agent.",Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org 2 drugs when current monotherapy failed to control BP adequately.,Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
"224  Valsartan/Amlodipine Combination Therapy in Amlodipine Monotherapy Failure http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org additional measurements; otherwise, the nondominant arm was  used.",Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org considered to be related to the medication were 6.3 and 4.5%  in the A and AV groups, respectively, and common symptoms included dizziness and leg edema.",Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
"226  Valsartan/Amlodipine Combination Therapy in Amlodipine Monotherapy Failure http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org 5/160 mg was better than amlodipine 10 mg when amlodipine  5 mg had been inadequate in BP control, with blood pressure outcome evaluated by 24-hour ambulatory BP monitoring.",Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org statins, can influence BP control.",OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
228  Valsartan/Amlodipine Combination Therapy in Amlodipine Monotherapy Failure http://dx.doi.org/10.4070/kcj.2016.46.2.222 www.e-kcj.org valsartan hydrochlorothiazide diuretic for initial control and titration  to achieve optimal therapeutic effect (Val-DICTATE) trial.,Non-OADS,/arxiv_data1/oa_pdf/88/29/kcj-46-222.PMC4805567.pdf
"8) However, Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.229 Print ISSN 1738-5520 • On-line ISSN 1738-5555 White Blood Cell Count to Mean Platelet Volume Ratio Is a Prognostic Factor in Patients with Non-ST Elevation Acute Coronary Syndrome with or without Metabolic Syndrome Mohammad Reza Dehghani, MD1, Yousef Rezaei, MD2, Sanam Fakour, MD3, and Nasim Arjmand, MD3 1Department of Cardiology, 2Seyyed-al-Shohada Heart Center,3School of Medicine, Urmia University of Medical Sciences, Urmia, Iran Background and Objectives: Leukocyte and platelet have been found to be associated with metabolic syndrome (MetS).",Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
"230  Metabolic Syndrome and White Blood Cell/Mean Platelet Volume Ratio http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org the main mechanism involved in how MetS increases these risks  remains to be elucidated.8) In terms of the pathophysiology of MetS,  inflammation has been reported to be a main factor that leads to the development of MetS and cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org Table 1.,OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
232  Metabolic Syndrome and White Blood Cell/Mean Platelet Volume Ratio http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org drug histories, conventional cardiovascular risk factors, and  biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
234  Metabolic Syndrome and White Blood Cell/Mean Platelet Volume Ratio http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org Table 3.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org cohort study has revealed that inflammation defined by elevated  C-reactive protein is correlated with MetS and insulin resistance and that both inflammation and MetS can independently predict new cardiovascular events.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
236  Metabolic Syndrome and White Blood Cell/Mean Platelet Volume Ratio http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org pathways has been shown previously.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org Acknowledgments We acknowledge the contribution of Dr. Leila Taghipour-Sani  who cooperated in gathering the primary data for cohort patients.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
238  Metabolic Syndrome and White Blood Cell/Mean Platelet Volume Ratio http://dx.doi.org/10.4070/kcj.2016.46.2.229 www.e-kcj.org 26.,Non-OADS,/arxiv_data1/oa_pdf/19/60/kcj-46-229.PMC4805568.pdf
"3)  Many trials report that cardiovascular risk is higher in patients with  CD compared to the normal population.4)5)6)  The main mechanisms  that are inculpated for cardiovascular risk include endothelial dysfunction, hyperhomocysteinemia and an increased systemic Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.239 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Assessment of Aortic Elasticity in Patients with Celiac Disease Nermin Bayar, MD1, Ayhan Hilmi Çekin, MD2, Şakir Arslan, MD1, Göksel Ça ğırcı, MD1, Selçuk Küçükseymen, MD1,   Serkan Çay, MD3, Ferda Akbay Harmandar, MD2, and Bayram Ye şil, MD4 1Cardiology Department, 2Gastroenterology Department, Antalya Education and Research Hospital, Antalya,  3Cardiology Department, Yüksek İhtisas Education and Research Hospital, Ankara,  4Internal Medicine Department, Antalya Education and Research Hospital, Antalya, Turkey Background and Objectives: Celiac disease (CD) is a chronic autoimmune disorder induced by dietary gluten intake by individuals who are  genetically sensitive.",Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
"240  Celiac Disease and Aortic Elasticity http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org inflammatory response.7-9) One trial reported that traditional  cardiovascular risk factors were less common among patients with  CD who also developed coronary artery disease.10) Therefore, it is  important to define the new risk factors in order to identify the cardiovascular risk in patients with CD.",Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org 63 healthy volunteers (71% female, mean age 42±5) as control group  were enrolled in the study.",Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
242  Celiac Disease and Aortic Elasticity http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org lymphocyte ratios than those who did not follow the GFD.,Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org with respect to the traditional risk factors.,Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
244  Celiac Disease and Aortic Elasticity http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org properties could not be demonstrated in our study although the  inflammation was lowered with GFD.,Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.239 www.e-kcj.org 25.,Non-OADS,/arxiv_data1/oa_pdf/2e/94/kcj-46-239.PMC4805569.pdf
"2-10) However,  there is no data on overall complications of cardiac catheterization Original Article http://dx.doi.org/10.4070/kcj.2016.46.2.246 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Complications of Cardiac Catheterization in Structural Heart Disease Ko Eun Lee, MD1, Yeon Jeong Seo, MD1, Gi Beom Kim, MD1, Hyo Soon An, MD2, Young Hwan Song, MD3,   Bo Sang Kwon, MD1, Eun Jung Bae, MD1, and Chung Il Noh, MD1 1Department of Pediatrics, Seoul National University Children’s Hospital, Seoul, 2Department of Pediatrics, Seoul National University Boramae Hospital, Seoul,  3Department of Pediatrics, Bundang Seoul National University Hospital, Seongnam, Korea Background and Objectives: Cardiac catheterization is used to diagnose structural heart disease (SHD) and perform transcatheter  treatment.",Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org for SHD in Korea and the associated risk factors.,OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
248  Complications of Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org identified during the 10-year study period.,Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org Complications A total of 314 patients had a total of 335 complications that  were grouped into 16 categories and 3 severity scales (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
250  Complications of Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org frequent in infants (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org SHD (p=0.012).,OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
"252  Complications of Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org ICU admission, and concomitant EPS procedure.",Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org oxygenation insertion.,OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
254  Complications of Cardiac Catheterization http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org direct current cardioversion.,Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.246 www.e-kcj.org enquiry into cardiac catheter complications.,Non-OADS,/arxiv_data1/oa_pdf/a9/b7/kcj-46-246.PMC4805570.pdf
"Emergency coronary angiogram was performed via the right  femoral artery, which was successfully cannulated with a single Case Report http://dx.doi.org/10.4070/kcj.2016.46.2.256 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Received: February 19, 2015 Revision Received:  May 11, 2015 Accepted:  June 2, 2015 Correspondence: Yong-Seok Kim, MD, Department of Internal Medicine,  Dongguk University Ilsan Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, KoreaTel: 82-31 -961-7147, Fax: 82-31-961-7786 E-mail:  harrison72@dumc.or.kr • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/61/8a/kcj-46-256.PMC4805571.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/8a/kcj-46-256.PMC4805571.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.256 www.e-kcj.org puncture .,OADS,/arxiv_data1/oa_pdf/61/8a/kcj-46-256.PMC4805571.pdf
"258  Internal Pudendal Artery Bleeding associated with Coronary Intervention http://dx.doi.org/10.4070/kcj.2016.46.2.256 www.e-kcj.org arterial branches unrelated to the access site has been described in  several case reports with the use of abciximab.4)5) Our report is another interesting case of spontaneous bleeding from  an unusual arterial branch, which may draw attention to a disastrous  complication in association with the administration of abciximab  concurrent with conventional anticoagulation and dual antiplatelet therapies.",Non-OADS,/arxiv_data1/oa_pdf/61/8a/kcj-46-256.PMC4805571.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.256 www.e-kcj.org by an experienced operator, the risk of puncture site-related bleeding  may be reduced with a radial approach.7)8) Fourth, some investigators  suggested that immediate post-PCI reversal of anticoagulation  by protamine was associated with a significant reduction in major  bleeding complications among patients undergoing primary stenting with adjunctive abciximab therapy.",Non-OADS,/arxiv_data1/oa_pdf/61/8a/kcj-46-256.PMC4805571.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2016.46.2.260 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Cardiac Metastasis of Leiomyosarcoma Complicated  with Complete Atrio-Ventricular Block and Ventricular Tachycardia  Yae Min Park, MD1, Jae Ouk Shin, MD1, Minsu Kim, MD1, Woong Chol Kang, MD1, Jeonggeun Moon, MD1,  Wook-Jin Chung, MD1 and Yon Mi Sung, MD2 1Cardiology Division, Department of Internal Medicine, 2Department of Radiology, Gachon University Gil Medical Center, Incheon, Korea We described a case of a 54-year-old male who presented with dizziness and dyspnea due to cardiac metastasis of leiomyosarcoma.",Non-OADS,/arxiv_data1/oa_pdf/3e/55/kcj-46-260.PMC4805572.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/55/kcj-46-260.PMC4805572.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.260 www.e-kcj.org Administered amiodarone and ß-blocker suppressed further events  of VT and the patient was discharged uneventfully.,Non-OADS,/arxiv_data1/oa_pdf/3e/55/kcj-46-260.PMC4805572.pdf
262  Cardiac Metastasis of Leiomyosarcoma http://dx.doi.org/10.4070/kcj.2016.46.2.260 www.e-kcj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/55/kcj-46-260.PMC4805572.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.2.260 www.e-kcj.org There was no histopathological diagnosis of cardiac lesion,  however, we diagnosed the mass as a malignant metastasis  because of the simultaneous similar pattern of widespread metastatic lung lesions with prior histopathologic confirmation of metastatic malignant leiomyosarcoma.",Non-OADS,/arxiv_data1/oa_pdf/3e/55/kcj-46-260.PMC4805572.pdf
"His body gauge was 66 cm (75-90 percentile) and  Case Report http://dx.doi.org/10.4070/kcj.2016.46.2.264 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Complicated Azygos Vein Aneurysm in an Infant Presenting  with Acute Pulmonary Thromboembolism Jaeyoung Choi, MD1, Jinyoung Song, MD1, June Huh, MD1, I-Seok Kang, MD1, Ji-Hyuk Yang, MD2, and Tae-Gook Jun, MD2 1Department of Pediatrics, Heart Vascular Stroke Institute, 2Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea  Azygos vein aneurysm is a rare cause of mediastinal mass.",Non-OADS,/arxiv_data1/oa_pdf/20/b4/kcj-46-264.PMC4805573.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/b4/kcj-46-264.PMC4805573.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.264 www.e-kcj.org 9.6 kg (>97 percentile).,OADS,/arxiv_data1/oa_pdf/20/b4/kcj-46-264.PMC4805573.pdf
"266  Azygos Vein Aneurysm with Pulmonary Thromboembolism http://dx.doi.org/10.4070/kcj.2016.46.2.264 www.e-kcj.org Discussion  To our knowledge, this is the first pediatric case report of a  complicated azygos vein aneurysm requiring surgical intervention.",Non-OADS,/arxiv_data1/oa_pdf/20/b4/kcj-46-264.PMC4805573.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.264 www.e-kcj.org References  1.,Non-OADS,/arxiv_data1/oa_pdf/20/b4/kcj-46-264.PMC4805573.pdf
"Int J  Cardiol 2015;195:40-4.Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2016.46.2.268 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Characteristic Doppler Pattern of the Left Ventricular Outflow Tract in a Patient with Orthostatic Hypotension Sanghoon Shin, MD, Ja Young Lee, RN, Jong-Kwan Park, MD, Seungjin Oh, MD, Dong Woon Jeon, MD,  Joo Young Yang, MD, and Se-Jung Yoon, MD Division of Cardiology, National Health Insurance Service Ilsan Hospital, Goyang, Korea Received: July 24, 2015  / Accepted: August 27, 2015 Correspondence: Se-Jung Yoon, MD, Cardiology Division, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea Tel: 82- 31-900-0630, Fax: 82- 31-900-0933, E-mail: drpuooh@hanmail.net • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/f1/71/kcj-46-268.PMC4805574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/71/kcj-46-268.PMC4805574.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.268 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/f1/71/kcj-46-268.PMC4805574.pdf
"The relationship between red cell Letter to the Editor http://dx.doi.org/10.4070/kcj.2016.46.2.270 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Red Cell Distribution Width and Coronary Artery Calcification Sevket Balta, MD, Ali Osman Yildirim, MD, and Cengiz Ozturk, MD Department of Cardiology, Gulhane Medical Academy, Ankara, Turkey Received:  October 27, 2015 Accepted:  November 24, 2015 Correspondence:  Sevket Balta, MD, Department of Cardiology, Gulhane  School of Medicine, Tevfik Saglam St., 06018 Etlik-Ankara, TurkeyTel: 90-312-3044281, Fax: 90-312-3044250E-mail: drsevketb@gmail.com • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/kcj-46-270.PMC4805575.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/kcj-46-270.PMC4805575.pdf
http://dx.doi.org/10.4070/kcj.2016.46.2.270 www.e-kcj.org distribution width and homozygous M694V mutation in familial  Mediterranean fever patients.,Non-OADS,/arxiv_data1/oa_pdf/9c/c6/kcj-46-270.PMC4805575.pdf
"272  http://dx.doi.org/10.4070/kcj.2016.46.2.270 www.e-kcj.orgRed Cell Distribution Width and Coronary Calcification Score First of all, my gratitude for your interest in our work published in  the Korean Circulation Journal,  2015 September .",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/kcj-46-270.PMC4805575.pdf
"Copyright © 2016 The Korean Society of Cardiology273 Korean Circulation Journal Before correction  Jae-Hyeong Park, MD1,2*, Kenya Kusunose, MD1,3*, Deborah H. Kwon, MD1, Margaret M. Park, BS1,4, Serpil C. Erzurum, MD4,5,  James D. Thomas, MD1, Richard A. Grimm, MD1, Brian P. Griffin, MD1, Thomas H. Marwick, MD1,6, and Zoran B. Popovi ć, MD1 1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA,  2Cardiology Division of Internal Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea,  3Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan, 4Department of Pathobiology, Lerner Research Institute, 5Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA, 6Menzies Research Institute, Tasmania, Australia   After correctionJae-Hyeong Park, MD 1,2*, Kenya Kusunose, MD1,3*, Deborah H. Kwon, MD1, Margaret M. Park, BS1,4, James D. Thomas, MD1,  Richard A. Grimm, MD1, Brian P. Griffin, MD1, Thomas H. Marwick, MD1,5, and Zoran B. Popovi ć, MD1 1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA,  2Cardiology Division of Internal Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea,  3Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan, 4Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA, 5Menzies Research Institute, Tasmania, AustraliaErratum http://dx.doi.org/10.4070/kcj.2015.46.2.273 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Korean Circ J 2015;45:398-407http://dx.doi.org/10.4070/kcj.2015.45.5.398 The authors have decided to remove one of the authors, Serpil C. Erzurum, MD, who was cited as the 5th author on  the manuscript published in Volume 45(5), page 398-407.",Non-OADS,/arxiv_data1/oa_pdf/7a/c6/kcj-46-273.PMC4805576.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/65/33/535_2015_Article_1107.PMC4805704.pdf
Available at: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/2c/d1/520_2015_Article_3036.PMC4805705.pdf
http://www.hhs.gov/ohrp/humansubjects/ guidance/45cfr46.html .,Non-OADS,/arxiv_data1/oa_pdf/2c/d1/520_2015_Article_3036.PMC4805705.pdf
http://www.cadth.c a/media/pdf/186_ EconomicGuidelines_e.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/a1/6f/520_2016_Article_3116.PMC4805708.pdf
"National Institute for Health and Clinical Excellence (NICE), London, http://www.nicedsu.org.uk/Evidence-Synthesis- TSDseries%282391675%29.htm 7.",Non-OADS,/arxiv_data1/oa_pdf/a1/6f/520_2016_Article_3116.PMC4805708.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medi- um, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate ifchanges were made.Support Care Cancer (2016) 24:2217 –2224 2223",Non-OADS,/arxiv_data1/oa_pdf/1d/b2/520_2015_Article_3024.PMC4805713.pdf
"Accessedon June 30, 2015 at http://www.assessmentcenter.net / 24.",Non-OADS,/arxiv_data1/oa_pdf/1d/b2/520_2015_Article_3024.PMC4805713.pdf
Available from: http://groeiweb.pgdata.nl/Groeiweboud/calculator.asp 32.,Non-OADS,/arxiv_data1/oa_pdf/ab/8f/520_2015_Article_2993.PMC4805718.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom- mercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, pro-vide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4d/be/520_2015_Article_3004.PMC4805720.pdf
"Carefully designed prospective  or large population-based studies, with strict definitions and  outcomes are needed to limit biases and to provide solid  evidence regarding the optimal management of older patients  with pancreatic cancer.Departments of Surgery aAthens Naval and Veterans Hospital Christos  Agalianos); bKonstantopouleion General Hospital of Athens (Christos  Dervenis), Greece Conflict of Interest: None Correspondence to: Christos Agalianos, Department of General  Surgery, Athens Naval & Veterans Hospital, 70 Dinokratous Str, 11521  Athens, Greece, e-mail: xagali@gmail.com Received 24 December 2015; accepted 28 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0002EDITORIAL",Non-OADS,/arxiv_data1/oa_pdf/27/25/AnnGastroenterol-29-101.PMC4805729.pdf
"Keywords Guidelines, rectal cancer, surgical treatment, consensus, Delphi Ann Gastroenterol 2016; 29 (2): 103-126 Conflict of Interest: The process of developing the present consensus on  rectal cancer management was financially supported by Sanofi Hellas with  a grant offered to the Hellenic Society of Medical Oncologists (HeSMO) Correspondence to: Nikolaos Gouvas, Department of General Surgery,  Metropolitan Hospital of Piraeus, Greece,   e-mail: nikos.gouvas@gmail.com Received 29 June 2015; accepted 1 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0003 Introduction Introduction of total mesorectal excision (TME) [1,2],  accurate preoperative image staging [3] and preoperative  treatment when indicated, by means of radiation therapy (RT)  or/and chemotherapy (ChT) [4], has resulted in considerable  improvement in oncological outcomes of patients with rectal  cancer during the last three decades [5].",Non-OADS,/arxiv_data1/oa_pdf/d5/5d/AnnGastroenterol-29-103.PMC4805730.pdf
They are  available at https://www.rcpath.org/asset/E94CE4A2%2DD72 2%2D44A7%2D84B9D68294134CFC/.,OADS,/arxiv_data1/oa_pdf/d5/5d/AnnGastroenterol-29-103.PMC4805730.pdf
": +32 16 340238, Fax: +32 16 344419,   e-mail: hans.prenen@uzleuven.be Received 13 November 2015; accepted 28 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0004Patients with inflammatory bowel disease have an additional risk of developing cancer compared  with the general population.",Non-OADS,/arxiv_data1/oa_pdf/25/58/AnnGastroenterol-29-127.PMC4805731.pdf
": +1 215 955 1533,  e-mail: Andrew.ofosu@jefferson.edu Received 4 November 2015; accepted 29 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0006Clostridium difficile  (C. difficile ) infection (CDI) is the most common cause of  healthcare-associated  infections in US hospitals.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/AnnGastroenterol-29-147.PMC4805733.pdf
Available at: http://www.cdc.gov/ drugresistance/pdf/ar-threats-2013-508.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/AnnGastroenterol-29-147.PMC4805733.pdf
Available  at: http://www.shea-online.org/View/ArticleId/109/Rationale-for- Hand-Hygiene-Recommendations-after-Caring-for-a-Patient- with-Clostridium-difficile-Inf.aspx.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/AnnGastroenterol-29-147.PMC4805733.pdf
http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/ Vaccines/UCM361393.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/AnnGastroenterol-29-147.PMC4805733.pdf
Fecal transplant pills: Large-scale production begins � Nonprofit  stool bank launched by MIT researchers completes first  dose-finding study � http://globenewswire.com/news-relea se/2015/10/28/780862/10154319/en/Fecal-transplant-pills-Large- scale-production-begins.html.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/AnnGastroenterol-29-147.PMC4805733.pdf
": +30 26510 07611,   Fax: +30 26510 07883, e-mail: dchristo@uoi.gr Received 14 January 2015; accepted 26 January 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0007Abstract",Non-OADS,/arxiv_data1/oa_pdf/95/f0/AnnGastroenterol-29-155.PMC4805734.pdf
": +1409 656 6475, e-mail: rashmee84@gmail.com Received 11 October 2015; accepted 30 November 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0001",Non-OADS,/arxiv_data1/oa_pdf/bd/c0/AnnGastroenterol-29-162.PMC4805735.pdf
": +1 409 656 6475, e-mail: rashmee84@gmail.com Received 16 November 2015; accepted 14 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0008REVIEW ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/ea/2e/AnnGastroenterol-29-168.PMC4805736.pdf
": +43 50 8648 3944, Fax: +43 50 8648 67 3944,  e-mail: holger.gothe@umit.at Received 07 December 2015; accepted 02 February 2016 DOI: http://dx.doi.org/http://dx.doi.org/10.20524/aog.2016.0009Abstract",Non-OADS,/arxiv_data1/oa_pdf/93/64/AnnGastroenterol-29-174.PMC4805737.pdf
": +30 2810 392253, Fax: +30 2810 542085,  e-mail: ikoutroub@med.uoc.gr Received 8 January 2015; accepted 15 February 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0010Abstract",Non-OADS,/arxiv_data1/oa_pdf/9e/fb/AnnGastroenterol-29-180.PMC4805738.pdf
": +30 210 5832087,   Fax: +30 210 5326454, e-mail: ktriant@med.uoa.gr Received 21 October 2015; accepted 12 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0011",Non-OADS,/arxiv_data1/oa_pdf/ab/a0/AnnGastroenterol-29-188.PMC4805739.pdf
"[cited  2015  June 22]; Available from: http://www.google.gr/search?clie nt=safari&rls=en&q=aga+institute+patient+satisfaction&ie=U TF-8&oe=UTF-8&gfe_rd=cr&ei=AmqIVdudB4jCVMyBgZAF.Q1  This is a Google Search URL, and not an AGA Document.",OADS,/arxiv_data1/oa_pdf/ab/a0/AnnGastroenterol-29-188.PMC4805739.pdf
"Papatheodoridis) Athens, Greece Conflict of Interest: None Correspondence to: Theoni Kanellopoulou, 32 Dimarchiou str., 12242  Aegaleo, Greece, Tel/Fax: +30 211 4018120,   e-mail: theokanel@gmail.com Received 15 October 2015; accepted 22 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0013",Non-OADS,/arxiv_data1/oa_pdf/7e/97/AnnGastroenterol-29-201.PMC4805741.pdf
": +30 2310 950680, Fax: +30 2310 992940,  e-mail: em_sinakos@yahoo.com Received 31 July 2015; accepted 15 February 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0014Abstract",Non-OADS,/arxiv_data1/oa_pdf/0f/82/AnnGastroenterol-29-208.PMC4805742.pdf
": +91 172 2725056,  Fax: + 91 172 2744401, e-mail: deepakkbhasin@gmail.com or  dkbhasind@hotmail.com Received 2 November 2015; accepted 30 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0015Abstract",Non-OADS,/arxiv_data1/oa_pdf/d7/fb/AnnGastroenterol-29-214.PMC4805743.pdf
"The aim of the present study was to investigate the outcome  of pancreatic resection in the elderly at a tertiary care center  for pancreatic diseases, with special focus on postoperative  morbidity and mortality.Department of Surgery, Clinical Sciences Lund, Lund University, and  Skåne University Hospital, Lund, Sweden Conflict of Interest: None Correspondence to: Roland Andersson, MD, PhD, Department of  Surgery, Clinical Sciences Lund Lund University and Skåne University  Hospital, Lund, SE-221 85 Lund, Sweden, Tel: + 46 46 17 23 59,   e-mail: roland.andersson@med.lu.se Received 15 October; accepted 14 November 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0016Abstract",Non-OADS,/arxiv_data1/oa_pdf/62/ed/AnnGastroenterol-29-221.PMC4805744.pdf
": +1 216 207 1228, e-mail: awaghray@metrohealth.org Received 14 September 2015; accepted 16 September 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0017IMAGE OF THE MONTH Figure 1 Gastric mucosa after percutaneous endoscopic gastrostomy  tube placement Figure  2  Severe gastritis 1  week after percutaneous endoscopic  gastrostomy tube placement A 53-year-old male with a past medical history significant  for stage IV metastatic esophageal adenocarcinoma underwent  palliative esophageal stenting for malignancy-related  dysphagia.",Non-OADS,/arxiv_data1/oa_pdf/bf/4b/AnnGastroenterol-29-226.PMC4805745.pdf
": +81 22 222 6181,   Fax: +81 22 267 0856, e-mail: rinhashimoto@gmail.com Received 5 November 2015; accepted 9 November 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0018Spontaneous resolution of intramural gastric abscess without  treatment Rintaro Hashimoto, Akimichi Chonan Sendai Kousei Hospital, Japan Figure 1  Endoscopic view of gastric wall abscess.",Non-OADS,/arxiv_data1/oa_pdf/8e/91/AnnGastroenterol-29-227.PMC4805746.pdf
": +1 516 582 8772, Fax: +1 718 250 8120,   e-mail: kinooo2002@gmail.com Received 14 November 2015; accepted 23 November 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0019IMAGE OF THE MONTH Figure 1 (A, B) Endoscopic images showing contained perforation at  the recto-sigmoid junction (C) Endoscopic closure of the defect at the  recto-sigmoid junction using standard over-the-scope clip technique BA C",Non-OADS,/arxiv_data1/oa_pdf/b6/d9/AnnGastroenterol-29-228.PMC4805747.pdf
": +1 718 250 6976, Fax: +1 718  250 6825, e-mail: melaona@yahoo.com Received 21 January 2016; accepted 26 January 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0020IMAGE OF THE MONTH Figure  2 (A) Through-the-scope (TTS) balloon dilatation of  diaphragm-like stricture; and (B) post-TTS balloon dilatation of  diaphragm-like stricture B AFigure 1 (A) Colonoscopy revealing  nonsteroidal anti-inflammatory  drug-induced diaphragm-like colonic stricture; and (B) biopsy  showing lamina propria fibrosis with eosinophilic infiltration B A",Non-OADS,/arxiv_data1/oa_pdf/e5/7e/AnnGastroenterol-29-229.PMC4805748.pdf
": +1 423 741 9179,   e-mail: Chaudharidhara@yahoo.com Received 5 November 2015; accepted 9 December 2015 DOI: http://dx.doi.org/10.20524/aog.2016.0022CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/e5/af/AnnGastroenterol-29-233.PMC4805750.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/ label/2014/206545lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e5/af/AnnGastroenterol-29-233.PMC4805750.pdf
": +30 2310 950680, Fax: +30 2310 992940,  e-mail: em_sinakos@yahoo.com Received 24 December 2015; accepted 6 January 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0023Title:  Prednisolone or pentoxifylline for alcoholic hepatitis Authors:  Thursz MR, Richardson P , Allison M, Austin A, Bowers M, Day CP , Downs N, Gleeson D, MacGilchrist A,  Grant A, Hood S, Masson S, McCune A, Mellor J, O’Grady J, Patch D, Ratcliffe I, Roderick P , Stanton L, Vergis N,  Wright M, Ryder S, Forrest EH; STOPAH Trial Journal:  N Engl J Med  2015;372:1619-1628",Non-OADS,/arxiv_data1/oa_pdf/63/7a/AnnGastroenterol-29-236.PMC4805751.pdf
"Investigators from the  University of Pittsburgh presented a retrospective study that  examined the  role of adjuvant radiotherapy based on margin  clearance, based on the data that increased margin clearance is Departments of aRadiation Oncology, University Hospitals Seidman  Cancer Center, Case Comprehensive Cancer Center, Case Western  Reserve University, Cleveland, OH (Suzanne Russo); bMedicine and  Cancer Center, Tufts Medical Center, Boston, MA (Muhammad Wasif  Saif), USA Conflict of Interest: None Correspondence to: Muhammad Wasif Saif, Department of Medicine  and Cancer Center, Tufts Medical Center, 800 Washington Street Box  245, Boston, MA 02111, USA, e-mail: wasiftufts@yahoo.com Received 05 February 2016; accepted 06 February 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0024",Non-OADS,/arxiv_data1/oa_pdf/ec/03/AnnGastroenterol-29-238.PMC4805752.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/0d/main.PMC4805774.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.11.002 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/0d/main.PMC4805774.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/ea/main.PMC4805775.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2016.02.002 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/ea/main.PMC4805775.pdf
(2014) was used (available at http://www.math.uzh.ch/as/index.php?id ¼254&L¼1).,Non-OADS,/arxiv_data1/oa_pdf/27/ea/main.PMC4805775.pdf
Available at: http://www.sidra.ibge.gov.br/ bda/pecua/%20default.asp?,Non-OADS,/arxiv_data1/oa_pdf/27/ea/main.PMC4805775.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/d3/main.PMC4805777.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2016.02.003 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/d3/main.PMC4805777.pdf
"Although the optimal treatment regimen and dose have not yet been determined, our data suggest that peptoids (modi ﬁed peptides) derived from the L4 region of LACK, which will be highly speci ﬁc and effective, will ful ﬁll the target product pro ﬁle published by DNDi ( http://www.dndi.org/diseases-projects/ diseases/chagas/target-product-pro ﬁle.html and http://www.dndi.",Non-OADS,/arxiv_data1/oa_pdf/e8/d3/main.PMC4805777.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/81/main.PMC4805778.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.12.002 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/81/main.PMC4805778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/b7/main.PMC4805780.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2016.01.002 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/b7/main.PMC4805780.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/87/main.PMC4805781.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2016.02.004 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/87/main.PMC4805781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/c2/main.PMC4805782.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2016.01.003 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/c2/main.PMC4805782.pdf
Editor: H. Jane Dyson./C2112016 The Authors 0006-3495/16/01/0095/8 http://dx.doi.org/10.1016/j.bpj.2015.11.016 Biophysical Journal Volume 110 January 2016 95–102 95,Non-OADS,/arxiv_data1/oa_pdf/0f/da/main.PMC4805863.pdf
Editor: Brian Salzberg./C2112016 The Authors 0006-3495/16/01/0007/7 http://dx.doi.org/10.1016/j.bpj.2015.11.025 Biophysical Journal Volume 110 January 2016 7–13 7,Non-OADS,/arxiv_data1/oa_pdf/41/f8/main.PMC4805867.pdf
"Astandard in pharmacology is the DrugBank database 3,4 accessible at http://www.drugbank.ca (version 4.3).",OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
Query-ing this database provided the molecular drug targetscoded as UniProt IDs (http://www.uniprot.org).,OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
These wereconverted to National Center for Biotechnology Information numbers of the coding genes using the DAVID database 5 (http://david.abcc.ncifcrf.gov/conversion.jsp).,OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"This pro- vided a 1,501 31,384 “drug vs. gene” association matrix as the basis of subsequent computational analyses.Associating genes with biological processes The global knowledge about the roles of genes in an orga- nism is represented in publicly accessible knowledge bases, of which the gold-standard in functional genomics isthe GO knowledgebase (http://www.geneontology.org/6).Genes are annotated to a controlled vocabulary of GO terms (categories) providing a canonical description of their known biological functions.",OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"The process was performed using the Data-bionic emergent self-organizing map Tools, 14publicly available at http://www.uni-marburg.de/fb12/datenbionik/software.",OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"To assess this approach, a suitable disease-relevant gene set was obtained from the MalaCards database 16of human maladies (http://www.malacards.org/, MCID:CHR090) comprised of 553 genes considered to be involved in chronic lymphatic leukemia (CLL).",Non-OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"It will requirefuture inclusion of additional databases, such as ChEMBL(https://www.ebi.ac.uk/chembl/), and associated refinements of the presently proposed methodology toward AI.",Non-OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"26,27They use, for example, software packages, such as the systems biology workbench (http://jdesigner.sourceforge.net/Site/Welcome.html), the Metabolic Pathway Designer andAnalyzer (http://sourceforge.net/projects/metabolic1491/), or the Figure 4 U-Matrix (top view) on a pseudo three-dimensional map of the grouping of analgesic drugs in the high-dimensionalspace.",Non-OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
"& Moerchen, F. Databionic ESOM tools 2005. http://databionic-esom.sour- ceforge.net/devel.html (2005).",OADS,/arxiv_data1/oa_pdf/fc/83/PSP4-5-192.PMC4805871.pdf
Editor: David Piston./C2112016 The Authors 0006-3495/16/01/0218/16 http://dx.doi.org/10.1016/j.bpj.2015.10.045 218 Biophysical Journal Volume 110 January 2016 218–233,Non-OADS,/arxiv_data1/oa_pdf/f7/19/main.PMC4805874.pdf
A complete listing of ADNI investigators can be found at:http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf See Rabinovici (doi:10.1093/brain/aww025) for a scientiﬁc commentary on this article.,Non-OADS,/arxiv_data1/oa_pdf/2d/41/aww015.PMC4806222.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/41/aww015.PMC4806222.pdf
Automated volume measures were performed with FreeSurfer version 5.1 (http://surfer.nmr.mgh.harvard.edu/fswiki).,OADS,/arxiv_data1/oa_pdf/2d/41/aww015.PMC4806222.pdf
"http://ida.loni.usc.edu Helen Wills Neuroscience Institute, UC Berkeley and Lawrence BerkeleyNational Laboratory California; 2015.",Non-OADS,/arxiv_data1/oa_pdf/2d/41/aww015.PMC4806222.pdf
"2, 113–117http://dx.doi.org/10.1080/10495398.2015.1116446 New Rapid Method of DNA Isolation from Milk Somatic Cells Joanna Pokorska, Dominika Kułaj, Magdalena Dusza, Justyna Żychlińska-Buczek and Joanna Makulska Department of Cattle Breeding, University of Agriculture in Krakow, Institute of Animal Science, Krakow, Poland ABSTRACT Isolation of genomic DNA is one of the basic steps in many different molecular analyses.",Non-OADS,/arxiv_data1/oa_pdf/4e/75/labt-27-113.PMC4806335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/75/labt-27-113.PMC4806335.pdf
"5, 543 /C0549, http://dx.doi.org/10.1080/13607863.2015.1023767",Non-OADS,/arxiv_data1/oa_pdf/49/bf/camh-20-543.PMC4806344.pdf
Participants gave full-informed written consent toparticipate in the study and ethical approval was obtainedfrom the London Multicentre Research Ethics Committee.Further details of ELSA can be found at http://www.ifs.org.uk/elsa/documentation.php.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/camh-20-543.PMC4806344.pdf
"(Cell Mol Gastroenterol Hepatol 2016;2:131 –157; http://dx.doi.org/10.1016/j.jcmgh.2015.11.009 ) Keywords: Enterocyte Traf ﬁcking; Brush Border; Rab11a; Rab8a; Syntaxin 3; NHE3; MYO5B.Microvillus inclusion disease (MVID) is caused by inactivating mutations in myosin Vb (MYO5B).1–3 Neonates with MVID have severe life-threatening diarrhea usually beginning in the ﬁrst week of life.4,5Recent studies using in vitro investigations in correlation with humanpatient pathologic tissues have shown insights into thepossible pathophysiology of MVID.",Non-OADS,/arxiv_data1/oa_pdf/50/63/main.PMC4806369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/63/main.PMC4806369.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.11.009,OADS,/arxiv_data1/oa_pdf/50/63/main.PMC4806369.pdf
"PCR amplicons were sequenced from both directions using Sanger sequen- cing (Macrogen Inc., Geumcheongu, Seoul, South Korea) and the chromato- grams were analysed using Geneious version 6.1.5 (http://www.geneious.com, Kearse et al., 2012).",OADS,/arxiv_data1/oa_pdf/06/54/hdy201597a.PMC4806576.pdf
Raw Illumina sequences were ﬁltered and trimmed to the length of 80 bp using FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html; key: citeulike: 9103573).,OADS,/arxiv_data1/oa_pdf/06/54/hdy201597a.PMC4806576.pdf
All coding sequences were ﬁrst checked for the presence of premature stop codons using Geneious version 6.1.5 (http://www.geneious.,Non-OADS,/arxiv_data1/oa_pdf/06/54/hdy201597a.PMC4806576.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)mtDNA for monitoring Wolbachia dynamics HL Yeap et al 276 Heredity",Non-OADS,/arxiv_data1/oa_pdf/06/54/hdy201597a.PMC4806576.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Oscheius Entomopathogenic nematodes Whole-genome sequencingGenome assemblyGenome annotation Speci ﬁcations Organism Oscheius sp.,Non-OADS,/arxiv_data1/oa_pdf/02/d0/main.PMC4806700.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/LNBV00000000 .,OADS,/arxiv_data1/oa_pdf/02/d0/main.PMC4806700.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.017 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/02/d0/main.PMC4806700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/d0/main.PMC4806700.pdf
3 (4) (2015) http://dx.doi.org/ 10.1128/genomeA.00747-15 (e00747 –15).,Non-OADS,/arxiv_data1/oa_pdf/02/d0/main.PMC4806700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/bgw018.PMC4806711.pdf
"TCGA methylation data of stomach, esophageal and  colon cancer Publically available 450K methylation data of 395 stomach adenocarci - nomas, 295 colon adenocarcinomas and 185 esophageal cancers [89 EAC  and 96 esophageal squamous cell carcinomas (ESCC)] were obtained from  the TCGA Data Portal ( https://tcga-data.nci.nih.gov/ ) on 10 December  2015 ( 18,19).",OADS,/arxiv_data1/oa_pdf/fc/f5/bgw018.PMC4806711.pdf
Epstein–Barr virus information for stomach tumors was obtained  from http://gdac.broadinstitute.org/runs/awg_stad__2013_09_30/ samples_summary_report/ .,OADS,/arxiv_data1/oa_pdf/fc/f5/bgw018.PMC4806711.pdf
Acknowledgements The results shown here are in part based on data generated by  the TCGA Research Network: http://cancergenome.nih.gov/ .,OADS,/arxiv_data1/oa_pdf/fc/f5/bgw018.PMC4806711.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/65/iew013.PMC4806712.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/25/iew016.PMC4806713.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/a0/iew005.PMC4806714.pdf
(http://www.R-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/00/a0/iew005.PMC4806714.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/ff/iew015.PMC4806715.pdf
Phylogenetic Analysis The sequence alignment was created and processed using the pro-grams Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/;accessed February 2016) and BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html; accessed February 2016).,OADS,/arxiv_data1/oa_pdf/cc/ff/iew015.PMC4806715.pdf
Transmembrane do-main prediction was performed using the TMHMM Server v. 2.0(http://www.cbs.dtu.dk/services/TMHMM-2.0/; accessed February2016).,OADS,/arxiv_data1/oa_pdf/cc/ff/iew015.PMC4806715.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
Reading frames wereobtained using EMBOSS Transeq (http://www.ebi.ac.uk/Tools/st/emboss_transeq/) and then aligned using BLASTp (http://blast.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
"predisi.de), and the isoelectric point (pI) and molecular mass were calculated by the Compute pI/MW tool (http://web.expasy.org/compute_pi/).",OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
"Sequences from Acyrthosiphon pisum , (Harris) Aedes aegypti , (L.) Anopheles gambiae Giles, Antheraea polyphemus (Cramer), Apis mellifera , (L.) Bombyx mori , (L.) Culex quinquefas- ciatus , (Say) Dendroctonus ponderosae , Hopkins Drosophila mela- nogaster , Meigen H. oblita ,Nasonia vitripennis , (Walker) Phyllopertha diversa , Waterhouse Solenopsis invicta, Buren and Tribolium castaneum , (Herbst) present in the GenBank database (http://www.ncbi.nlm.nih.gov/genbank), were translated into amino acid sequences using Bioperl ( Stajich et al.",OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
"Finally, all predicted sequences were checked by BLASTx (http://blast.ncbi.nlm.nih.gov/Blast.cgi) searches against the nonre-dundant GenBank database.",OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
the PubChem database (http://pubchem.ncbi.nlm.nih.gov).,OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
The ligand fileswere prepared using the AutoDockTools package ( Sanner 1999 ) (http://autodock.scripps.edu) provided by AutoDock by accepting all rotatable bonds.,OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
"Modeling To build the OBP model, different templates were chosen from thePDB database (http://www.rcsb.org/pdb/home/home.do) according to their amino acidic identity ( Fig.",OADS,/arxiv_data1/oa_pdf/7c/6d/iew008.PMC4806717.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/ott-9-1599.PMC4806760.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1599–1603OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1599Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10127 8The CT and Us features of ewing’s sarcoma/ primary neuroectodermal tumor of the kidney:  two case reports and review of literature Da-Fu Zhang* Zhen-Hui Li* De-Pei Gao Guang-Jun Yang Ying-Ying Ding Guan-shun Wang Xing-Xiang Dong Department of radiology, The  Third Hospital of Kunming Medical  University, Tumor Hospital of Yunnan  Province, Kunming, People’s republic  of China *These authors contributed equally  to this workAbstract:  Ewing’s sarcoma/primary neuroectodermal tumor (EWS/PNET) is an extraordinarily  rare primary tumor of the kidney with characteristic histology.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/ott-9-1599.PMC4806760.pdf
"Tumor necrosis and hemorrhage were Correspondence: Ying-Ying Ding;   De-Pei Gao Department of radiology, The Third  Hospital of Kunming Medical University,  Tumor Hospital of Yunnan Province,  Kunzhou road, Kunming 650118,  People’s republic of China Tel +86 138 8828 9061;   +86 159 6940 2258 email d_yying@hotmail.co m;  gaodepei311@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: The CT and US features of EWS/PNET of the kidney DOI: http://dx.doi.org/10.2147/OTT.S101278",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/ott-9-1599.PMC4806760.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/ott-9-1599.PMC4806760.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/b2/ott-9-1599.PMC4806760.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1635–1639OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1635ShO rT repO rTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10232 7Can we avoid dose escalation for intermediate- risk prostate cancer in the setting of short-course  neoadjuvant androgen deprivation?",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
nsw.gov.a u Journal name: OncoTargets and Therapy Article Designation: Short Report Y ear: 2016 Volume: 9 Running head verso: Shakespeare et al Running head recto: Dose escalation for prostate cancer patients receiving ADT DOI: http://dx.doi.org/10.2147/OTT.S102327,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"Available from: https://www.rcr.ac.uk/sites/default/files/publication/ Dose-Fractionation_Final.pd f. Accessed November 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"Available from: https://www.eviq.org.au/ Protocol/tabid/66/categoryid/185/id/234/Radiation +Oncology%2c + Prostate%2c +Intermediate +Risk%2c +EBRT%2c +Definitive.asp x.  Accessed November 29, 2015.",OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls /pdf/prostate.pd f. Accessed November 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/ott-9-1635.PMC4806761.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).HIV/AIDS - Research and Palliative Care 2016:8 67–74HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  67ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S9671 3economic and health implications from earlier  detection of HIV infection in the United Kingdom Vladimir Zah1,2 Mondher T oumi1 1ecole Doctoral Interdisciplinaire  Sciences-Santé (eDISS), University of  lyon, lyon, France; 2ZRx Outcomes  Research Inc., Mississauga, Canada Correspondence: Vladimir Zah   ZRx Outcomes Research Inc., 3373  Cawthra Road, Mississauga,   On l5A2X8, Canada   T el +1 416 953 4427   Fax +1 905 364 5313   email vzah@outcomesresearch.c aPurpose:  To model the budget and survival impact of implementing interventions to increase  the proportion of HIV infections detected early in a given UK population.",Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
"Available from: https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/401662/2014_ PHE_HIV_annual_report_draft_Final_07-01-2015.pd f. Accessed Janu - ary 4, 2016.",OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
Available from: http://www.bhiva.org/News.aspx?NewsID =  870a36f4-9fea-4a31-ada0-1e5fafd927d 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
Available from: https://www.nice.org.uk/ guidance/ph33.,Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
Available from: https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
Available  from: http://www.nice.org.uk/guidance/ta235/resources/osteosarcoma- mifamurtide-discounting-of-health-benefits-in-special-circumstances2.,Non-OADS,/arxiv_data1/oa_pdf/b5/52/hiv-8-067.PMC4806762.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/b3/ott-9-1589.PMC4806763.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1589–1597OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1589Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10242 1aberrant expression of microrna-99a and its  target gene mTOr associated with malignant  progression and poor prognosis in patients with  osteosarcoma Jiali Zhao1,2,* Fengli chen3,* Quan Zhou2 Wei Pan2 Xinhong Wang2 Jin Xu2 li ni1 huilin Yang1 1Department of Orthopedics,   The First affiliated hospital of  soochow University, suzhou,   2Department of Orthopedics,   The affiliated huai’an hospital of  Xuzhou Medical college and The  second People’s hospital of huai’an,   huai’an, 3central laboratory, huai’an  First People’s hospital, nanjing  Medical University, huai’an, Jiangsu,   People’s republic of china *These authors contributed equally  to this workBackground:  The mammalian target of rapamycin (mTOR) has been reported to act as a  target gene of microRNA (miR)-99a in various cancer cells and identified as an independent  prognostic marker of human osteosarcoma.",Non-OADS,/arxiv_data1/oa_pdf/f2/b3/ott-9-1589.PMC4806763.pdf
"Keywords:  microRNA-99a, mammalian target of rapamycin, osteosarcoma, quantitative  real-time PCR, prognosis Introduction Osteosarcoma, the most frequent primary malignant sarcoma of the bone in adolescents  and young adults, derives from primitive bone-forming mesenchyme.1 This disease has an  estimated annual incidence rate of 4 million worldwide.2 Despite great progress in thera - peutic strategies, including surgery, adjuvant chemotherapy, radiotherapy, and biological  therapy, the prognosis of patients with osteosarcoma remains unsatisfactory due to bone  destruction, neoplastic bone formation, and pulmonary metastasis.3 Approximately 80%  of patients with osteosarcoma eventually develop recurrent metastatic osteosarcoma fol - lowing surgical operation, and the 3-year survival rate after pulmonary metastasectomy correspondence: huilin Yang Department of Orthopedics, The First  Affiliated Hospital of Soochow University,  188 shizi street, suzhou 215006, Jiangsu,  People’s republic of china Tel/fax +86 512 6778 0101 email haeyspine@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhao et al Running head recto: Clinical significance of miR-99a and mTOR in osteosarcoma DOI: http://dx.doi.org/10.2147/OTT.S102421",Non-OADS,/arxiv_data1/oa_pdf/f2/b3/ott-9-1589.PMC4806763.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/b3/ott-9-1589.PMC4806763.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/b3/ott-9-1589.PMC4806763.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/0f/ott-9-1105.PMC4806764.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1105–1114OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1105Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10283 7YaP induces cisplatin resistance through activation  of autophagy in human ovarian carcinoma cells lan Xiao1,* Xiao-Yan shi2,* Ying Zhang1 Ying Zhu1 lin Zhu3 Wang Tian1 Bing-Kun Zhu1 Zhao-lian Wei1 1Department of Obstetrics and  gynecology, First affiliated hospital,   anhui Medical University, hefei, 2Key  laboratory for Molecular Diagnosis  of hubei Province, central hospital  of Wuhan, T ongji Medical college,   huazhong University of science  and T echnology, Wuhan, 3Obstetrics  and gynecology hospital of Fudan  University ( shanghai red house  Obstetrics and gynecology hospital),   shanghai, People’s republic of china *These authors contributed equally  to this workObjective:  To identify the role of YAP in cisplatin resistance in human ovarian cancer cells  and in the regulation of autophagy in these cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/df/0f/ott-9-1105.PMC4806764.pdf
"Previous studies have suggested that autophagy is also a response to certain forms of  therapeutic stress, including cytotoxic chemotherapy.2 Autophagy-induced drug resistance  in cancer cells has been a challenge to cancer treatment,3 as it functions as an adaptive  response that mediates resistance to these treatments.4 However, the role of autophagy  is still a topic of intense debate, as it is not clear whether this cellular process functions  as a pro-survival or pro-death mechanism to counteract or mediate the cytotoxic effects  of anticancer agents.5,6 There is growing evidence for the role of cisplatin treatment in  inducing autophagic response in various cancer cells,7–9 including human ovarian cancer correspondence: Zhao-lian Wei Department of Obstetrics and  Gynecology, the First Affiliated Hospital,  an hui Medical University, hefei 230020,  People’s republic of china Tel +86 139 6677 5226 Fax +86 551 6292 3079 email zhaolian_wei@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xiao et al Running head recto: YAP induces cisplatin resistance DOI: http://dx.doi.org/10.2147/OTT.S102837",Non-OADS,/arxiv_data1/oa_pdf/df/0f/ott-9-1105.PMC4806764.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/df/0f/ott-9-1105.PMC4806764.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/0f/ott-9-1105.PMC4806764.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/42/ott-9-1623.PMC4806765.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy OncoTargets and Therapy 2016:9 1623–1633Dove press submit your manuscript | www.dovepress.co m Dove press  Original researchopen access to scientific and medical research Open access Full T ext article 1623 http: //dx.doi.org/10.2147/OTT .S9690 2mir-663 overexpression induced by endoplasmic  reticulum stress modulates hepatocellular  carcinoma cell apoptosis via transforming growth  factor beta 1 Yawei huang1,* Jiatao liu1,* lulu Fan1 Fang Wang1 hanqing Yu1 Wei Wei2 guoping sun1 1Department of Oncology, The  First affiliated hospital of anhui  Medical University, 2institute of  clinical Pharmacology, anhui Medical  University, hefei, anhui, People’s  republic of china *These authors contributed equally  to this workAbstract:  microRNAs are commonly dysregulated in a number of human cancers, for example,  hepatocellular carcinoma (HCC), but the precise mechanism of dysregulation has not been  extensively studied.",Non-OADS,/arxiv_data1/oa_pdf/e7/42/ott-9-1623.PMC4806765.pdf
"A number of cellular stress factors, including hypoxia, starvation, glycosylation  state changes, among others, disturb the normal endoplasmic reticulum (ER) function correspondence: guoping sun Department of Oncology, The First  Affiliated Hospital of Anhui Medical  University, 218 Jixi road, hefei, anhui  Province, 230022, People’s republic  of china Tel +86 551 38 0560 9309 email sungp@ahmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Huang et al Running head recto: The role of miR-663 in ER stress DOI: http://dx.doi.org/10.2147/OTT.S96902",Non-OADS,/arxiv_data1/oa_pdf/e7/42/ott-9-1623.PMC4806765.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e7/42/ott-9-1623.PMC4806765.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/42/ott-9-1623.PMC4806765.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/62/ott-9-1605.PMC4806767.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1605–1621OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1605Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9884 9aa-PMe, a novel asiatic acid derivative, induces  apoptosis and suppresses proliferation, migration,  and invasion of gastric cancer cells Yue Jing1 gang Wang1 Ying ge1 Minjie Xu1 shuainan Tang1 Zhunan gong1,2 1center for new Drug research  and Development, 2Jiangsu Key  laboratory for Molecular and Medical  Biotechnology, college of life  sciences, n anjing normal University,   nanjing, People’s republic of chinaAbstract:  Asiatic acid (AA; 2 α,3β,23-trihydroxyurs-12-ene-28-oic acid) is widely used for  medicinal purposes in many Asian countries due to its various bioactivities.",Non-OADS,/arxiv_data1/oa_pdf/f2/62/ott-9-1605.PMC4806767.pdf
"Among all the malignant tumors, gastric  cancer is the second leading cause of global cancer-related death,1 especially in East  Asian countries such as the People’s Republic of China, Japan, and Korea.2,3 The  development of gastric cancer is a multi-step process, starting from normal mucosa and  developing to chronic gastritis, then to precancerous lesions including gastric atrophy,  intestinal metaplasia and dysplasia, and eventually to invasive cancer.4 Gastric cancer  is also frequently associated with lymph node metastasis, peritoneal dissemination,  and hematogenous metastasis.5 It is believed that alterations of various regulators (eg,  Bcl-2 and c-Myc), tumor suppressor genes (eg, Bax), DNA repair genes, cell cycle  regulators (eg, cyclin D1, CDK4, CDK6, and P15), cell adhesion molecules (eg, Matrix  metalloproteinase [MMP]-2 and MMP-9), and growth factor/receptor system are col - lectively involved in the onset and progression of gastric cancer.6–8 Rapid proliferation,  migration, invasion, and multidrug resistance of tumor cells are responsible for poor  prognosis of gastric cancer.9 At present, surgery and chemotherapy10,11 are the two main correspondence: Zhunan gong Jiangsu Key laboratory for Molecular  and Medical Biotechnology, college of  life sciences, nanjing normal University,  no 1 Wenyuan road, nanjing, Jiangsu  210046, People’s republic of china Tel/fax +86 25 8589 1736 email gongzhunan@njnu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jing et al Running head recto: AA-PMe in gastric cancer therapy DOI: http://dx.doi.org/10.2147/OTT.S98849",Non-OADS,/arxiv_data1/oa_pdf/f2/62/ott-9-1605.PMC4806767.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/62/ott-9-1605.PMC4806767.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/62/ott-9-1605.PMC4806767.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 1–9Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  1REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S5036 0Emergency department ultrasound probe  infection control: challenges and solutions Hamid Shokoohi Paige Armstrong Ryan Tansek Department of Emergency Medicine,   George washington University  Medical Center, washington DC, USA Correspondence: Hamid Shokoohi   Department of Emergency Medicine,  George washington University Medical  Center,  2120 L Street, Nw Suite  450,  washington DC  20037, USA   Email shokoohi@gwu.ed uAbstract:  Point-of-care ultrasound (US) has become a cornerstone in the diagnosis and treatment  of patients in the emergency department (ED).",Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
"A complete list of FDA-cleared liquid sterilants and  high-level disinfectants is available at http://www.fda.gov/ MedicalDevices/Safety/AlertsandNotices/ucm194429.ht m. In addition to traditional cleaning of US equipment, new  technologies are providing further possibilities (Table  5).",Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
Available from: http://www.nanosonics.com.,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
"Available  from: http://www.sonosite.com/sites/default/files/support_docs/ Disinfectants _ENG_P06703-08A_e.pd f. Accessed September  15,  2014.",OADS,/arxiv_data1/oa_pdf/8e/0f/oaem-7-001.PMC4806800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/07/oaem-7-011.PMC4806801.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 11–15Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  11OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7929 1Establishment of ultrasound as a diagnostic aid   in the referral of patients with abdominal pain   in an emergency department – a pilot study liv la cour Poulsen1 Emilie stokholm Bækgaard1 Per grosen istre1 Thomas Andersen schmidt1 T orben larsen2 1Emergency Department, copenhagen  University hospital, holbaek,   Denmark; 2Department of Obstetrics  and gynecology, copenhagen  University hospital, holbaek,   Denmark correspondence: liv la cour Poulsen   Emergency Department, copenhagen  University hospital, smedelundsgade 60,  4300 holbæk, Denmark   Tel +45 616 000 41   Email livlacour@hotmail.co mPurpose:  Ultrasonography is a noninvasive, cheap, and fast way of assessing abdominal pain  in an emergency department.",Non-OADS,/arxiv_data1/oa_pdf/a2/07/oaem-7-011.PMC4806801.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/a2/07/oaem-7-011.PMC4806801.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/07/oaem-7-011.PMC4806801.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/aa/oaem-7-017.PMC4806802.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 17–20Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  17CAsE rEpO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OAEM.S7544 2treatment and prevention of infection   following bites of the Antarctic fur seal   (Arctocephalus gazella ) timur Kouliev1 Victoria Cui2 1Beijing United Family Hospital,   Beijing, people’s republic of China;   2Department of Biological sciences,   Columbia University, New Y ork,    NY, UsA Correspondence: Victoria Cui   6401 Deer Hollow Lane, Austin, tX, UsA   tel +1 512 289 3718   Email cui.victoria@gmail.co mAbstract:  In recent decades, an increasing number of people have traveled to sub-Antarctic  and Antarctic regions each year for research, tourism, and resource exploitation.",Non-OADS,/arxiv_data1/oa_pdf/df/aa/oaem-7-017.PMC4806802.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/df/aa/oaem-7-017.PMC4806802.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/aa/oaem-7-017.PMC4806802.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 21–24Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  21REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S8213 3Assessment of the safety and ease of use   of the naloxone auto-injector for the reversal   of opioid overdose Mark A Merlin1,2 Navin Ariyaprakai1 Faizan H Arshad1,2 1Newark Beth israel Medical Center,   Newark, NJ, USA; 2Monmouth Ocean   Hospital Service Corporation (MONOC),   wall T ownship, NJ, USA Correspondence: Mark A Merlin   Newark Beth israel Medical Center,    201 Lyons Avenue D-11, Newark,   NJ, USA   Email m arkamerlin@gmail.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Additionally,  in August  2013, the Substance Abuse and Mental Health  Services Administration introduced the Opioid Overdose  Toolkit ( http://evzio.com/hcp/about-naloxone/samhsa- opioid-overdose-toolkit.ph p), a federal resource promoting  safety and prevention information.23,24 This extensive docu - ment provides information for medical professionals, first  responders, patients, caregivers, and overdose survivors.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
Available from http://www.cdc.gov/drugoverdose/index.,OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Available from:  http://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_ poisoning_ deaths_1999-2012.pd f. Accessed January  20, 2015.",OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2014/205787Orig1s000SumR.pd f. Accessed January  28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"Available from: http://www.pbm.va.gov/PBM/clinicalguidance/ abbreviatedreviews/ Naloxone_Autoinjector_EVZIO_Abbreviated_ Review_revised_2014_07_16.doc x. Accessed January  28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
"A vailable from:  http://store.samhsa.gov/shin/content//PEP15-FEDGUIDEOTP/PEP15- FEDGUIDEOTP .pd f. Accessed January  8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/77/oaem-7-021.PMC4806803.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/fe/oaem-7-025.PMC4806804.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 25–29Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  25OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S8239 3Pediatric fractures – an educational needs  assessment of canadian pediatric emergency  medicine residents Andrew c Dixon Department of Pediatrics, University  of Alberta, Edmonton, AB, canada correspondence: Andrew c Dixon   Division of Pediatric Emergency Medicine,  Department of Pediatrics, Faculty of  Medicine and Dentistry, University  of Alberta, Edmonton clinic health  Academy (EchA),  11405 –  87 Avenue,  Edmonton, AB T6g  1c9, canada   Tel +1 780  248 5574  Fax +1 888 775 8876  Email a ndrew.dixon@ albertahealthservices.c aObjectives:  To determine the gaps in knowledge of Canadian pediatric emergency medicine  residents with regards to acute fracture identification and management.",Non-OADS,/arxiv_data1/oa_pdf/85/fe/oaem-7-025.PMC4806804.pdf
"Available from: http://www.royalcollege.ca/cs/ groups/public/documents/document/y2vk/mdaw/~edisp/tztest3rcp - sced000685.pd f. Accessed November  26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/85/fe/oaem-7-025.PMC4806804.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/85/fe/oaem-7-025.PMC4806804.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/fe/oaem-7-025.PMC4806804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/b4/oaem-7-031.PMC4806805.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 31–37Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  31REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7458 0Assessing inhalation injury in the emergency  room Shinsuke Tanizaki Department of Emergency   Medicine, Fukui Prefectural   Hospital, Fukui, Japan Correspondence: Shinsuke Tanizaki   Department of Emergency Medicine,  Fukui Prefectural Hospital,   2-8-1, Yotsui, Fukui 9108526, Japan   Tel +81 77 654 5151   Fax +81 77 657 2991   Email sytanizak@yahoo.co.j pAbstract:  Respiratory tract injuries caused by inhalation of smoke or chemical products are  related to significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/13/b4/oaem-7-031.PMC4806805.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/13/b4/oaem-7-031.PMC4806805.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/b4/oaem-7-031.PMC4806805.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 45–54Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  45REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S6997 4Acute care of older patients in the emergency  department: strategies to improve patient  outcomes John J McCabe Sean P Kennelly Department of Age-Related Health  Care, Tallaght Hospital, Dublin, ireland Correspondence: Sean P Kennelly   Department of Age-Related Health Care,  Tallaght Hospital, Tallaght, Dublin 24,  ireland   Email sean.kennelly@amnch.i eAbstract:  Older patients in the emergency department (ED) are a vulnerable population who  are at a higher risk of functional decline and hospital reattendance subsequent to an ED visit,  and have a high mortality rate in the months following an ED attendance.",Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
"Available from: http://ec.europa.eu/economy_finance/ publications/european_economy/2012/pdf/ee-2012-2_en.pd f. Accessed  June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
"Available from http://www.publications.parliament.uk/pa/cm201213/ cmselect/cmhealth/6/6vw03.ht m. Accessed June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
"Delirium Risk  Assessment  Tool; Available from: http://www.aci.health.nsw.gov.au/chops/key-areas/ risk-and-prevention/delirium-risk-assessment-too l. Accessesd June 9,  2015.",Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/07/oaem-7-045.PMC4806806.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/89/oaem-7-039.PMC4806807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 39–44Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  39REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7368 4T umor lysis syndrome in the emergency  department: challenges and solutions Silvio A Ñamendys-Silva1,2 Juan M Arredondo- Armenta1 Erika P Plata-Menchaca2 Humberto Guevara-García1 Francisco J García-Guillén1 Eduardo Rivero-Sigarroa2 Angel Herrera-Gómez1 1Department of Critical Care  Medicine, instituto Nacional de  Cancerología, 2Department of Critical  Care Medicine, instituto Nacional de  Ciencias Médicas y Nutrición Salvador  Zubirán, Mexico City, Mexico Correspondence: Silvio A Ñamendys-Silva   Department of Critical Care Medicine,  instituto Nacional de Cancerología,   Av San Fernando No 22, Col   Sección Xvi, Delegación Tlalpan,   CP 14080 México City, DF, México   Tel +52 55 4747 1020 ext 13015, 13016   Email snamendys@incan.edu.m xAbstract:  Tumor lysis syndrome (TLS) is the most common oncologic emergency.",Non-OADS,/arxiv_data1/oa_pdf/8b/89/oaem-7-039.PMC4806807.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/8b/89/oaem-7-039.PMC4806807.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/89/oaem-7-039.PMC4806807.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 55–68Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  55REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S6832 4Emergency surgery in the elderly: challenges and  solutions Andrew D w T orrance1 Susan L Powell2 Ewen A Griffiths3 1west Midlands Surgical Research  Collaborative, Academic Department  of Surgery, University of Birmingham,   Queen Elizabeth Hospital,   Birmingham, 2Department of  Geriatric Medicine, Heart of England  NHS Foundation Trust, Solihull  Hospital, Solihull, 3Department of  Upper Gastrointestinal Surgery,   University Hospitals Birmingham NHS  Foundation Trust, Birmingham, UK Correspondence: Ewen A Griffiths   Level 7, Area 6, New Queen Elizabeth  Hospital, University Hospitals   Birmingham NHS Foundation Trust,   Edgbaston, Birmingham B15 2wB, UK   T el +44 121 371 5883   Fax +44 121 371 5996   Email ewen.griffiths@uhb.nhs.u kAbstract:  Elderly patients frequently present with surgical emergencies to health care  providers,  and outcomes in this group of patients remain poor.",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Note:  Data were downloaded from the world Bank web site ( http://www.worldbank.or g).64,OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Being aware that elderly patients present  with atypical features compared with younger patients can help  focus radiological investigation appropriately.42,43 Early CT  imaging significantly improves management of elderly patients  with acute abdomen, and its liberal use is recommended.44 Realistic risk prediction and identification of frailty The report of the Royal College of Surgeons of England on  the “Higher Risk General Surgical Patient” includes discus - sion on the use of risk assessment in emergency surgery.17  There are many risk prediction models available to the  emergency clinician, eg, ASA, P-POSSUM, and APACHE-2  (http://riskprediction.org.uk /).",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Available from: http://www.ncepod.org.uk/2010report3/ downloads/EESE_fullReport.pd f. Accessed August 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Available from: http://www.ncepod.org.uk/ pdf/1999/99full.pd f. Accessed August 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available  from: https://www.rcseng.ac.uk/publications/docs/access-all-age s.  12.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available from: https://www.nice.org.uk/guidance/cg12 4.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available from: http://www.bgs.org.uk/ campaigns/fff/fff_full.pd f.  48.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available from: https://www.nice.org.uk/guidance/cg10 3.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available from: http://www.kingsfund.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Available from: http://www.bgs.org.uk/campaigns/silverb/silver_book_ complete.pd f. Accessed August 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Available  from: http://www.worldbank.org /.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/04/oaem-7-055.PMC4806808.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/22/oaem-7-069.PMC4806809.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 69–77Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  69REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7127 9Targeted temperature management in emergency  medicine: current perspectives Benton R Hunter1 Timothy J Ellender1,2 1Department of Emergency Medicine,  2Department of Critical Care Medicine,  indiana University School of Medicine,  indiana University, indianapolis, iN, USA Correspondence: Benton R Hunter   Department of Emergency Medicine,  indiana University School of Medicine,  indiana University, 2806 East High Grove  Circle, Zionsville, iN 46077, USA   Tel +1 317 413 2318   Email brhunter@iupui.ed uAbstract:  Landmark trials in 2002 showed that therapeutic hypothermia (TH) after out-of- hospital cardiac arrest due to ventricular tachycardia or ventricular fibrillation resulted in  improved likelihood of good neurologic recovery compared to standard care without TH.",Non-OADS,/arxiv_data1/oa_pdf/2b/22/oaem-7-069.PMC4806809.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/2b/22/oaem-7-069.PMC4806809.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/22/oaem-7-069.PMC4806809.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/5e/oaem-7-079.PMC4806810.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 79–84Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  79OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7464 6canadian Triage and Acuity scale: testing   the mental health categories Anne-Marie Brown1 Diana E clarke1 Julia spence2 1college of nursing, Faculty of health  sciences, University of Manitoba,   Winnipeg, MB, canada; 2st Michael’s  hospital, Faculty of Medicine,   University of T oronto, T oronto, On ,   canada correspondence: Anne-Marie Brown   college of nursing, Faculty of health  sciences, University of Manitoba,  89 curry Place, Winnipeg, MB r3T 2n2,  canada   Tel +1 204 474 9080   Fax +1 204 474 7683   Email a nne-marie.brown@umanitoba.c aPurpose:  The study tested the inter-rater reliability and accuracy of triage nurses’ assignment  of urgency ratings for mental health patient scenarios based on the 2008 Canadian Triage  and Acuity Scale (CTAS) guidelines, using a standardized triage tool.",Non-OADS,/arxiv_data1/oa_pdf/fc/5e/oaem-7-079.PMC4806810.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/fc/5e/oaem-7-079.PMC4806810.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/5e/oaem-7-079.PMC4806810.pdf
Available from: http://hdl.handle.net/1993/449 3.,OADS,/arxiv_data1/oa_pdf/fc/5e/oaem-7-079.PMC4806810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/e6/oaem-7-085.PMC4806811.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Emergency Medicine 2015:7 85–92Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  85REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S7128 2Clinical decision aids for chest pain in the  emergency department: identifying low-risk  patients william Alley Simon A Mahler Department of Emergency Medicine,   wake Forest Baptist Medical Center,   winston-Salem, NC, USA Correspondence: william Alley   Department of Emergency Medicine,   wake Forest Baptist Medical Center,   Medical Center Boulevard,   winston-Salem, NC  27157, USA   Email walley@wakehealth.ed uAbstract:  Chest pain is one of the most common presenting complaints in the emergency  department, though only a small minority of patients are subsequently diagnosed with acute  coronary syndrome (ACS).",Non-OADS,/arxiv_data1/oa_pdf/d7/e6/oaem-7-085.PMC4806811.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/d7/e6/oaem-7-085.PMC4806811.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/e6/oaem-7-085.PMC4806811.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/oaem-5-017.PMC4806814.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Emergency Medicine 2013:5 17–22Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  17OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S5022 6Feasibility of rapid polymerase chain reaction for  detection of methicillin-resistant Staphylococcus  aureus  colonization among emergency  department patients with abscesses Michael s Pulia1 Mary calderone2 Brad hansen2 christine E stake3 Mark cichon3 Zhanhai li4 nasia safdar5 1Division of Emergency Medicine,   University of Wisconsin school of  Medicine and Public health, Madison,   Wi, UsA; 2loyola University stritch  school of Medicine, Maywood, il,   UsA; 3Department of Emergency  Medicine, loyola University Medical  center, Maywood, il, UsA; 4University  of Wisconsin Department of  Biostatistics and Medical informatics,   Madison, Wi, UsA; 5William s  Middleton Veterans Affairs Medical  center and the Department of  Medicine, Division of infectious  Disease, University of Wisconsin  school of Medicine and Public health,   Madison, Wi, UsA correspondence: Michael Pulia   University of Wisconsin school of  Medicine and Public health, Division   of Emergency Medicine, F2/203 clinical  science center, 600 highland Ave,  Madison, Wi 53792, UsA   Tel +1 708 420 1321   Fax +1 312 873 3896   Email mspulia@medicine.wisc.ed uPurpose:  In the era of community-associated methicillin-resistant Staphylococcus aureus   (MRSA), clinicians face a difficult challenge when selecting antibiotics to treat abscesses.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/oaem-5-017.PMC4806814.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/oaem-5-017.PMC4806814.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/oaem-5-017.PMC4806814.pdf
Available from: http://www.idsociety.org/ Stewardship_Policy /.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/oaem-5-017.PMC4806814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/53/oaem-5-023.PMC4806815.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Emergency Medicine 2013:5 23–28Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  23OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S5302 1can eye-tracking technology improve situational  awareness in paramedic clinical education?,Non-OADS,/arxiv_data1/oa_pdf/ca/53/oaem-5-023.PMC4806815.pdf
Available from: http://www.reuters.com/article/2011/09/19/ idUS88105 +19-Sep-2011 +BW2011091 9.,Non-OADS,/arxiv_data1/oa_pdf/ca/53/oaem-5-023.PMC4806815.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/ca/53/oaem-5-023.PMC4806815.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/53/oaem-5-023.PMC4806815.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Emergency Medicine 2013:5 29–32Open Access Emergency Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  29REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S3904 2Auto-transfusion tourniquets: the next evolution  of tourniquets David H Tang1,2,3 Bohdan T Olesnicky1,3 Michael w Eby1,4 Lawrence E Heiskell1,5 1international School of Tactical  Medicine, Palm Springs, CA, USA;   2Eisenhower Medical Center, Rancho  Mirage, CA, USA; 3High Desert  Medical Center, Joshua Tree, CA, USA;   4veterans Administration Loma Linda  Healthcare System, Loma Linda,    CA, USA; 5Fallbrook Community  Hospital, Fallbrook, CA, USA Correspondence: David H Tang   Global Protection Medical Group, LLC  74-785 Highway 111, Suite 105,   indian wells, CA, 92210, USA   Email dtangips@aol.co mAbstract:  In this article, we discuss the relationship between hemorrhagic shock and the  pathophysiology of shock using conventional tourniquets.",Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
"Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-emergency-medicine-journa lOpen Access Emergency Medicine is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
"Available from: http://www.dtic.mil/dtic/ tr/fulltext/u2/a444678.pd f. Accessed September 7, 2013.",OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
"Available from: http://www.nsbri.org/ HumanPhysSpace/focus2/spaceflight-leg.htm l. Accessed September 7,  2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
"Available at: http://www.emergencyeed.com/ uploads/1/9/1/4/19141635/study_-_auto_transfusion_mk0036200_ compressed_2.pd f. Accessed October 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
Available from: http://www.emergencyeed.com/safety.,Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
Available from: http://www.hemaclear.com.,Non-OADS,/arxiv_data1/oa_pdf/5d/43/oaem-5-029.PMC4806816.pdf
Data available from the Dryad Digital Repository: http://dx.doi.org/ 10.5061/dryad.bd6h3.,OADS,/arxiv_data1/oa_pdf/c9/a3/hdy201555a.PMC4806900.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Oceanic island colonisation by a coastal ﬁsh SS t e f a n n i et al 537 Heredity",Non-OADS,/arxiv_data1/oa_pdf/c9/a3/hdy201555a.PMC4806900.pdf
"Discussion The 2014 guidelines from the American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Societyof America (IDSA) ( Recommendations for Testing, Managing, and Treating Hepatitis C (http://www.hcvguidelines.org) rec- ommend evaluation for advanced fibrosis in all persons withHCV infection in order to facilitate an appropriate decision regarding treatment strategy and to determine the need for initiating additional screening measures.",Non-OADS,/arxiv_data1/oa_pdf/63/16/JCTH-4-012.PMC4807138.pdf
[13] http://www.hcvguidelines.org/.,Non-OADS,/arxiv_data1/oa_pdf/0e/04/JCTH-4-020.PMC4807139.pdf
References [1] http://www.who.int/mediacentre/factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/1f/15/JCTH-4-054.PMC4807144.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.104",Non-OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
"Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 105 http://dx.doi.org/10.4041/kjod.2016.46.2.104INTRODUCTION   The stability of the outcome of orthodontic treatment  is a major clinical concern, as retraction of periodontal fibers might cause many cases to eventually relapse, particularly after alignment of the anterior teeth of the mandible.",Non-OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
"Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 106 http://dx.doi.org/10.4041/kjod.2016.46.2.104signs suggesting bruxism or clenching, advanced dental  abrasion/attrition/erosion, and a need for mandibular canine-to-canine fixed retention.",Non-OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
"Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 107 http://dx.doi.org/10.4041/kjod.2016.46.2.1043.6, 18.4 ± 3.7, and 17.0 ± 3.4 years, respectively, in the  FRC, spiral flex, and TDW groups.",OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
"Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 108 http://dx.doi.org/10.4041/kjod.2016.46.2.104who are allergic to metals or who are undergoing MRI  assessments, and FRC retainers can be bonded to dental tissues.",Non-OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 109 http://dx.doi.org/10.4041/kjod.2016.46.2.104other brands).,Non-OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
Sobouti et al • Twisted dead soft wire as a fixed retainer www.e-kjo.org 110 http://dx.doi.org/10.4041/kjod.2016.46.2.104of Hawley and vacuum-formed retainers: a single- center randomized controlled trial.,OADS,/arxiv_data1/oa_pdf/26/04/kjod-46-104.PMC4807147.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSReview Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.111",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 112 http://dx.doi.org/10.4041/kjod.2016.46.2.111INTRODUCTION   Although many studies have investigated the various  prognostic factors affecting the success of miniscrew implant (MI) insertion, conflicting results have made the identification of critical factors difficult.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 113 http://dx.doi.org/10.4041/kjod.2016.46.2.111following: (1) systematic review or meta-analysis,  (2) patient satisfaction, (3) orthognathic surgery, (4) radiographic evaluation, (5) microbiology, (6) case report, (7)  in vitro  studies, (8) literature review, (9)  only one article from a particular research group, (10) studies based on the five confounding factors that used different dichotomizations (e.g., the age division of < 18 years vs. ≥ 18 years), and (11) studies on MIs inserted into the retromolar pad, lingual side, or palatal side.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 114 http://dx.doi.org/10.4041/kjod.2016.46.2.111Table 1.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 115 http://dx.doi.org/10.4041/kjod.2016.46.2.111Table 2.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 116 http://dx.doi.org/10.4041/kjod.2016.46.2.111trim-and-fill method, which accounts for unpublished  data by imputing missing studies to yield an unbiased estimate of the effect size.",OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 117 http://dx.doi.org/10.4041/kjod.2016.46.2.1110.46 (95% CI, 0.26−0.80) indicated that long MIs (≥ 8  mm) had success rates that were 2.17 (= 1/0.46) times higher than the rates obtained with short MIs (< 8 mm).",OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 118 http://dx.doi.org/10.4041/kjod.2016.46.2.111Table 3.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 119 http://dx.doi.org/10.4041/kjod.2016.46.2.111success rates according to MI diameter, four studies  were considered.",OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 120 http://dx.doi.org/10.4041/kjod.2016.46.2.111that short screws (< 8 mm) with small diameters (< 1.2  mm) should be avoided, which is consistent with the present results.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 121 http://dx.doi.org/10.4041/kjod.2016.46.2.111prospective studies are deemed more reliable than  retrospective studies.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 122 http://dx.doi.org/10.4041/kjod.2016.46.2.111maxilla.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 123 http://dx.doi.org/10.4041/kjod.2016.46.2.111Age   In the present meta-analysis, significantly higher  success rates were identified in patients who were ≥ 20 years of age compared to in patients who were < 20 years of age.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 124 http://dx.doi.org/10.4041/kjod.2016.46.2.111Sugahara T, Takano-Yamamoto T. Factors associated  with the stability of titanium screws placed in the posterior region for orthodontic anchorage.",OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Ottawa (ON): Ottawa Health Research Institute; [accessed 2006 May 11] Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 125 http://dx.doi.org/10.4041/kjod.2016.46.2.111Epidemiol 1994;140:290-6.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
Hong et al • Factors associated with success of mini-impalnts www.e-kjo.org 126 http://dx.doi.org/10.4041/kjod.2016.46.2.111Appendix 1.,OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
"Search strategy for the electronic databases used in this meta-analysis Databases of published articles Search strategy used Pubmed http://www.ncbi.nlm.nih.gov/pubmed(((((((factor[ti]) OR factors[ti]) OR success[ti]) OR failure[ti]) OR orthodontic[ti]) OR anchorage[ti]) OR stability[ti]) AND ((((((((((((((((miniimplant[ti]) OR miniimplants[ti]) OR mini implant[ti]) OR mini implants[ti]) OR mini-implant[ti]) OR mini-implants[ti]) OR miniscrew[ti]) OR miniscrews[ti]) OR mini screw[ti]) OR mini screws[ti]) OR mini-screw[ti]) OR mini-screws[ti]) OR microscrew[ti]) OR microscrews[ti]) OR micro screw[ti]) OR micro screws[ti]) OR micro-screw[ti]) OR micro-screws[ti]) OR microimplant[ti]) OR microimplants[ti]) OR micro implant[ti]) OR micro implants[ti]) OR micro-implant[ti]) OR micro-implants[ti]) NOT (systematic review[ti]) NOT (meta-analysis) NOT (patient satisfaction) NOT (orthognathic surgery) NOT (radiographic evaluation) NOT (microbiology) NOT (in vitro) NOT (case reports) NOT (case report) NOT (literature review) NOT (literature reviews)) Scopushttp://www.scopus.comALL(factor OR success OR failure OR orthodontic OR anchorage OR stability) AND ALL(miniimplant* OR ""mini implant*"" OR ""mini-implant*"" OR miniscrew* OR ""mini screw*"" OR ""mini-screw*"" OR microscrew* OR ""micro screw*"" OR ""micro-screw*"" OR microimplant* OR ""micro implant*"" OR ""micro-implant*"") AND PUBYEAR > 2002 AND PUBYEAR < 2015 AND LANGUAGE(english) AND NOT ""systematic review"" AND NOT ""meta analysis"" AND NOT ""patient satisfaction"" AND NOT ""orthognathic surgery"" AND NOT ""radiographic evaluation"" AND NOT microbiology AND NOT ""in vitro"" AND NOT ""case report"" AND NOT ""literature review"" AND ( LIMIT-TO(DOCTYPE,""ar"" ) ) AND ( LIMIT-TO(SUBJAREA,""DENT"" ) OR LIMIT-TO(SUBJAREA,""MULT"" ) ) Web of Sciencehttp://www.webofknowledge.comTI=((factor OR success OR failure OR orthodontic OR anchorage OR stability) AND ((miniimplant) OR (mini implant) OR (mini-implant) OR (miniscrew) OR (mini screw) OR (mini-screw) OR (microscrew) OR (micro screw) OR (micro-screw) OR (microimplant) OR (micro implant) OR (micro-implant)) NOT (systematic review) NOT (meta-analysis) NOT (patient satisfaction) NOT (orthognathic surgery) NOT (radiographic evaluation) NOT (microbiology) NOT (in vitro) NOT (case report) NOT (literature review)) AND SU=Dentistry NOT TS=(Animal OR Beagle OR Rabbit OR Rat OR pig)",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/kjod-46-111.PMC4807148.pdf
- Korean J Orthod 2016;46:55-61. http://dx.doi.org/10.4041/kjod.2016.46.2.6363www.e-kjo.orgpIssN 2234-7518 eIssN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/6a/c0/kjod-46-63.PMC4807149.pdf
"Replied by  Yoon-Goo Kang Department of Orthodontics, College of Dentistry, Kyung Hee University,  Seoul, Korea www.e-kjo.org http://dx.doi.org/10.4041/kjod.2016.46.2.63This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.References 1.",Non-OADS,/arxiv_data1/oa_pdf/6a/c0/kjod-46-63.PMC4807149.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.65",Non-OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
"Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 66 http://dx.doi.org/10.4041/kjod.2016.46.2.65 INTRODUCTION   The invisible orthodontic technique is considered one  of the greatest developments in orthodontic clinical treatment technology in the 21st century, and since its inception there have been great improvements in new technologies such as three-dimensional (3D) reconstruction, modern engineering, and computer-aided design and computer-aided manufacturing (CAD/CAM).",Non-OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 67 http://dx.doi.org/10.4041/kjod.2016.46.2.65 for orthodontic force measurement (Figure 2A).,OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
"Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 68 http://dx.doi.org/10.4041/kjod.2016.46.2.65 6, 7, 8, 9, 10, 11, 12, and 14 days.",OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
"Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 69 http://dx.doi.org/10.4041/kjod.2016.46.2.65 the orthodontic forces generated by most pairs of  aligners, demonstrating that the amount of activation of the aligner was an important factor affecting invisible orthodontic force.",OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 70 http://dx.doi.org/10.4041/kjod.2016.46.2.65 Orthodonticforce(N) 0 Time(day)468 21 0 010 8 6 4 2A 13 57 912 ** ** ** Orthodonticforce(N) 0 Time(day)468 21 0 010 8 6 4 2B 13 57 912 ** ** ** ** Orthodonticforce(N) Orthodonticforce(N)0 0Time(day) Time(day)4 46 68 82 210 100 010 108 86 64 42 2 C E1 13 35 57 79 9 12 12** **** **** *Orthodonticforce(N) 0 Time(day)468 21 0 010 8 6 4 2D 13 57 912** ** ** ** * ** Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
"Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 71 http://dx.doi.org/10.4041/kjod.2016.46.2.65 N. Hahn et al.14 reported that the orthodontic force of  0.8-mm thick aligners with 0.151 mm activation was  2.38—3.14 N. In the current study, the periodontal ligament could not be simulated in the resin model.",OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
Li et al • Aligner's activation amount and orthodontic force www.e-kjo.org 72 http://dx.doi.org/10.4041/kjod.2016.46.2.65 4.,Non-OADS,/arxiv_data1/oa_pdf/96/cf/kjod-46-65.PMC4807150.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.73",Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 74 http://dx.doi.org/10.4041/kjod.2016.46.2.73 INTRODUCTION   Friction between the bracket slot and archwire is one  of the most important factors to be considered in sliding mechanics.,Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 75 http://dx.doi.org/10.4041/kjod.2016.46.2.73  Table 1.,OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
"Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 76 http://dx.doi.org/10.4041/kjod.2016.46.2.73 ASLB + posterior-ASLB) and four hybrid types (group  3, anterior-CB + posterior-PSLB-type 1; group 4, anterior-CB + posterior-PSLB-type 2; group 5, anterior-ASLB + posterior-PSLB-type 1; group 6, anterior-ASLB + posterior-PSLB-type 2) (n = 13 per group, Table 1).",OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 77 http://dx.doi.org/10.4041/kjod.2016.46.2.73 DISCUSSION   There has been consistent agreement that SLBs exhibit  lower friction than CBs when coupled with small round archwires.,Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
"Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 78 http://dx.doi.org/10.4041/kjod.2016.46.2.73 rotation, in-and-out, tipping, and torque that could  result in unwanted friction during measurements.5,9,29    Numerous studies have evaluated the frictional force using a rectangular wire in one or several brackets in a straight form.",Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
"Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 79 http://dx.doi.org/10.4041/kjod.2016.46.2.73 Tables 2 and 3) might be similar to a case report by Paik  et al.,18 who introduced hybrid sliding mechanics for low  friction (a combination of CBs on the anterior teeth, PSLBs on the second premolars, and conventional tubes on the first and second molars).",Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
Kim and Baek • Friction in hybrid bracket systems www.e-kjo.org 80 http://dx.doi.org/10.4041/kjod.2016.46.2.73 of tooth mobility during orthodontic treatment  using a periotest.,Non-OADS,/arxiv_data1/oa_pdf/c7/63/kjod-46-73.PMC4807151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.81",Non-OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
"Choi et al • Lip-line cant and aging www.e-kjo.org 82 http://dx.doi.org/10.4041/kjod.2016.46.2.81INTRODUCTION   Previous studies have reported that all healthy people  exhibit some degree of facial asymmetry, including indi-viduals whose faces are perceived as normal.",Non-OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
"Choi et al • Lip-line cant and aging www.e-kjo.org 83 http://dx.doi.org/10.4041/kjod.2016.46.2.81deviation angle and lip-line cant, posteroanterior cephalo- grams were taken with a metal ball attached to each ear rod in the head holder as the reference to ensure the Frankfort horizontal plane was parallel to the floor.",Non-OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
"Choi et al • Lip-line cant and aging www.e-kjo.org 84 http://dx.doi.org/10.4041/kjod.2016.46.2.81  Our patients had an average of 1.6o of lip-line cant (SD,  1.0o) before orthodontic treatment.",Non-OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
Choi et al • Lip-line cant and aging www.e-kjo.org 85 http://dx.doi.org/10.4041/kjod.2016.46.2.81the actions of three muscles: the upward pull from  the zygomaticus major and levator anguli oris muscles and the downward pull from the depressor anguli oris muscle.,Non-OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
Choi et al • Lip-line cant and aging www.e-kjo.org 86 http://dx.doi.org/10.4041/kjod.2016.46.2.81Dentofacial Orthop 2007;132:279.e1-6.,OADS,/arxiv_data1/oa_pdf/37/d8/kjod-46-81.PMC4807152.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.87",Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
Kim et al • Frictional properties of lingual brackets www.e-kjo.org 88 http://dx.doi.org/10.4041/kjod.2016.46.2.87INTRODUCTION   Lingual appliances were developed in the 1980s as  an esthetic treatment option for adult orthodontic patients.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
"Kim et al • Frictional properties of lingual brackets www.e-kjo.org 89 http://dx.doi.org/10.4041/kjod.2016.46.2.87CL-LB with a narrow bracket width (STb; Ormco), and  one type of self-ligating lingual bracket (In-Ovation L; GAC, Dentsply Corp., York, PA, USA) were tested under three tooth displacement conditions: no displacement (control); a 2-mm palatal displacement of the maxillary right lateral incisor (MXLI); and a 2-mm gingival displacement of the maxillary right canine (MXC) (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
Kim et al • Frictional properties of lingual brackets www.e-kjo.org 90 http://dx.doi.org/10.4041/kjod.2016.46.2.87maxillary right second molar tube was gripped with a  custom-designed adaptor.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
Kim et al • Frictional properties of lingual brackets www.e-kjo.org 91 http://dx.doi.org/10.4041/kjod.2016.46.2.87with Tukey’s honest significant difference (HSD) post  hoc test was performed for the statistical analysis.,OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
Kim et al • Frictional properties of lingual brackets www.e-kjo.org 92 http://dx.doi.org/10.4041/kjod.2016.46.2.87Table 3.,OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
"Kim et al • Frictional properties of lingual brackets www.e-kjo.org 93 http://dx.doi.org/10.4041/kjod.2016.46.2.87MXC, followed by a 2-mm palatal displacement of the  MXLI and the control group (all p < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
"Kim et al • Frictional properties of lingual brackets www.e-kjo.org 94 http://dx.doi.org/10.4041/kjod.2016.46.2.87results of their study and those of the present study  seems to originate from differences in experimental design, and specifically the use of three anterior teeth and a straight archwire in the study by Lombardo et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
Kim et al • Frictional properties of lingual brackets www.e-kjo.org 95 http://dx.doi.org/10.4041/kjod.2016.46.2.87REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/ad/84/kjod-46-87.PMC4807153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.2.96",Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 97 http://dx.doi.org/10.4041/kjod.2016.46.2.96INTRODUCTION   Maxillary molar distalization is a frequently preferred  nonextraction treatment option for patients with Class II malocclusion.,Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 98 http://dx.doi.org/10.4041/kjod.2016.46.2.96were attached to the Nance appliance using a 0.8- mm stainless steel wire.,Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 99 http://dx.doi.org/10.4041/kjod.2016.46.2.96  There were no significant differences in the pretreat- ment variables between groups (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
"Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 100 http://dx.doi.org/10.4041/kjod.2016.46.2.96hand, the increase in the distance between the second  premolar cusp tips (U5 distance) was significantly greater in KIDS group than in Frog group.",Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 101 http://dx.doi.org/10.4041/kjod.2016.46.2.96may be attributed to the design of the appliances.,Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
"Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 102 http://dx.doi.org/10.4041/kjod.2016.46.2.96CONCLUSION   In summary, expansion and the amount of rotation  per millimeter of first molar distalization was greater with KIDS than with the Frog appliance.",OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
Uzuner et al • Transversal dental changes intraoral distalizers www.e-kjo.org 103 http://dx.doi.org/10.4041/kjod.2016.46.2.96with a pendulum appliance K-loop combination.,Non-OADS,/arxiv_data1/oa_pdf/6e/ce/kjod-46-96.PMC4807154.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/b2/aps-43-131.PMC4807167.pdf
ORCID T ae Gon Kim http://orcid.org/0000-0002-6738-4630 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/b2/aps-43-131.PMC4807167.pdf
Available from: http://www.ka - mje.or.kr/intro.php?body=publishing_ethics.,Non-OADS,/arxiv_data1/oa_pdf/91/b2/aps-43-131.PMC4807167.pdf
Available from:  http://publicationethics.org/files/redundant%20publica - tion%20B.pdf.,Non-OADS,/arxiv_data1/oa_pdf/91/b2/aps-43-131.PMC4807167.pdf
Available  from: http://www.icmje.org/recommendations/browse/ publishing-and-editorial-issues/overlapping-publications.,Non-OADS,/arxiv_data1/oa_pdf/91/b2/aps-43-131.PMC4807167.pdf
"134Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/d0/aps-43-134.PMC4807168.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/a8/aps-43-145.PMC4807169.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/fe/aps-43-153.PMC4807170.pdf
Available from: http://stat.mw.go.,OADS,/arxiv_data1/oa_pdf/a9/fe/aps-43-153.PMC4807170.pdf
Available from: http://stat.mw.go.kr/front/statData/publi - cationView.jsp?menuId=47&bbsSeq=13&nttSeq=10104& searchKey=&searchWord=&nPage=7.,OADS,/arxiv_data1/oa_pdf/a9/fe/aps-43-153.PMC4807170.pdf
"160Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/87/aps-43-160.PMC4807171.pdf
Landmarks and measurements in the balanced angular proportional analysis (BAPA) of frontal facial images We connected to the balanced angular proportional analysis (BAPA) website (http://bapa.co.kr).,OADS,/arxiv_data1/oa_pdf/e8/87/aps-43-160.PMC4807171.pdf
This result has been posted at http://blog.naver.com/ artprs/110179850681.,Non-OADS,/arxiv_data1/oa_pdf/e8/87/aps-43-160.PMC4807171.pdf
Available from:  http://www.vjo.it/wp-content/uploads/2012/08/zone.,Non-OADS,/arxiv_data1/oa_pdf/e8/87/aps-43-160.PMC4807171.pdf
"172Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/12/aps-43-172.PMC4807172.pdf
http://dx.doi.org/  10.1097/iop.0000000000000456.,Non-OADS,/arxiv_data1/oa_pdf/f6/12/aps-43-172.PMC4807172.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/5b/aps-43-181.PMC4807173.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/9c/aps-43-189.PMC4807174.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/d3/aps-43-197.PMC4807175.pdf
"204Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/77/aps-43-204.PMC4807176.pdf
"Received: 1 Dec 2015 • Revised: 20 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.210   Arch Plast Surg 2016;43:210-212 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/4c/aps-43-210.PMC4807177.pdf
"Received: 15 Oct 2015 • Accepted: 14 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.212   Arch Plast Surg 2016;43:212-214 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/4c/aps-43-210.PMC4807177.pdf
"Received: 15 Oct 2015 • Accepted: 14 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.212   Arch Plast Surg 2016;43:212-214 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/aps-43-212.PMC4807178.pdf
"Received: 22 Apr 2015 • Revised: 8 Jun 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.214   Arch Plast Surg 2016;43:214-216 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/aps-43-212.PMC4807178.pdf
"Received: 22 Apr 2015 • Revised: 8 Jun 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.214   Arch Plast Surg 2016;43:214-216 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/13/aps-43-214.PMC4807179.pdf
"Received: 13 Apr 2015 • Revised: 11 May 2015 • Accepted: 21 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.216   Arch Plast Surg 2016;43:216-218 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/13/aps-43-214.PMC4807179.pdf
"Received: 13 Apr 2015 • Revised: 11 May 2015 • Accepted: 21 May 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.216   Arch Plast Surg 2016;43:216-218 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/f1/aps-43-216.PMC4807180.pdf
"Received: 13 May 2015 • Revised: 3 Jun 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.218   Arch Plast Surg 2016;43:218-221 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/f1/aps-43-216.PMC4807180.pdf
"Received: 13 May 2015 • Revised: 3 Jun 2015 • Accepted: 9 Jun 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.2.218   Arch Plast Surg 2016;43:218-221 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/f4/aps-43-218.PMC4807181.pdf
Available from: http://www.hscic.gov.uk/catalogue/PUB02731/clin- audi-supp-prog-mast-brea-reco-2011-rep1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/03/aps-43-222.PMC4807182.pdf
"Received: 11 Oct 2015 • Revised: 9 Dec 2015 • Accepted: 14 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171  http://dx.doi.org/ 10.5999/aps.2016.43.2.222 • Arch Plast Surg 2016;43:222-223 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.Communication",Non-OADS,/arxiv_data1/oa_pdf/63/03/aps-43-222.PMC4807182.pdf
Available  from: http://www.associationofbreastsurgery.org.uk/media/23851/ final_oncoplastic_guidelines_for_use.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/03/aps-43-222.PMC4807182.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/3b/f2/srep20730.PMC4807242.pdf
Clin Infect Dis14:801– 807. http://dx.doi.org/10.1093/clinids/14.4.801 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1093/ clinids/3.2.246 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/S0140 -6736(09)61204-6 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1542/peds.2008-1482 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1002/lary.24190 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/j.vaccine.2011.02.088 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1038/nrmicro1871 .12.,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ IAI.01475-06 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/ 374624 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/423820 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Dis 194: 682– 688. http://dx.doi.org/ 10.1086/505710 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1097/ 00006454-200003000-00003 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
N Engl JMed 344:403– 409. http://dx.doi.org/10.1056/NEJM200102083440602 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Pediatr Infect Dis J 24:823– 828. http://dx.doi.org/ 10.1097/01.inf.0000178066.24569.98 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/S0264-410X(03)00230-5 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1056/ NEJMoa022823 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/ 521833 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1371/ journal.pgen.0020031 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Mol Micro- biol 27:73– 83. http://dx.doi.org/10.1046/j.1365-2958.1998.00658.x .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1371/ journal.ppat.0030168 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/CVI.00381-13 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JCM.05182-11 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1371/journal.pone.0097825 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/mBio.00035-12 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
ClinInfect Dis 47:476 – 484. http://dx.doi.org/10.1086/590001 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1099/mic.0.054270-0 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.3109/02713683.2010.492462 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Chemother 20:423– 428. http://dx.doi.org/10.1016/j.jiac.2014.03.010 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1111/ j.1469-0691.2009.02775.x .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Clin Microbiol 41:4415– 4417. http://dx.doi.org/ 10.1128/JCM.41.9.4415-4417.2003 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1128/IAI.68.3.1374-1382.2000 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JCM.00461-08 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/j.ijmm.2013.06.006 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1097/ MRM.0000000000000001 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1099/00221287-144-11-3049 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
N Engl J Med 346:429 – 437. http://dx.doi.org/10.1056/NEJMra011994 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1093/jac/ dkf506 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ JCM.01551-07 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JCM.43.3.1285-1293.2005 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1099/ jmm.0.031450-0 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1371/ journal.pone.0076309 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Dis194:689 – 696. http://dx.doi.org/10.1086/506453 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JCM.42.9.3942-3949.2004 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1038/ng.2895 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/ j.vaccine.2009.04.021 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1097/00006454-199506000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/S1473-3099(04)00938-7 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Expert Rev Vaccines 11:841– 855. http://dx.doi.org/10.1586/erv.12.53 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/ 431679 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1086/514205 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Infect Immun 74: 6739 – 6749. http://dx.doi.org/10.1128/IAI.00954-06 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Infect Immun 68:4604 – 4610. http://dx.doi.org/10.1128/IAI.68.8.4604-4610.2000 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1074/jbc.M802519200 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ IAI.00755-12 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Streptococcus pneumoniae detects and responds to foreign bacterial peptide fragments in its environment.Open Biol 4:130244. http://dx.doi.org/10.1098/rsob.130224 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1128/IAI.72.7.3902-3906.2004 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1172/JCI36731 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/genomeA.00520-13 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1111/j.1462 -5822.2006.00857.x .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1126/ science.1092385 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/IAI.00488-12 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1001/jama.299.22.2682 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/CMR.15.2.167-193.2002 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1038/nrmicro821 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/j.tim.2012.11.005 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JB.01369-06 .Keller et al.,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1001108 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1002/ (SICI)1097-0290(19970120)53:2 /H11021151::AID-BIT4 /H110223.0.CO;2-N .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1111/j.1365-2958.2006.05310.x .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1001/jama.296.2.202 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1371/ journal.pone.0019844 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1097/ INF.0b013e318154b273 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ MMBR.65.2.187-207.2001 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1097/00001432-200206000-00004 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1093/gbe/ evv178 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ IAI.00682-10 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1099/ mic.0.28610-0 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ IAI.73.5.2680-2689.2005 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/ j.mib.2005.11.001 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
BMC Genomics 15:863. http://dx.doi.org/10.1186/1471-2164 -15-863 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/317602 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Dis 175: 839 – 846. http://dx.doi.org/ 10.1086/513980 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ IAI.01126-07 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/IAI.70.5.2526-2534.2002 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1093/gbe/evu263 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
Nat Genet 45: 656 – 663. http://dx.doi.org/10.1038/ng.2625 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/JCM.44.3.743-749.2006 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/ JCM.43.4.1694-1698.2005 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1111/1469-0691.12196 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1097/01.inf.0000238143.96607.ec .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1056/NEJMoa022521 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.3949/ ccjm.75.7.507 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/ j.diagmicrobio.2010.09.019 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/j.jiac.2015.10.006 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/IAI.01148-08 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1074/jbc.M114.610212 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/j.molimm.2014.06.029 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1016/ j.it.2008.04.008 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Dis 134:595– 604. http://dx.doi.org/ 10.1093/infdis/134.6.595 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1093/oﬁd/ofu037 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1086/ 597042 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/CVI.00456-15 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
J Infect Dis 206:73– 80. http://dx.doi.org/ 10.1093/infdis/jis307 .,OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/10.1128/IAI.00881-09 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
http://dx.doi.org/ 10.1128/mBio.00200-12 .,Non-OADS,/arxiv_data1/oa_pdf/f6/eb/mBio.01792-15.PMC4807366.pdf
"The result-ing data set, containing 5,782 (2,125 /H110011,749/H110011,908) positions, was used for phylogenetic inference under a partitioned model withmaximum-likelihood criterion and a Bayesian approach in Treeﬁnderversion 03.2011 (http://www.treeﬁnder.de) and MrBayes version 3.2.5(76).",OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1101/cshperspect.a011403 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Nat Commun 6:6238. http://dx.doi.org/10.1038/ ncomms7238 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
BMC Evol Biol 13: 190. http://dx.doi.org/10.1186/1471-2148-13-190 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1038/nrg2319 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/ j.cell.2014.07.047 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1007/BF00239219 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Aquat Biosyst 8:24.http://dx.doi.org/10.1186/ 2046-9063-8-24 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/0020 -7519(94)90070-1 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.2741/1944 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Sex Transm Infect 89:439 – 443. http://dx.doi.org/10.1136/ sextrans-2013-051105 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.pt.2012.11.001 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
n. Protist 165: 825– 838. http://dx.doi.org/10.1016/ j.protis.2014.09.002 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1093/gbe/evt012 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.protis.2011.01.001 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1371/ journal.pone.0012415 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.ijpara.2013.02.005 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1111/j.1550-7408.1974.tb03733.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1111/j.1550-7408.1981.tb02829.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1128/EC.4.3.516 -525.2005 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/0014-4894(78)90141-8 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/0020-711X(85)90058-8 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1111/j.1550-7408.1994.tb05934.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Biochem Biophys Res Commun343:443– 449. http://dx.doi.org/10.1016/j.bbrc.2006.02.168 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1371/journal.pone.0060209 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/S0020-7519(03)00124-3 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.exppara.2007.09.007 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.femsle.2005.09.012 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/j.protis.2015.08.004 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
J Eukaryot Microbiol 54:57– 65. http://dx.doi.org/ 10.1111/j.1550-7408.2006.00150.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/ 10.1093/infdis/4.2.223 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
nov. Int J Syst Evol Microbiol 50(Pt 2):887– 899. http://dx.doi.org/ 10.1099/00207713-50-2-887 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/ 10.1017/S0031182006000746 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Endosymbiosis in trypanosomatid protozoa: the bacterium division is controlled during the host cell cycle.Front Microbiol 6:520. http://dx.doi.org/10.3389/fmicb.2015.00520 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1099/ ijs.0.026138-0 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Int J Syst Bacteriol 37:456 – 457. http://dx.doi.org/ 10.1099/00207713-37-4-456 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/ 10.1002/jez.1402300302 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/ 10.1111/j.1462-2920.2010.02396.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1099/ ijs.0.001149-0 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1128/mBio.01356-15 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1111/j.1550 -7408.2009.00464.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.14411/fp.2014.023 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
n. J Eukaryot Microbiol http://dx.doi.org/10.1111/jeu.12268 .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1128/AEM.66.12.5116-5122.2000 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/0166 -6851(95)02526-X .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Protist 165:594 – 604. http://dx.doi.org/10.1016/j.protis.2014.07.001 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/S1055-7903(03)00177-5 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1017/ S003118200400592X .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/ j.ympev.2009.10.014 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1111/j.1550-7408.2005.00078.x .,Non-OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1093/sysbio/ sys029 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Protist 163: 616 – 631. http://dx.doi.org/10.1016/ j.protis.2011.12.004 .,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
Nat Methods 9:772. http://dx.doi.org/10.1038/nmeth.2109 .Kostygov et al.,OADS,/arxiv_data1/oa_pdf/80/82/mBio.01985-15.PMC4807368.pdf
http://dx.doi.org/10.1016/S1047-2797(00)00072-7 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Nat Rev Microbiol 13:269 –284 http://dx.doi.org/10.1038/ nrmicro3432 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Scienti- ﬁcworldjournal 4(Suppl 1):76 – 88. http://dx.doi.org/10.1100/ tsw.2004.50 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1056/ NEJMcp1104429 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/ j.ijantimicag.2011.09.009 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Nat Rev Urol 7:653– 660. http://dx.doi.org/10.1038/nrurol.2010.190 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1371/ journal.pone.0026578 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/AAC.02824-14 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.3201/eid1805.111153 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1586/eri.12.110 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Expert Rev Vaccines11:663– 676. http://dx.doi.org/10.1586/erv.12.36 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1073/ pnas.0915077107 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/JB.01744-06 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/ JB.188.3.977-987.2006 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Mol Microbiol 37:424 – 432. http://dx.doi.org/10.1046/ j.1365-2958.2000.02008.x .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Proc Natl Acad Sc iUSA 111: 457– 462. http://dx.doi.org/ 10.1073/pnas.1311592111 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/IAI.01952-06 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2003.03833.x .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1093/emboj/20.12.3074 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1007/978-1-4899 -1828-4_56 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1046/j.1365-2958.2003.03490.x .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1038/ nsmb.2261 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1093/nar/gkn860 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1093/nar/ gkq366 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Mol Microbiol 35: 877– 887. http://dx.doi.org/10.1046/j.1365-2958.2000.01762.x .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2002.02918.x .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/JB.185.7.2236 -2242.2003 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/ j.abb.2012.02.007 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichiacoli O1:K1:H7 in a mouse model of ascending urinary tract infection.Infect Immun 74:461– 468. http://dx.doi.org/10.1128/IAI.74.1.461 -468.2006 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/j.micpath.2013.07.001 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1074/jbc.M113.516641 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Crystal structures of interleukin 17A and its complex with IL-17receptor A. Nat Commun 4:1888. http://dx.doi.org/10.1038/ ncomms2880 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Annu Rev Immunol 26: 453– 479. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090357 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/j.immuni.2013.01.004 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1016/j.cyto.2015.05.008 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1038/nri3831 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1111/j.1574 -695X.2012.00931.x .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1189/jlb.1009659 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.4049/ jimmunol.1101231 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1371/journal.pone.0078013 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1038/nri980 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/ JVI.76.3.1285-1292.2002 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1073/pnas.97.4.1695 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1128/JVI.78.3.1440-1447.2004 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
J Immunol187:4392– 4402. http://dx.doi.org/10.1016/1074-7613(95)90070-5 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
J Mol Biol 335:641– 654. http://dx.doi.org/10.1016/j.jmb.2003.10.070 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/ 0092-8674(92)90274-G .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1016/0092-8674(92)90273-F .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/0092-8674(95)90076-4 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1074/jbc.270.27.15974 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1099/0022-1317-81-5-1223 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.4049/jimmunol.164.6.3246 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/IAI.05594-11 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1128/IAI.01010-09 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1128/IAI.05322-11 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
ProteinExpr Purif 47:446 – 454. http://dx.doi.org/10.1016/j.pep.2005.12.011 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/ 10.1016/j.pep.2005.01.016 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Crystal structures of the DsbG disulﬁde isomerase reveal an unstable disulﬁde.Proc Natl Acad Sc iUSA 101: 8876 – 8881. http://dx.doi.org/10.1073/ pnas.0402769101 .83.,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
ActaCrystallogr D Biol Crystallogr 61:449 – 457. http://dx.doi.org/10.1107/ S0907444905001307 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1107/S0907444906022116 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1107/S0907444902016657 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1074/ jbc.M804231200 .,Non-OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1016/ j.cpc.2007.08.012 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
Appl Environ Microbiol66:4555– 4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000 .,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1093/ bioinformatics/btr039 .IrmA Is a Novel UPEC IL Receptor Mimic Protein March/April 2016 Volume 7 Issue 2 e02046-15 ®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/dd/a8/mBio.02046-15.PMC4807369.pdf
http://dx.doi.org/10.1093/nar/gkv437 .Wang et al.,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1146/annurev.micro.60.080805.142115 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1038/ismej.2012.62 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/AEM.01508-09 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/AEM.01543-07 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
Science 307:1598. http://dx.doi.org/10.1126/science.1105486 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1021/ja207172s .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1126/science.1188418 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/ AEM.70.8.4692-4701.2004 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1039/b909133e .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1046/j.1529-8817.1999.3530493.x .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1371/ journal.pone.0043996 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1128/AEM.02717-09 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1016/j.aquaculture.2005.11.039 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/ AEM.66.10.4237-4246.2000 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.3354/ame01359 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
Front Microbiol 5:311. http://dx.doi.org/10.3389/ fmicb.2014.00311 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1021/ja508782y .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.7164/ antibiotics.37.1294 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/AEM.71.11.7263 -7270.2005 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1021/jo7018416 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1039/b711474e .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/AEM.02339-07 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1039/c4cc01924e .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1074/ jbc.M110.196667 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1038/nature10862 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
BMC Microbiol 9:265. http://dx.doi.org/10.1186/1471 -2180-9-265 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/AEM.00531-08 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1146/annurev.biochem.73.011303.074021 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1038/ nchembio779 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1021/ja00048a019 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1128/JB.05818-11 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1146/ annurev.genet.35.102401.090913 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1038/nrm907 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1146/annurev.cellbio.21.012704.131001 .,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1146/annurev.micro.091208.073248 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/10.1099/ ijs.0.63724-0 .,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
http://dx.doi.org/ 10.1038/72017 .Wang et al.,OADS,/arxiv_data1/oa_pdf/f6/ff/mBio.02118-15.PMC4807370.pdf
The RNA-seq reads were mapped to a synthetic mouse genome (mm10) in which all the single polymorphic nucleotides (as annotated byWellcome Trust Sanger Institute sequencing; ftp://ftp-mouse.sanger- .ac.uk/current_snps/ ) between AJ and B6 were masked with Bowtie2 (2.2.3) (44) and TopHat (v2.0.4) (45).,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
"Inbrief, we used 934 AXB/BXA genetic informative markers obtained from http://www.genenetwork.org to perform a genome-wide scan in R/qtl (48).",OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/IAI.01654-13 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
Vaccine27:597– 605. http://dx.doi.org/10.1016/j.vaccine.2008.10.079 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/ IAI.68.3.1480-1484.2000 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1002/ 1615-9861(200201)2:1 /H1102185::AID-PROT85 /H110223.0.CO;2-S .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1099/jmm.0.46313-0 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/ IAI.02030-05 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
NatImmunol 11:395– 402. http://dx.doi.org/10.1038/ni.1864 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.4049/ jimmunol.1402764 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1111/j.1462-5822.2012.01816.x .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1074/jbc.M706854200 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.4049/ jimmunol.1100377 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1074/jbc.M113.490086 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
Microbiol Mol Biol Rev 76:383– 404. http://dx.doi.org/ 10.1128/MMBR.05027-11 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/IAI.01382-10 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1111/j.1462-5822.2006.00719.x .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/ IAI.00795-06 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1189/jlb.0306219 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1371/ journal.pgen.1005619 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1128/ IAI.00992-09 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003114 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1111/j.1462-5822.2011.01643.x .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1038/nrg1206 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1016/S0959-437X(03)00051-0 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1016/j.pbi.2007.01.003 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1016/j.coi.2012.09.005 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1111/j.1558-5646.2007.00100.x .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
Nat Immunol 16:467– 475. http://dx.doi.org/ 10.1038/ni.3118 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/ 10.1016/j.micpath.2005.02.003 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/ 10.1016/j.molimm.2008.04.006 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
Cell Host Microbe 9:472– 483. http://dx.doi.org/ 10.1016/j.chom.2011.04.015 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
Nat Methods9:676 – 682. http://dx.doi.org/10.1038/nmeth.2019 .43.,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/ 10.1101/gr.166033.113 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1186/gb-2009-10-3-r25 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
http://dx.doi.org/10.1038/nbt.2450 .,Non-OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
BioInformatics 19:889 – 890. http://dx.doi.org/ 10.1093/bioinformatics/btg112 .,OADS,/arxiv_data1/oa_pdf/38/f5/mBio.02243-15.PMC4807373.pdf
"[http://dx.doi.org/10.1038/nrm2330 ] [PMID: 18216768 ] [2] van Meer, G. Cellular lipidomics.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1038/sj.emboj.7600798 ] [PMID: 16138081 ] [3] Simons, K.; Sampaio, J.L.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1101/cshperspect.a004697 ] [PMID: 21628426 ] [4] English, A.R.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1101/cshperspect.a013227 ] [PMID: 23545422 ] [5] Amazon, J.J.; Feigenson, G.W.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1103/PhysRevE.89.022702 ] [PMID: 25353504 ] [6] García-Sáez, A.J.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.febslet.2009.12.036 ] [PMID: 20036662 ] [7] Serhan, C.N.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1042/BST20130235 ] [PMID: 24256283 ] [9] Franker, M.A.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1242/jcs.115030 ] [PMID: 23729742 ] [10] Pokorný, J.; Pokorný, J.; Kobilková, J. Postulates on electromagnetic activity in biological systems and cancer.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1039/c3ib40166a ] [PMID: 24166132 ] [11] Cifra, M.; Pokorný, J.; Havelka, D.; Kucera, O.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.biosystems.2010.02.007 ] [PMID: 20178826 ] [12] Havelka, D.; Cifra, M.; Kučera, O.; Pokorný, J.; Vrba, J. High-frequency electric field and radiation characteristics of cellular microtubule network.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.jtbi.2011.07.007 ] [PMID: 21782830 ] [13] Blobel, G. Intracellular protein topogenesis.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1080/05704920701829043 ] [17] Neumeister, V.; Scheibe, M.; Lattke, P.; Jaross, W. Determination of the cholesterol-collagen ratio of arterial atherosclerotic plaques using near infrared spectroscopy as a possible measure of plaque stability.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/S0021-9150(02)00279-4 ] [PMID: 12417275 ] [18] Jaross, W.; Neumeister, V.; Lattke, P.; Schuh, D. Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
[http://dx.doi.org/10.1016/S0021-9150(99)00203-8 ] [PMID: 10559519 ],OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1021/cm2028367 ] [PMID: 22919122 ] [20] Burke, B.; Stewart, C.L.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/B978-0-12-397920-9.00006-8 ] [PMID: 24947235 ] [21] Cau, P.; Navarro, C.; Harhouri, K.; Roll, P.; Sigaudy, S.; Kaspi, E.; Perrin, S.; De Sandre-Giovannoli, A.; Lévy, N. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.semcdb.2014.03.022 ] [22] Cain, N.E.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.4161/19491034.2014.990857 ] [PMID: 25425085 ] [23] Guo, T.; Fang, Y. Functional organization and dynamics of the cell nucleus.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.3389/fpls.2014.00378 ] [PMID: 25161658 ] [24] Tapley, E.C.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.ceb.2012.10.014 ] [PMID: 23149102 ] [25] Rothballer, A.; Kutay, U.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1007/s00412-013-0417-x ] [PMID: 23736899 ] [26] Burns, L.T.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.ceb.2012.01.009 ] [PMID: 22326668 ] [27] Rothballer, A.; Schwartz, T.U.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.4161/nucl.23387 ] [PMID: 23324460 ] [28] Faenza, I.; Fiume, R.; Piazzi, M.; Colantoni, A.; Cocco, L. Nuclear inositide specific phospholipase C signalling - interactions and activity.",OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1111/febs.12450 ] [PMID: 23890371 ] [29] Farooqui, A.A.; Ong, W.Y.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10.1016/j.bbalip.2010.02.002 ] [30] Wu, G.; Chen, X.; Peng, J.; Cai, Q.; Ye, J.; Xu, H.; Zheng, C.; Li, X.; Ye, H.; Liu, X. Millimeter wave treatment induces apoptosis via activation of the mitochondrial-dependent pathway in human osteosarcoma cells.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"[http://dx.doi.org/10..3892/ijo2012.1330 ] [PMID: 22246399 ] Received: May 5, 2015 Revised: September 4, 2015 Accepted: September 22, 2015 © Werner Jaross; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/96/cf/TOBIOCJ-10-12.PMC4807408.pdf
[http://dx.doi.org/10.1016/S0140-6736(04)17140-7] [PMID: 15464184] [4] K.M.,OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
[http://dx.doi.org/10.1001/jama.283.9.1175] [PMID: 10703780] [5] U.,OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"Nations,  ""The  millennium  development  goals  report  2014"",  Available  at:  http://www.un.org/millenniumgoals/2014%20MDG%20 report/MDG%202014%20English%20web.pdf [6] UNAIDS, Progress Report on the Global Plan towards the Elimination of New HIV Infections among children by 2015 and keeping their Mothers Alive.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.4236/jbise.2014.71007] [9] R. Malkin, and C. Howard, ""A foilized polyethylene pouch for the prevention of transmission of HIV from mother to child"", Open Biomed.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.2174/1874120701206010092] [PMID: 23028405] [10] R. Malkin, and K. von Oldenburg Beer, ""Diffusion of novel healthcare technologies to resource poor settings"", Ann.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1007/s10439-013-0750-5] [PMID: 23377566] [11] R. Malkin, ""A pouch may be prevent the transmission of HIV from mother to child"", J. Biomed.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.5963/BER0202002] [12] A.  Choy,  M.  Ortiz,  and  R.  Malkin,  ""Accurate  dosing  of  antiretrovirals  at  home  using  a  foilized,  polyethylene  pouch  to  prevent  the transmission of HIV from mother to child"", Medicine (Baltimore), vol.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1097/MD.0000000000001030] [PMID: 26107673] [13] SSP  Stockouts  National  Survey,  Stock  Outs  in  South  Africa:  A  National  Crisis.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
Available  from:  http://stockouts.org/ uploads/3/3/1/1/3311088/stop_stockouts_report_2013pdf_1.pdf [14] M.A.,Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
[http://dx.doi.org/10.1097/QAD.0000000000000105] [PMID: 24361627] [15] A.E.,OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
[http://dx.doi.org/10.1186/1744-8603-9-30] [PMID: 23889824] [16] T.R.,Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1371/journal.pone.0097194] [PMID: 24810609] [17] C. Ronsmans, J.F.",OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1046/j.1365-3156.2003.01111.x] [PMID: 14516306] [18] D. Montagu, G. Yamey, A. Visconti, A. Harding, and J. Yoong, ""Where do poor women in developing countries give birth?",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1371/journal.pone.0017155] [PMID: 21386886] [19] L. Grenier, J. Smith, S. Currie, and S. Suhowatsky, Advance Distribution of Misoprostol for SelfAdministration: Expanding Coverage for the Prevention of Postpartum Hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1186/1471-2393-14-189] [PMID: 24894566] [21] M. Nikanjam, D. Kabamba, T.R.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1128/AAC.00842-12] [PMID: 22869579] [22] I.  Boehringer  Ingelheim,  Pharmaceuticals,  ""Viramune:  Medication  Guide"".",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
Available  at  :  http://www.fda.gov/downloads/Drugs/ DrugSafety/ucm089818.pdf [23] L.M.,Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"[http://dx.doi.org/10.1097/QAD.0000000000000197] [PMID: 24463393] Received: March 31, 2015 Revised: October 27, 2015 Accepted: October 27, 2015 © Dahinten and Malkin; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/ef/TOBEJ-10-12.PMC4807409.pdf
"Available  from:  https://aoanjrr.dmac.adelaide.edu.au/documents/10180/127202/Annual%20 Report%202013?version=1.2&t=1385685288617 [2] Kurtz SM, Ong KL, Lau E, Bozic KJ.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.2106/JBJS.M.00285 ] [PMID: 24740658 ] [3] Walker PS, Soudry M, Ewald FC, McVickar H. Control of cement penetration in total knee arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1016/S0883-5403(00)90762-9 ] [PMID: 10794233 ] [6] Kim YH, Walker PS, Deland JT.",OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1054/arth.2001.22270 ] [PMID: 11402413 ] [9] Huiskes R, Sloof TJ.",OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.2106/JBJS.K.01116 ] [PMID: 23283372 ] [12] Li C, Kotha S, Mason J.",OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1097/00003086-198505000-00037 ] [PMID: 3978966 ] [17] Eriksson RA, Albrektsson T. The effect of heat on bone regeneration: an experimental study in the rabbit using the bone growth chamber.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1016/0278-2391(84)90417-8 ] [PMID: 6593442 ] [18] Whitehouse MR, Atwal NS, Pabbruwe M, Blom AW, Bannister GC.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1177/095441199420800106 ] [20] Fukushima H, Hashimoto Y, Yoshiya S, et al.",OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1186/1749-799X-9-13 ] [PMID: 24602486 ] [22] Pijls BG, Valstar ER, Nouta K-A, et al.",OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.3109/17453674.2012.747052 ] [PMID: 23140091 ] [23] Larsen ST, Ryd L. Temperature elevation during knee arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
[http://dx.doi.org/10.3109/17453678909149314 ] [PMID: 2816321 ] [24] Hulliger L. Studies on the effect of artificial resins (palacos and ostamer) in tissue cultures.,Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1007/BF00415596 ] [25] DiPisa JA, Sih GS, Berman AT.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.3109/17453679209154733 ] [PMID: 1441953 ] [27] Lee HB, Turner DT.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1002/jbm.820110504 ] [PMID: 893489 ] [28] Brauer GM, Steinberger DR, Stansbury JW.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1002/jbm.820200614 ] [PMID: 3722218 ] Received: July 12, 2015 Revised: September 10, 2015 Accepted: September 30, 2015 © Vertullo et al.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/TOORTHJ-10-19.PMC4807410.pdf
"[http://dx.doi.org/10.1302/0301-620X.88B2.17163 ] [PMID: 16434517 ] [2] Moskal JT, Capps SG.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/j.arth.2010.11.011 ] [PMID: 21296551 ] [3] Sendtner E, Schuster T, Wörner M, Kalteis T, Grifka J, Renkawitz T. Accuracy of acetabular cup placement in computer-assisted, minimally- invasive THR in a lateral decubitus position.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s00264-010-1042-4 ] [PMID: 20495801 ] [4] Wixson RL, MacDonald MA.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/j.arth.2005.04.024 ] [PMID: 16214003 ] [5] Honl M, Schwieger K, Salineros M, Jacobs J, Morlock M, Wimmer M. Orientation of the acetabular component.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1302/0301-620X.88B10.17587 ] [PMID: 17012436 ] [6] Jenny JY, Boeri C, Dosch JC, Uscatu M, Ciobanu E. Navigated non-image-based positioning of the acetabulum during total hip replacement.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s00264-007-0479-6 ] [PMID: 18004568 ] [7] Fukui T, Fukunishi S, Nishio S, Shibanuma N, Yoshiya S. Use of image-free navigation in determination of acetabular cup orientation: analysis of factors affecting precision.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
[http://dx.doi.org/10.3928/01477447-20100510-61 ] [PMID: 20954628 ],Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.3928/01477447-20120919-52 ] [PMID: 23026246 ] [9] Parratte S, Argenson JN.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.2106/JBJS.F.00529 ] [PMID: 17332097 ] [10] Wassilew GI, Perka C, Janz V, König C, Asbach P, Hasart O.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/j.arth.2011.06.038 ] [PMID: 22000576 ] [11] Ybinger T, Kumpan W. Enhanced acetabular component positioning through computer-assisted navigation.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s00264-007-0430-x ] [PMID: 17661035 ] [12] Ybinger T, Kumpan W, Hoffart HE, Muschalik B, Bullmann W, Zweymüller K. Accuracy of navigation-assisted acetabular component positioning studied by computed tomography measurements: methods and results.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/j.arth.2006.10.001 ] [PMID: 17826270 ] [13] Hakki S, Bilotta V, Oliveira JD, Dordelly L. Acetabular center axis: is it the future of hip navigation?",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.3928/01477447-20100510-52 ] [PMID: 20954629 ] [14] Hakki S, Dordelly L, Oliveira D. Comparative study of acetabular center axis vs anterior pelvic plane registration technique in navigated hip arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.5301/HIP.2011.8860 ] [PMID: 22135017 ] [16] Dorr LD, Malik A, Wan Z, Long WT, Harris M. Precision and bias of imageless computer navigation and surgeon estimates for acetabular component position.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1186/1749-799X-6-40 ] [PMID: 21831275 ] [18] Crowe JF, Mani VJ, Ranawat CS.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s00256-013-1574-y ] [PMID: 23354528 ] [20] Reynolds D, Lucas J, Klaue K. Retroversion of the acetabulum.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1302/0301-620X.81B2.8291 ] [PMID: 10204935 ] [21] Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR. Dislocations after total hip-replacement arthroplasties.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
[http://dx.doi.org/10.1007/s11999-012-2700-1 ] [PMID: 23283671 ] [23] Murray DW.,Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s11999-012-2370-z ] [PMID: 22544668 ] [25] Kennedy  JG,  Rogers  WB,  Soffe  KE,  Sullivan  RJ,  Griffen  DG,  Sheehan  LJ.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/S0883-5403(98)90052-3 ] [PMID: 9726318 ] [26] Widmer KH, Zurfluh B. Compliant positioning of total hip components for optimal range of motion.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/j.orthres.2003.11.001 ] [PMID: 15183439 ] [27] McCollum DE, Gray WJ.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
[http://dx.doi.org/10.1302/0301-620X.87B6.14745 ] [PMID: 15911655 ],Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1016/0883-5403(92)90008-E ] [PMID: 1613521 ] [30] Vandenbussche E, Saffarini M, Taillieu F, Mutschler C. The asymmetric profile of the acetabulum.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s11999-007-0062-x ] [PMID: 18196426 ] [31] Cobb J, Logishetty K, Davda K, Iranpour F. Cams and pincer impingement are distinct, not mixed: the acetabular pathomorphology of femoroacetabular impingement.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s11999-010-1347-z ] [PMID: 20431974 ] [32] Köhnlein W, Ganz R, Impellizzeri FM, Leunig M. Acetabular morphology: implications for joint-preserving surgery.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s11999-008-0682-9 ] [PMID: 19130159 ] [33] Richolt JA, Effenberger H, Rittmeister ME.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.3109/10929080500229447 ] [PMID: 16298919 ] [34] Digioia AM III, Jaramaz B, Plakseychuk AY, et al.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1054/arth.2002.30411 ] [PMID: 11938515 ] [35] Fukunishi S, Fukui T, Imamura F, Nishio S. Assessment of accuracy of acetabular cup orientation in CT-free navigated total hip arthroplasty.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.4081/or.2012.e33 ] [PMID: 23589761 ] [37] Jingushi S, Ohfuji S, Sofue M, et al.",OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"[http://dx.doi.org/10.1007/s00776-011-0025-7 ] [PMID: 21359510 ] Received: July 2, 2015 Revised: December 4, 2015 Accepted: December 7, 2015 © Wada et al.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/26/TOORTHJ-10-26.PMC4807411.pdf
<http://aidsinfo.nih.gov/contentfiles/lvguidelines/ PerinatalGL.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/89/7a/PSP4-5-147.PMC4807435.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Unbound Lopinavir Pharmacokinetics in the Third Trimester Chen et al .,OADS,/arxiv_data1/oa_pdf/89/7a/PSP4-5-147.PMC4807435.pdf
PAGE Abstract #3333 <http://www.page-meeting.org/?abstract 5 3333>(2015).,Non-OADS,/arxiv_data1/oa_pdf/d5/a5/PSP4-5-123.PMC4807465.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Combined Analyses in Pharmacogenetic Studies Tessier et al.,OADS,/arxiv_data1/oa_pdf/d5/a5/PSP4-5-123.PMC4807465.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/9b/rjw043.PMC4807615.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
112Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.02.008 2352-8273/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1111/1467-9280.00371 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"American Journal of Public Health ,103,5 0 –56.http://dx.doi.org/10.2105/AJPH.2012.300828 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"http://dx.doi.org/ 10.1006/jesp.2001.1491 .Ashmore, R. D., Deaux, K., & McLaughlin-Volpe, T. (2004).",OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/0033-2909.130.1.80 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/0042098009360680 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1093/aje/153.4.363 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1016/S0140-6736(06)68185-3 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1111/ 1467-9280.00277 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/ AJPH.2005.076547 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1176/appi.ps.56.5.557 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1177/1368430207088036 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1177/1065912913478839 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/ 0033-295X.95.2.256 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1111/j.1467-9280.2006.01716.x .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/0146167214564969 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/a0035403 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1146/ annurev.publhealth.26.021304.144542 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/AJPH.2014.302046 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/AJPH.90.6.867 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/ AJPH.2010.195537 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/ AJPH.2004.060749 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/0022146515582100 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1017/ S1742058X04042031 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Critical Public Health ,21,8 1 –93.http://dx.doi.org/10.1080/09581596.2010.493173 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/AJPH.2009.168815 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/AJPH.2011.300382 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/0022-3514.77.3.588 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Current Directions in Psychological Science , 22,5 1 –56.http://dx.doi.org/10.1177/0963721412461500 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1111/j.1540-6237.2009.00648.x .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1353/dem.2006.0008 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1348/014466609X480426 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Journal of Health and Social Behavior ,35,8 0 –94.http://dx.doi.org/10.2307/ 2626958 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.2105/AJPH.86.4.471 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1016/j.jesp.2005.04.010 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"http://dx.doi.org/10.1016/S0006-3223(03)00177-X .McEwen, B. S. (2000).",OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Protective and damaging effects of mediators of stress: Elaborating and testing the concepts of allostasis and allostatic load.Annals of the New York Academy of Sciences ,896 ,3 0 –47.http://dx.doi.org/ 10.1111/j.1749-6632.1999.tb08103.x .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/j.socscimed.2013.06.032 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/0146167209347380 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/a0023741 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/ a0012702 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/0146167207312960 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.1093/poq/nft027 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Du Bois Review ,1 ,2 7 –47.http://dx.doi.org/10.1017/ S1742058X0808003X .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/ 10.2105/AJPH.2012.300933 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Current Diretions in Psycho- logical Science ,19,1 4 –18.http://dx.doi.org/10.1177/0963721409359292 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1177/1090198104265598 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1037/1099-9809.13.4.321 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Psychological Science ,10, 80–83.http://dx.doi.org/10.1111/1467-9280.00111 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1186/ 1476-069X-13-91 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
"Current Hyper- tension Reports ,12,1 0 –16.http://dx.doi.org/10.1007/s11906-009-0084-8 .",Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/S0065-2601(02)80009-0 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/j.socscimed.2007.05.010 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1016/j.socscimed.2011.12.037 .,OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1126/science.1198364 .,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
http://dx.doi.org/10.1111/ j.1467-9280.2009.02417.x .A.T.,Non-OADS,/arxiv_data1/oa_pdf/43/95/main.PMC4807633.pdf
1     13   (Source http://www.fda.gov/radiation-emittingproducts) Fig.,Non-OADS,/arxiv_data1/oa_pdf/7f/d7/CCR-12-12.PMC4807712.pdf
October 2005. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/34/78/CCR-12-27.PMC4807715.pdf
"gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073153.pdf [5] http://www.azcert.org/medical-pros/drug-lists/drug-lists.cfm [6] Pert CB, Snyder S H. Opiate receptor: demonstration in nervous tissue.",Non-OADS,/arxiv_data1/oa_pdf/34/78/CCR-12-27.PMC4807715.pdf
"April 11, 2001; http://www.fda.gov/down-loads/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHu-manMedicalProducts/UCM173871.pdf [29] European Agency for the Evaluation of Medical Products.",Non-OADS,/arxiv_data1/oa_pdf/34/78/CCR-12-27.PMC4807715.pdf
http://www.ucl.ac.uk/nicor/audits/ heartfailure/additionalfiles/pdfs/annualreports/annual12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/0d/CCR-12-37.PMC4807717.pdf
[6] Growth diffrentiation factor 15. http://www.ncbi.nlm.nih.gov/gene/ 9518.,OADS,/arxiv_data1/oa_pdf/4e/0d/CCR-12-37.PMC4807717.pdf
Available at: http:// http://www.who.int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/84/05/CCR-12-47.PMC4807718.pdf
CRISPR/ This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/0a/nihms766484.PMC4807727.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, one table, and three data files and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2016.02.036 .",OADS,/arxiv_data1/oa_pdf/76/0a/nihms766484.PMC4807727.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 171–172Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.com Dove press 171 E X P E RT  O P I N I O Nopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S101395Quality improvement teaching at medical school:  a student perspective Pooja Nair Ishani Barai Sunila Prasad Karishma Gadhvi Department of Medicine, Imperial  College School of Medicine, Imperial  College London, London, UKAbstract:  Guidelines in the UK require all doctors to actively take part in quality improvement.",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
"This course com -Correspondence: Pooja Nair Department of Medicine, Sir Alexander  Fleming Building, Exhibition Road,   South Kensington Campus, Imperial  College, London SW7 2AZ, UK Email pooja.nair11@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: EXPERT OPINION Y ear: 2016 V olume: 7 Running head verso: Nair et al Running head recto: Quality improvement teaching at medical school DOI: http://dx.doi.org/10.2147/AMEP .S101395",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-   reviewed, open access journal that aims to present and publish research   on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
Available from: http://www.gmc-uk.org/static/ documents/content/GMC_Revalidation_A4_Guidance_GMP_Frame - work_04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
Available from: http://www.ihi.org/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
Available from: http://www.aomrc.org.uk/doc_view/227- undergraduate-guidance-for-medical-education-integrating-the-mlcf.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/amep-7-171.PMC4807889.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b0/f6/vhrm-12-085.PMC4807890.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/b0/f6/vhrm-12-085.PMC4807890.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Vascular Health and Risk Management 2016:12 85–103Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  85ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7470 3A clinical approach to obstructive sleep apnea as  a risk factor for cardiovascular disease Micha T Maeder1 Otto D Schoch2 Hans Rickli1 1Department of Cardiology,   2Department of Respiratory Medicine,   Kantonsspital St Gallen, St Gallen,   Switzerland Correspondence: Micha T Maeder   Department of Cardiology, Kantonsspital  St Gallen, Rorschacherstrasse 95,  CH-9007 St Gallen, Switzerland   T el +41 71 494 1039   Fax +41 71 494 6142   email Micha.maeder@kssg.c hAbstract:  Obstructive sleep apnea (OSA) is associated with cardiovascular risk factors,   cardiovascular diseases, and increased mortality.",Non-OADS,/arxiv_data1/oa_pdf/b0/f6/vhrm-12-085.PMC4807890.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b0/f6/vhrm-12-085.PMC4807890.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/f6/vhrm-12-085.PMC4807890.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diabetes, Metabolic syndrome and Obesity: Targets and Therapy 2016:9 101–108submit your manuscript | www.dovepress.co m Dove press  101 http: //dx.doi.org/10.2147/DMSO.S10362 0lifestyle intervention for Weight loss: a group- based program for emiratis in ajman, United arab  emirates amena sadiya1,* sarah abdi1,* salah abusnana2 1lifestyle clinic, 2research and  education Department, rashid center  for Diabetes and research, ajman,   United arab emirates *These authors contributed equally to  this work correspondence: amena sadiya   lifestyle clinic, rashid center for  Diabetes and research, PO Box 21499,  ajman, United arab emirates   T el +971 5 0353 9532   Fax +971 6 7434 547   email amena.sadiya@rcdr.a eBackground:  Lifestyle Intervention for Weight Loss (LIFE-8) is developed as a structured,  group-based weight management program for Emiratis with obesity and type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
Available from http://www.uptodate.com/contents/obesity-in- adults-behavioral-therapy?source =search_result&search =obesity +in+  adults+behavioral +therapy&selectedTitle =1∼150.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/dmso-9-101.PMC4807891.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/99/bctt-8-047.PMC4807892.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Breast cancer: Targets and Therapy 2016:8 47–52submit your manuscript | www.dovepress.co m Dove press  47 http: //dx.doi.org/10.2147/BCTT .S9918 4Factors affecting local recurrence and distant  metastases of invasive breast cancer after   breast-conserving surgery in chiang Mai   University hospital chagkrit Ditsatham1 areewan somwangprasert1 Kirati Watcharachan1 Phanchaporn  Wongmaneerung1 Jiraporn Khorana2 1Division of head, neck, and Breast  surgery,  2Division of Pediatric surgery,   Department of surgery, Faculty of  Medicine, chiang Mai University,   chiang Mai, Thailand correspondence: chagkrit Ditsatham   Department of surgery, Faculty of  Medicine, chiang Mai University,   110 intavaroros rd,  amphoe Muang,  chiang Mai  50200, Thailand   Tel +66 53 945 532  Fax +66 53 946 139  email nansurg7@gmail.co mBackground:  The purpose of this study was to collect data regarding breast cancer profiles  and factors that affect local recurrence and distant metastasis after breast-conserving surgery  (BCS) in Chiang Mai University Hospital.",Non-OADS,/arxiv_data1/oa_pdf/35/99/bctt-8-047.PMC4807892.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/35/99/bctt-8-047.PMC4807892.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 181–186Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.com Dove press 181 O R I G I N A L  R E S E A R C Hopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S98462Simulation experiences of paramedic students:   a cross-cultural examination Brett Williams1 Chloe Abel1 Eihab Khasawneh2 Linda Ross1 Tracy Levett-Jones3 1Department of Community  Emergency Health & Paramedic  Practice, Monash University,  Frankston, Victoria, Australia; 2Faculty  of Applied Medical Sciences, Jordan  University of Science and Technology,  Irbid, Jordan; 3School of Nursing  and Midwifery, The University of  Newcastle, Callaghan,   New South Wales, AustraliaBackground:  Simulation-based education is an important part of paramedic education and   training.",Non-OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
"Keywords:  allied health worker, culture, paramedics, simulation, undergraduate, student,  education Introduction The role of a paramedic has developed significantly in the last 30 years, moving away  from a “stretcher-bearer” into the role of an autonomous clinician, practicing skillful  medical procedures in the prehospital environment.1 Along with advances within the  profession itself, the education model for paramedics has also evolved from a traditional  “apprentice model with on-the-job training” into a professional-level tertiary educational  program, incorporating 3 years of “preemployment” university education.1 University-level  education provides students with comprehensive understanding of advanced concepts in  anatomy, physiology, professional behavior, ethics and research, complemented by clinical  skill training and clinical exposure through both simulation and clinical placements.1,2 Once qualified, paramedics are required to perform high-level clinical skills, often  in suboptimal and uncontrolled environments.3 However, the ability to expose students Correspondence: Brett Williams Department of Community Emergency  Health & Paramedic Practice, Monash  University – Peninsula Campus, PO Box  527, McMahons Road, Frankston, Victoria  3199, Australia Tel +61 3 9904 4407 Fax +61 3 9904 4168 Email brett.williams@monash.eduJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCH Y ear: 2016 V olume: 7 Running head verso: Williams et al Running head recto: Cross-cultural simulation DOI: http://dx.doi.org/10.2147/AMEP .S98462",Non-OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-   reviewed, open access journal that aims to present and publish research   on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/96/amep-7-181.PMC4807893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinical epidemiology 2016:8 37–47submit your manuscript | www.dovepress.co m Dove press  37 http: //dx.doi.org/10.2147/CLEP .S9301 4Treatment outcomes of hiV-positive patients on  first-line antiretroviral therapy in private versus  public HIV clinics in Johannesburg, South Africa Faith Moyo1 Charles Chasela2,3 alana T Brennan1,4 Osman Ebrahim5 Ian M Sanne1,6 lawrence long1 Denise evans1 1Health Economics and Epidemiology  Research Office, Department of  Internal Medicine, School of Clinical  Medicine, Faculty of Health Sciences,   University of the Witwatersrand,   Johannesburg, South Africa;   2epidemiology and Biostatistics  Department, School of Public Health,   Faculty of Health Sciences, University  of the Witwatersrand, Johannesburg,   South Africa; 3epidemiology and  Strategic Information (ESI), HIV/ AIDS/STIs and TB, Human Sciences  Research Council, Pretoria, South  Africa; 4Center for Global Health  and Development, Boston University,   Boston, MA, USA; 5Brenthurst Clinic,   Parktown, South Africa; 6Right  to Care, Helen Joseph Hospital,   Westdene, Johannesburg, South Africa Correspondence: Faith Moyo   Health Economics and Epidemiology  Research Office, Department of Internal  Medicine, School of Clinical Medicine,  Faculty of Health Sciences, University   of the Witwatersrand, Unit 2, 39 Empire  Road, Parktown, Johannesburg, 2193,  South Africa   email faith.moyo@.yahoo.co.z aBackground:  Despite the widely documented success of antiretroviral therapy (ART),  stakeholders continue to face the challenges of poor HIV treatment outcomes.",Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
The poster’ s abstract was published in “Poster Abstracts” in  the AIDS 2014 Conference website: http://pag.aids2014.org/ EPosterHandler.axd?aid=468 7.,Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK138523#ch11.s 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
"Available from: http://www.fidssa.co.za/  Guidelines/2010_Adult_ART_ Guidelines.pd f. Accessed October 01,  2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
Available  from: http://www.jsi.com/JSIInternet/Resources/publication/display.c fm?txtGeoArea =INTL&id =11211&thisSection =Resource s. Accessed  July 22 2014.,OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
"Available from: http://www.who.int/hiv/pub/ guidelines/clinicalstaging.pd f. Accessed April 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/1d/e1/clep-8-037.PMC4807894.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/88/dddt-10-1201.PMC4807895.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1201–1215Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1201Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10210 2effects of acute and chronic administration of  neurosteroid dehydroepiandrosterone sulfate on  neuronal excitability in mice Dubravka svob strac1 Josipa Vlainic1 Janko samardzic2 Julija erhardt3 Zeljka Krsnik4 1laboratory for Molecular  neuropsychiatry, Division of  Molecular Medicine, rudjer Boskovic  institute, Zagreb, croatia; 2institute of  Pharmacology, clinical Pharmacology  and T oxicology, Medical Faculty,   University of Belgrade, Belgrade,   serbia; 3Department of animal  Physiology, Faculty of science,   University of Zagreb, 4croatian  institute for Brain research,   Department of n euroscience, school  of Medicine, University of Zagreb,   Zagreb, croatiaBackground:  Neurosteroid dehydroepiandrosterone sulfate (DHEAS) has been associated  with important brain functions, including neuronal survival, memory, and behavior, showing  therapeutic potential in various neuropsychiatric and cognitive disorders.",Non-OADS,/arxiv_data1/oa_pdf/e0/88/dddt-10-1201.PMC4807895.pdf
"Keywords:  dehydroepiandrosterone sulfate, mice, age and sex differences, seizure threshold,  motor activity, [3H]flunitrazepam binding Introduction Dehydroepiandrosterone sulfate (DHEAS) is a neurosteroid associated with various  important functions in the mammalian brain.1–4 Namely, DHEAS has been reported to  modulate neuronal plasticity,5–9 cognition, and emotions,10–15 thus showing therapeutic  potential in a variety of neuropsychiatric and cognitive disorders.2,16–20 It appears that  the effects of DHEAS in the central nervous system are mediated through its action on  multiple signaling pathways and neurotransmitter systems, which are also involved in  regulating the balance between excitation and inhibition in the brain.3,15,21–23 Perhaps, the correspondence: Dubravka svob strac Division of Molecular Medicine, rudjer  Boskovic institute, Bijenicka cesta 54,  10 000 Zagreb, croatia Tel +385 1 457 1268 Fax +385 1 456 1010 email dsvob@irb.h r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Svob Strac et al Running head recto: Effects of DHEAS on neuronal excitability DOI: http://dx.doi.org/10.2147/DDDT.S102102",Non-OADS,/arxiv_data1/oa_pdf/e0/88/dddt-10-1201.PMC4807895.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e0/88/dddt-10-1201.PMC4807895.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/88/dddt-10-1201.PMC4807895.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/07/copd-11-585.PMC4807896.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD International Journal of COPD 2016:11 585–595Dove press submit your manuscript | www.dovepress.co m Dove press  OrIg Inal researChopen access to scientific and medical research Open access Full T ext article 585 http: //dx.doi.org/10.2147/COPD.S9423 4Pharmacokinetics and safety of olodaterol  administered with the respimat soft Mist inhaler  in subjects with impaired hepatic or renal function Christina Kunz1 Doreen luedtke1 anna Unseld2 alan hamilton3 atef halabi4 Martina Wein5 stephan Formella6 1Translational Medicine and Clinical  Pharmacology, 2global Biometrics  and Clinical applications, Boehringer  Ingelheim Pharma gmbh and Co  Kg, Biberach, germany; 3Boehringer  Ingelheim, Burlington, On , Canada;   4Crs Clinical research services  Kiel gmbh, Kiel, 5Drug Metabolism  and Pharmacokinetics, Boehringer  Ingelheim Pharma gmbh and Co K g,   Biberach, 6Medicine Coordination,   Boehringer Ingelheim Pharma gmbh   and Co K g, Ingelheim, germanyPurpose:  In two trials, the influences of hepatic and renal impairment on the pharmacokinetics of  olodaterol, a novel long-acting inhaled β2-agonist for treatment of COPD, were investigated.",Non-OADS,/arxiv_data1/oa_pdf/5f/07/copd-11-585.PMC4807896.pdf
"Keywords:  chronic obstructive pulmonary disease, exposure, olodaterol, long-acting β2-agonist,  hepatic impairment, renal impairment Introduction Olodaterol (Striverdi®) is a novel, once-daily, long-acting β2-adrenergic receptor  agonist (LABA) with high β2-selectivity that has recently obtained regulatory approval  for the maintenance therapy of patients with COPD.1 A duration of bronchodila - tory action over 24 hours was demonstrated in preclinical studies,2,3 and has been  confirmed in Phase III clinical trials.4,5 In sum, the Phase III program demonstrated  the long-term efficacy and safety of once-daily inhaled doses of 5 and 10 μg olo - daterol in patients with moderate to very severe COPD continuing with usual-care  maintenance therapy, with a satisfactory safety profile.4 The inhalation device used  was the Respimat® Soft Mist™ inhaler, which delivers medication as a nebulized  aqueous solution.6Correspondence: Christina Kunz Translational Medicine and Clinical  Pharmacology, Boehringer Ingelheim  Pharma gmbh and Co Kg, 65  Birkendorfer strasse, Biberach an der  riss 88397, germany Tel +49 7351 549 6311 Fax +49 7351 839 6311 email christina.kunz@boehringer- ingelheim.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kunz et al Running head recto: Pharmacokinetics of olodaterol in hepatic and renal impairment DOI: http://dx.doi.org/10.2147/COPD.S94234",Non-OADS,/arxiv_data1/oa_pdf/5f/07/copd-11-585.PMC4807896.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5f/07/copd-11-585.PMC4807896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/07/copd-11-585.PMC4807896.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 597–602International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  597OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10333 5Inhalation errors due to device switch in patients  with chronic obstructive pulmonary disease and  asthma: critical health and economic issues alessandro roggeri1 Claudio Micheletto2 Daniela Paola roggeri1 1ProCure solutions, nembro,   Bergamo, Italy, 2respiratory Unit,   Mater salutis hospital, legnago,   Verona, ItalyBackground:  Different inhalation devices are characterized by different techniques of use.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"As stated by the Guide For Asthma  Management and Prevention (updated in 2015),8 up to 80% of asthma patients do not  use their inhaler adequately, and this could lead to poorer symptom control and to a Correspondence: alessandro roggeri ProCure solutions, Via Camozzi 1/C  24027, nembro, Bergamo, Italy Tel +39 035 521 121 email alessandro.roggeri@ procuresolutions.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Roggeri et al Running head recto: Economic impact of inhalation device errors DOI: http://dx.doi.org/10.2147/COPD.S103335",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
rome: Italian Medicines agency; 2015. available from: http://www.agenziafarmaco.gov.it/sites/default/files/Elenco_ farmaci_equivalenti_Principio_attivo_15.05.2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"Merhylprednisolone public price is available at Farmadati which is a database containing all the information about the  medicines for human or veterinary use registered in Italy, equivalent medicines, homeopathic and parapharmaceutical products; available from: http://www.farmadati.it .",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"Available from: http://www.gold - copd.org/uploads/users/files/GOLD_Report_2015_Sept2.pd f. Accessed  December 1, 2015.",OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"Available  from: http://www.gazzettaufficiale.it/eli/id/2013/01/28/13A00528/s g.  Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
Available from: http://www.mattoni.,Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/ab/copd-11-597.PMC4807897.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ccid-9-071.PMC4807898.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/5f/0b/ccid-9-071.PMC4807898.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and investigational Dermatology 2016:9 71–77submit your manuscript | www.dovepress.co m Dove press   http: //dx.doi.org/10.2147/CCID.S9809 1New developments in the treatment of rosacea –  role of once-daily ivermectin cream Leah A Cardwell1 Hossein Alinia1 Sara Moradi T uchayi1 Steven R Feldman1–3 1Department of Dermatology,   Center for Dermatology Research,   2Department of Pathology,   3Department of Public Health  Sciences, wake Forest School of  Medicine, winston-Salem, NC, USA Correspondence: Hossein Alinia   Department of Dermatology, Center  for Dermatology Research, w ake Forest  School of Medicine, Medical Center  Boulevard, 4618 Country Club Road   winston-Salem, NC 27104, USA   T el +1 336 716 7740   Fax +1 336 716 7732   email haliniamd@gmail.co mAbstract:  Rosacea is a chronic dermatological disorder with a variety of clinical  manifestations  localized largely to the central face.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ccid-9-071.PMC4807898.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ccid-9-071.PMC4807898.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ccid-9-071.PMC4807898.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/75/dddt-10-1225.PMC4807899.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1225–1232Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1225Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10250 6role of glycogen synthase kinase-3 β inhibitor  aZD1080 in ovarian cancer shuo chen Kai-Xuan sun Miao-Xiao Feng Xiu-Bo sang Bo-liang liu Yang Zhao Department of gynecology, The  First affiliated hospital of china  Medical University, shenyang, People’s  republic of chinaBackground:  Glycogen synthase kinase-3 β (GSK-3β) is a multifunctional serine/threonine  kinase that plays an important role in cancer tumorigenesis and progression.",Non-OADS,/arxiv_data1/oa_pdf/8a/75/dddt-10-1225.PMC4807899.pdf
"Recently, GSK-3 β knockdown and GSK-3 β inhibitors have been  shown to inhibit the proliferation of malignant cells in pancreatic,11 prostatic,12 and correspondence: Yang Zhao Department of gynecology, The First  Affiliated Hospital of China Medical  University, no 155, north of nanjing  street, heping Distrcit, shenyang 110001,  liaoning Province, People’s republic of  china Tel/fax +86 24 8328 3516 email yida.zhaoyang@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chen et al Running head recto: Inhibitory effect of AZD1080 on ovarian carcinoma cells DOI: http://dx.doi.org/10.2147/DDDT.S102506",Non-OADS,/arxiv_data1/oa_pdf/8a/75/dddt-10-1225.PMC4807899.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8a/75/dddt-10-1225.PMC4807899.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/75/dddt-10-1225.PMC4807899.pdf
Available at: http://exac.broadinstitute.org/.,Non-OADS,/arxiv_data1/oa_pdf/9a/cc/NG2015000687.PMC4807903.pdf
The public availability of very deep variant databases such as Exome Aggregation Consortium browser (http://exac.broadinstitute.org) is an important step in that direction.,Non-OADS,/arxiv_data1/oa_pdf/e4/e3/NG2015000497.PMC4807906.pdf
"Targeted resequencing of DEPDC5 .We used molecular inversion probes to capture all exons and 5 base pairs of flanking intronic DEPDC5 sequence; next-generation sequencing and data analysis were performed as described previously in 130 patients with epileptic spasms of unknown etiology.15,18Known epileptic encephalopathy genes had been excluded in many cases (unpublished data, Carvill et al., January 2015).18 We considered only nonsynonymous, splice site, or frameshift variants that were present at an allele frequency ,1% in;61,000 exomes of the Exome Aggregation Consortium (ExAC) data set (to exclude single nucleotide polymorphisms) (http://exac.broadinstitute.",Non-OADS,/arxiv_data1/oa_pdf/a1/f7/NG2015000240.PMC4807908.pdf
Combined Annotation Dependent Depletion (http://cadd.gs.washington.edu/) phred scaled scores r ange from 0 to 99.,OADS,/arxiv_data1/oa_pdf/a1/f7/NG2015000240.PMC4807908.pdf
"All PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) scores calculated under the HumVar model for mendelian disorders, range 0 –1, with 1 most likely to be damaging.",Non-OADS,/arxiv_data1/oa_pdf/a1/f7/NG2015000240.PMC4807908.pdf
"SIFT (http://sift.bii.a-star.edu.sg/) range 0 –1, with 0 predicted to be most damaging, Grantham scores range from 0 –215, with 215 predicted to be most damaging.",Non-OADS,/arxiv_data1/oa_pdf/a1/f7/NG2015000240.PMC4807908.pdf
"ONLINE RESOURCES ExAC: http://exac.broadinstitute.org/ PolyPhen-2: http://genetics.bwh.harvard.edu/pph2/ SIFT: http://sift.bii.a-star.edu.sg/ CADD: http://cadd.gs.washington.edu/ Received May 22, 2015.",OADS,/arxiv_data1/oa_pdf/a1/f7/NG2015000240.PMC4807908.pdf
We compared the significant cis-eSNP results in this study to published brain expression quantitative trait loci (eQTL) data from healthy controls (HCs)19and patients with neurodegenerative disease.20 Results for the former are deposited in http://www.braineac.org/ (referred to as the Braineac data set hereforth) and are from 10 brain regions in 134 patients without prominent neuropathology; we compared their CER and TCX cis-eSNP data to ours.,Non-OADS,/arxiv_data1/oa_pdf/77/b7/NG2015000281.PMC4807909.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary healthcare 2016:9 111–120submit your manuscript | www.dovepress.co m Dove press  111 http: //dx.doi.org/10.2147/JMDH.S9870 0association between sociodemographic  characteristics of female community health  volunteers and their knowledge and performance  on maternal and child health services in rural nepal Dilaram acharya1,2 Jitendra Kumar singh3,4 samaj adhikari5 Varidmala Jain6 1Department of community Medicine,   Kathmandu University, Devdaha  Medical college and research  institute, Devdaha-10, rupandehi,   nepal; 2Department of Public health,   Purbanchal University, sanjeevani  college of Medical sciences, Butwal,   rupandehi, nepal; 3Department of  community Medicine and Public  health, Janaki Medical college,   Tribhuvan University, Janakpur, nepal;   4Department of community Medicine,   institute of Medical sciences, Banaras  hindu University, india; 5institute  of Medicine, Maharajgunj Medical  campus,Tribhuvan University,   Kathmandu, nepal; 6Department  of Public health, Faculty of health  sciences, sam higginbottom institute  of agriculture,Technology and  sciences, allahabad, india.",Non-OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"Available from: http://dohs.gov.np/wp-content/uploads/2014/04/ Annual_Report_2070_71.pd f. Accessed February 18, 2016.",OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"Available from: http://dhsprogram.com/ pubs/pdf/FR257/FR257%5B13April2012%5D.pd f Nepal and Calverton,  Maryland, U.S.A.: Ministry of Health and Population, New ERA and ICF  International; 2012. kathmandu: 2012.",Non-OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"Available  from: http://dohs.gov.np/wp-content/uploads/2014/04/Annual_ Report_2069_70.pd f. Accessed February 18, 2016.",OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"Available from http://dohs.gov.np/wpcontent/uploads/chd/Nutrition/ Nutrition_Policy_and_Strategy_2004.pd f. Accessed on March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/cc/cf/jmdh-9-111.PMC4807928.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).risk Management and healthcare Policy 2016:9 21–32submit your manuscript | www.dovepress.co m Dove press  21 http: //dx.doi.org/10.2147/RMHP .S9328 5investigating the health care delivery system in  Japan and reviewing the local public hospital reform Xing Zhang Tatsuo Oyama national graduate institute for Policy  studies, T okyo, Japan correspondence: Tatsuo Oyama;   Xing Zhang   national graduate institute for   Policy studies,  7-22-1 roppongi,   Minato-ku, Tokyo  106-8677, Japan   Tel +81 3 6439 6000  Fax +81 3 6439 6010  email oyamat@grips.ac.j p;  tonyxingzhang@gmail.co mAbstract:  Japan’ s health care system is considered one of the best health care systems in  the world.",Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
"available from: http://www.mhlw.go.jp/toukei/list/79-1a.htm l.  accessed april 15, 2015.8 Abbreviation:  ssO, social security organizations; OP, other public hospitals.",Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
"available from: http://www.mhlw.go.jp/toukei/list/79-1a.htm l.  accessed april 15, 2015.8 Abbreviations:  lPh, local public hospital; OPh, other public hospital; Prh, private  hospital.",Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
available from: http://www005.upp.so-net.ne.jp/ byo-ren/2 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
available from: http://www005.upp.so-net.ne.jp/ byo-ren/2 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
available from: http://www005.upp.so-net.ne.jp/ byo-ren/2 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
available from: http://www005.upp.so-net.ne.jp/byo- ren/2 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
Available from: http://www.mhlw.go.jp/english/wp/ wp-hw7/index.htm l.  8.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
Available from: http://www.mhlw.go.jp/toukei/list/79-1a.,OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
Available from: http://www.soumu.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
Available from: http://www005.upp.so-net.,Non-OADS,/arxiv_data1/oa_pdf/cd/4a/rmhp-9-021.PMC4807930.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/58/ppa-10-355.PMC4807931.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 355–361Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  355OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9973 0Preferences of color and lip position for facial  attractiveness by laypersons and orthodontists Qingjuan shi1 hong Zheng2 rongdang hu1 1Department of Orthodontics,   hospital of stomatology, Wenzhou  Medical University, 2Department  of stomatology, People hospital of  Wenzhou, Wenzhou, People’s republic  of chinaBackground:  Previous studies have reported some evaluation methods about profiles, but so  far, they have no consistent agreement on the esthetic profiles of color images.",Non-OADS,/arxiv_data1/oa_pdf/6c/58/ppa-10-355.PMC4807931.pdf
"An ideal beauty  profile is of great importance in orthodontic treatments.6 The esthetic plane created  by Ricketts is broadly used, among the kinds of angles and lines, because of its easy  application and many studies have provided much data to evaluate it.6–8correspondence: rongdang hu Department of Orthodontics, hospital  of stomatology, Wenzhou Medical  University, 373 West college road,  325000 Wenzhou, People’s republic of  china Tel +86 577 8806 6080 Fax +86 577 8806 6080 email hurongdang1@163.co m  hong Zheng Department of stomatology,  People hospital of Wenzhou, no 57  lucheng cang hou Xiang, 325000  Wenzhou, People’s republic of china Tel +86 577 8805 9576 Fax +86 577 8805 9576 email zhenhongzh@126.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shi et al Running head recto: Preferences of color and lip position for facial attractiveness DOI: http://dx.doi.org/10.2147/PPA.S99730",Non-OADS,/arxiv_data1/oa_pdf/6c/58/ppa-10-355.PMC4807931.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6c/58/ppa-10-355.PMC4807931.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/37/ott-9-1671.PMC4807932.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1671–1677OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1671Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10134 4high expression of sox10 correlates with tumor  aggressiveness and poor prognosis in human  nasopharyngeal carcinoma Yu Zhao1,* Zhi-gang liu1,* Jiao Tang1 ren-fang Zou1 Xiao-yan chen2 guan-min Jiang3 Yan-fang Qiu1 hui Wang1 1Key laboratory of Translational  radiation Oncology, Department of  radiation Oncology, 2Department of  Pathology, 3Department of clinical  laboratory, hunan cancer hospital,   The affiliated cancer hospital of  Xiangya school of Medicine, central  south University, changsha, hunan,   People’s republic of china *These authors contributed equally  to this workPurpose:  The aim of the study was to detect the expression of Sox10 in human nasopharyngeal  carcinoma (NPC) and investigate the relationship between its expression and the clinicopatho - logical characteristics of NPC patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/37/ott-9-1671.PMC4807932.pdf
"Among these, Sox10  gene was the first Sox correspondence: Zhi-gang liu; hui Wang Key laboratory of Translational radiation  Oncology, Department of radiation  Oncology, hunan cancer hospital, The  Affiliated Cancer Hospital of Xiangya  school of Medicine, central south  University, changsha 4210013, hunan  Province, People’s republic of china email zhigangliu1983@hotmail.co m;  wanghui710327@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhao et al Running head recto: Sox10 expression correlates with a poor NPC prognosis DOI: http://dx.doi.org/10.2147/OTT.S101344",Non-OADS,/arxiv_data1/oa_pdf/e3/37/ott-9-1671.PMC4807932.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/37/ott-9-1671.PMC4807932.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/37/ott-9-1671.PMC4807932.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/6a/ott-9-1707.PMC4807933.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1707–1713OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1707Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9866 6Progesterone receptor loss identifies hormone  receptor-positive and her2-negative breast  cancer subgroups at higher risk of relapse: a  retrospective cohort study Jia-Yuan sun1,* san-gang Wu2,* Feng-Yan li1 huan-Xin lin1 Zhen-Yu he1 1Department of radiation Oncology,   sun Yat-sen University cancer center,   state Key laboratory of Oncology in  south china, collaborative innovation  center of cancer Medicine,   guangzhou, People’s republic of  china; 2Department of radiation  Oncology, Xiamen cancer center,   The First affiliated hospital of  Xiamen University, Xiamen, People’s  republic of china *These authors contributed equally  to this workBackground:  To assess the prognostic value of progesterone receptor (PR) expression in  patients with hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)- negative breast cancer subgroups.",Non-OADS,/arxiv_data1/oa_pdf/80/6a/ott-9-1707.PMC4807933.pdf
"Studies have confirmed that the risk factors correspondence: Zhen-Yu he Department of radiation Oncology, sun  Yat-sen University cancer center, state  Key laboratory of Oncology in south  china, collaborative innovation center  of cancer Medicine, 651 Dongfeng east  road, guangzhou 510060, People’s  republic of china Tel +86 20 8734 3543 Fax +86 20 8734 3392 email hezhy@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sun et al Running head recto: PR for HR +/HER2- BC DOI: http://dx.doi.org/10.2147/OTT.S98666",Non-OADS,/arxiv_data1/oa_pdf/80/6a/ott-9-1707.PMC4807933.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/80/6a/ott-9-1707.PMC4807933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/6a/ott-9-1707.PMC4807933.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/56/ott-9-1647.PMC4807934.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1647–1656submit your manuscript | www.dovepress.co m Dove press  1647 http: //dx.doi.org/10.2147/OTT .S9651 8Dove press Original researchopen access to scientific and medical research Open access Full T ext article Upregulation of metastasis-associated gene 2  promotes cell proliferation and invasion in  nasopharyngeal carcinoma Minhua Wu1,2,* Xiaoxia Ye2,* Xubin Deng3,* Yanxia Wu4 Xiaofang li4 lin Zhang1 1Department of histology and  embryology, southern Medical  University, guangzhou, 2Department  of histology and embryology,   guangdong Medical University,   Zhanjiang, 3affiliated cancer hospital  of guangzhou Medical University,   cancer center of guangzhou Medical  University, guangzhou, 4Pathological  Diagnosis and research center,   affiliated hospital of guangdong  Medical University, Zhanjiang,   People’s  republic of china *These authors contributed equally  to this workAims:  Metastasis-associated gene 2 ( MTA2 ) is reported to play an important role in tumor  progression, but little is known about the role of MTA2  in nasopharyngeal carcinoma (NPC).",Non-OADS,/arxiv_data1/oa_pdf/7b/56/ott-9-1647.PMC4807934.pdf
"They are components of nucleosome  remodeling and deacetylation complex.4 As a part of the nucleosome remodeling and  deacetylation complex, MTAs  are proved to modulate gene transcription by affecting correspondence: lin Zhang Department of histology and  embryology, southern Medical University,  1838 north guangzhou avenue,  guangzhou 510515, People’s republic  of china Tel +86 20 164 8205 email zlilyzh@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: MTA2 promotes proliferation and invasion of NPC cell DOI: http://dx.doi.org/10.2147/OTT.S96518",Non-OADS,/arxiv_data1/oa_pdf/7b/56/ott-9-1647.PMC4807934.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/56/ott-9-1647.PMC4807934.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/56/ott-9-1647.PMC4807934.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1721–1734OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1721Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10004 0Clinicopathological significance of STAT4 in  hepatocellular carcinoma and its effect on cell  growth and apoptosis Jianjun li1,* lu liang2,* Y ongru liu2 Yihuan luo2 Xiaona liang2 Dianzhong luo2 Zhenbo Feng2 Yiwu Dang2 lihua Yang3 gang chen2 1Department of General Surgery,   Western Branch, First Affiliated  Hospital of Guangxi Medical  University, nanning, guangxi Zhuang  autonomous region, People’s  Republic of China; 2Department of  Pathology, 3Department of Medical  Oncology, First Affiliated Hospital of  Guangxi Medical University, Nanning,   guangxi Zhuang autonomous region,   People’s Republic of China *These authors contributed equally  to this workBackground:  Recent studies showed that signal transducer and activator of transcription  4 (STAT4) was downregulated in hepatocellular carcinoma (HCC) tissues.",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
"Diverse  therapy strategies are available, including surgical resection, radiotherapy, and chemo - therapy, as well as liver transplantation.7,8 Although more than 70% of patients in early  stage can have a 5-year survival rate, their recurrences of HCC are inevitable,9,10 which  makes long-term outcome still unsatisfactory even after curative hepatectomy.11correspondence: lihua Yang Department of Medical Oncology, First  Affiliated Hospital of Guangxi Medical  University, 6 shuangyong road, nanning,  guangxi Zhuang autonomous region  530021, People’s Republic of China Fax +86 771 535 3121 email 150871746@qq.co m  gang chen Department of Pathology, First Affiliated  Hospital of Guangxi Medical University,  6 shuangyong road, nanning, guangxi  Zhuang autonomous region 530021,  People’s Republic of China Fax +86 771 535 6534 email chen_gang_triones@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Antioncogene role of STAT4 in HCC DOI: http://dx.doi.org/10.2147/OTT.S100040",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
"Among them,  STAT4 siRNA-1537 (siSTAT4-1537), siSTAT4-2281, and  siSTAT4-2314 were reported by Lv et al,18 while siSTAT4- 1134 was designed according to Reynolds et al’s work.19  Four STAT4 siRNAs were compared to identify regions  of similarity using BLAST http://blast.ncbi.nlm.nih.gov/ Blast.cg i.",OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/d1/ott-9-1721.PMC4807935.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/98/imcrj-9-073.PMC4807936.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case reports Journal 2016:9 73–75submit your manuscript | www.dovepress.co m Dove press  73 http: //dx.doi.org/10.2147/IMCRJ.S9880 1A rare case of anastomosis between the external  and internal jugular veins Ilias Karapantzos1 paul Zarogoulidis2 Charalampos Charalampidis3 Chrysanthi Karapantzou1 Ioannis Kioumis2 Kosmas tsakiridis4 Andrew Mpakas4 Nikolaos Sachpekidis4 John organtzis2 Konstantinos porpodis2 Konstantinos Zarogoulidis2 Georgia pitsiou2 Athanasios Zissimopoulos5 Christoforos Kosmidis6 evagelia Fouka2 theodoros Demetriou3 1ear, Nose and throat Department,   “Saint Luke” private hospital,   panorama, 2pulmonary Department,   “G.",Non-OADS,/arxiv_data1/oa_pdf/ca/98/imcrj-9-073.PMC4807936.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/ca/98/imcrj-9-073.PMC4807936.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/98/imcrj-9-073.PMC4807936.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/ott-9-1689.PMC4807937.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1689–1696OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1689Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9799 3statin use and mortality of patients with prostate  cancer: a meta-analysis Yang Meng1,* Yan-Biao liao2,* Peng Xu1 Wu-ran Wei1 Jia Wang1 1Department of Urology, 2Department  of cardiology, West china hospital of  sichuan University, chengdu, People’s  republic of china *These authors contributed equally  to this workObjective:  The aim of this meta-analysis was to investigate the effect of statin use on the  mortality of patients with prostate cancer (PCa).",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/ott-9-1689.PMC4807937.pdf
"Therefore, we performed a systematic review and meta-analysis of the available data  to explore the association of prediagnostic and postdiagnostic statin use with the risk  of death in patients with PCa.correspondence: Jia Wang Department of Urology, West china  hospital, sichuan University, 37 guo  Xue Xiang, chengdu 610041, People’s  republic of china Tel +86 136 8405 7512 Fax +86 28 8550 1670 email jiawang1414@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Meng et al Running head recto: Statins and prostate cancer mortality DOI: http://dx.doi.org/10.2147/OTT.S97993",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/ott-9-1689.PMC4807937.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/ott-9-1689.PMC4807937.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/4d/ott-9-1689.PMC4807937.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/opth-10-497.PMC4807938.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 497–501Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  497Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9707 0normal corneal endothelial cell density in  nigerians T emitope ewete1 efeoghene Uchenna ani2 adegboyega sunday alabi1 1MeCure eye Center, lagos,   2Department of Ophthalmology,   University of Port harcourt, Port  harcourt, nigeriaAim:  The aim of the study was to describe the corneal endothelial cell density of adults at the  MeCure Eye Center and to determine the relationship between age, sex, and corneal endothelial  cell density.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/opth-10-497.PMC4807938.pdf
"The cornea endothelium is a  very important factor in the optical transparency of the cornea, and this transparency  is maintained by its ability to pump water out of the corneal stroma against an osmotic  gradient; it also maintains corneal hydration.2,3 The cornea endothelium is metaboli - cally active and utilizes the Na+–K+ pump for keeping the stroma at its usual hydrated  state of 70% water to prevent stromal edema.4 The average normal mean corneal  endothelial cell density (MCD) is usually the highest at birth ( ~3,000 cells/mm2), and  it declines slowly; a minimal density of 400–500 cells/mm2 is required to sustain the  pumping activity of the endothelium, and values below this have been associated with  bullous keratopathy.5Correspondence: Temitope ewete MeCure eye Center, MeCure house,  Debo industrial Compound, Oshodi- apapa expressway, lagos, nigeria Tel +234 80 5353 6090 email temidemi2000@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ewete et al Running head recto: Corneal endothelial cell density of adults DOI: http://dx.doi.org/10.2147/OPTH.S97070",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/opth-10-497.PMC4807938.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/opth-10-497.PMC4807938.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/d9/opth-10-497.PMC4807938.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/b1/ppa-10-345.PMC4807939.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and adherence 2016:10 345–354submit your manuscript | www.dovepress.co m Dove press  345 http: //dx.doi.org/10.2147/PPA.S10189 8sociodemographic factors affecting the quality  of life of patients with asthma Bartosz Uchmanowicz1 Bernard Panaszek2 izabella Uchmanowicz1 Joanna Rosińczuk3 1Department of clinical nursing,   2Department and clinic of internal  Diseases, geriatry and allergology,   3Department of n ervous system  Diseases, Wroclaw Medical University,   Wroclaw, PolandBackground:  In recent years, there has been an increased interest in the subjective quality  of life (QoL) of patients with bronchial asthma.",Non-OADS,/arxiv_data1/oa_pdf/64/b1/ppa-10-345.PMC4807939.pdf
"Thus,  HRQoL comprises such components as the clinical condition and physical fitness of  patients, as well as their psychological condition, social status, and somatic sensations.3,5 correspondence: Bartosz Uchmanowicz Department of clinical nursing,  Division of nursing in internal Medicine  Procedures, Wroclaw Medical University,  Wroclaw, Poland email izabella.uchmanowicz@umed.wroc.p lJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Uchmanowicz et al Running head recto: Factors affecting the QoL of patients with asthma DOI: http://dx.doi.org/10.2147/PPA.S101898",Non-OADS,/arxiv_data1/oa_pdf/64/b1/ppa-10-345.PMC4807939.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/64/b1/ppa-10-345.PMC4807939.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/c8/cia-11-335.PMC4807940.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging Clinical Interventions in Aging 2016:11 335–340Dove press submit your manuscript | www.dovepress.co m Dove press  OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article 335 http: //dx.doi.org/10.2147/CIA.S10147 5Analgesic use among nursing homes residents,  with and without dementia, in Poland Agnieszka neumann- Podczaska1 T omasz nowak2 Aleksandra suwalska3 Dorota Łojko4 Roma Krzymińska- siemaszko2 Elżbieta Kozak-Szkopek5 Katarzyna Wieczorowska- T obis2 1Department of geriatrics and  gerontology, 2Department of  Palliative Medicine, Laboratory of  geriatrics, 3Department of Psychiatry,   Laboratory of Neuropsychobiology,   4Department of Adult Psychiatry,   Poznan University of Medical sciences,   Poznan, 5Department of geriatrics,   Medical University of Warsaw,   Warsaw, PolandAbstract:  Many age-associated diseases are accompanied by pain.",Non-OADS,/arxiv_data1/oa_pdf/34/c8/cia-11-335.PMC4807940.pdf
"szpitalna 27/33, 60-572  Poznan, Poland email suwalska_a@wp.p lJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Neumann-Podczaska et al Running head recto: Analgesic use in nursing homes DOI: http://dx.doi.org/10.2147/CIA.S101475",Non-OADS,/arxiv_data1/oa_pdf/34/c8/cia-11-335.PMC4807940.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/34/c8/cia-11-335.PMC4807940.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/c8/cia-11-335.PMC4807940.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jaa-9-065.PMC4807941.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/45/a3/jaa-9-065.PMC4807941.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Asthma and Allergy Journal of Asthma and Allergy 2016:9 65–70Dove press submit your manuscript | www.dovepress.co m Dove press  OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article 65 http: //dx.doi.org/10.2147/JAA.S9378 2step-down therapy in well-controlled asthmatic  patients using salmeterol xinafoate/fluticasone  propionate combination therapy Kazuya horiuchi Keita Kasahara Yusuke Kuroda haruna Morohoshi Y osuke hagiwara gen ishii respiratory Disease center, showa  University northern Y okohama  hospital, Y okohama-shi, Kanagawa-ken,   Japan correspondence: Kazuya horiuchi   respiratory Disease center, showa  University northern Y okohama hospital,  35-1 chigasaki-chuou, Tsuzuki-ku,  Y okohama-shi, Kanagawa-ken 224-8503,  Japan   T el +81 45 949 7000   Fax +81 45 949 7117   email poricelona0921@gmail.co mPurpose:  A combination therapy with inhaled corticosteroid (ICS) and a long-acting β agonist  (LABA) is the standard treatment for asthmatic patients, and step-down treatment is recom - mended once control has been achieved.",Non-OADS,/arxiv_data1/oa_pdf/45/a3/jaa-9-065.PMC4807941.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/45/a3/jaa-9-065.PMC4807941.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jaa-9-065.PMC4807941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/35/ott-9-1657.PMC4807942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1657–1670OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1657Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9787 3T umor necrosis factor-308 polymorphism with the  risk and prognosis of non-hodgkin lymphomas:  a meta-analysis study sicheng gao1,* guoqing Zhu2,* Yan lin1 Xingliang Fan1 Pingan Qian1 Junfeng Zhu3 Y ongchun Yu1 1central laboratory, shanghai  Municipal hospital of Traditional  chinese Medicine, shanghai  University of Traditional chinese  Medicine, 2Department of clinical  laboratory Medicine, shanghai T enth  People’s hospital, T ongji University,   3Department of hepatology, shanghai  Municipal hospital of Traditional  chinese Medicine, shanghai University  of Traditional chinese Medicine,   shanghai, People’s republic of china *These authors contributed equally  to this workBackground:  Tumor necrosis factor-308 (TNF-308) was implied to be associated with the  development of non-Hodgkin lymphoma (NHL).",Non-OADS,/arxiv_data1/oa_pdf/df/35/ott-9-1657.PMC4807942.pdf
"Keywords:  tumor necrosis factor, polymorphism, rs1800629, lymphomas, susceptibility,  survival outcome Introduction Non-Hodgkin lymphoma (NHL) is a heterogeneous group of neoplasms, developing  from B-cell, T-cell, and natural killer (NK)/T-cell, with various clinical and biological  features.1 There were ~355,900 new cases and 191,400 deaths from NHL worldwide  in 2008.2 The numbers continued to increase with estimated 385,700 new cases and  199,700 deaths in 2012.3 Epidemiologic studies have examined the etiology of NHL,  identifying smoking, alcohol use, infectious agents, family history of lymphoma,  autoimmune disease, asthma, and radiation exposure as risk factors.1,4–6 Tumor necrosis factor-alpha (TNF- α) is the activator of canonical pathway of  nuclear factor kappa B and is associated with the process of cellular growth, differen - tiation, and apoptosis.7 It is also noted that TNF- α is involved in the pathogenesis of  inflammatory, autoimmune, and malignant diseases.8 Accumulating evidence indicates  that the variation in the promoter of TNF- α polymorphism (rs1800629) is correlated  with the susceptibility to and progression and prognosis of NHL.9–11 The association between TNF-308G .A and the risk of NHL was examined in the  previous three reviews and meta-analyses.12–14 A previous study published in 2006 correspondence: Yongchun Yu;   Junfeng Zhu Department of hepatology, shanghai  Municipal hospital of Traditional  chinese Medicine, shanghai University of  Traditional chinese Medicine, no 274,  Middle Zhijiang road, shanghai 200071,  People’s republic of china Tel +86 159 1933 4391;   +86 21 5663 9828 email yueyongchun88@163.co m;  zhujftongling@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gao et al Running head recto: TNF-308 polymorphism and the risk of NHL and prognosis DOI: http://dx.doi.org/10.2147/OTT.S97873",Non-OADS,/arxiv_data1/oa_pdf/df/35/ott-9-1657.PMC4807942.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/df/35/ott-9-1657.PMC4807942.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/35/ott-9-1657.PMC4807942.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d7/a6/nss-8-087.PMC4807943.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/d7/a6/nss-8-087.PMC4807943.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Nature and Science of Sleep 2016:8 87–89Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  87Editorialopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/NSS.S10622 4Are we underestimating the lifelong benefits of  therapy for obstructive sleep apnea?",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/nss-8-087.PMC4807943.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/nss-8-087.PMC4807943.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/a6/nss-8-087.PMC4807943.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/09/ijn-11-1109.PMC4807944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1109–1117International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1109OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10299 1enhanced dissolution and oral absorption of  tacrolimus by supersaturable self-emulsifying drug  delivery system Dae ro lee1 Myoung Jin ho1 hyuck Jun Jung1 ha ra cho1 Jun seo Park1 suk-hyun Y oon2 Y ong seok choi1 Y oung Wook choi3 chung-hun Oh2,4,5 Myung Joo Kang1 1college of Pharmacy, 2Department  of Medical laser, graduate school,   Dankook University, Dongnam-gu,   choenan, chungnam, 3college of  Pharmacy, chung-ang University,   Dongjak-gu, seoul, 4Department of  Oral Physiology, college of Dentistry,   Dankook University, 5abel Medi- T ech Inc., Dongnam-gu, cheonan,   chungnam, KoreaAbstract:  A new Soluplus (polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol  graft copolymer)-based supersaturable self-emulsifying drug delivery system (S-SEDDS)  was formulated to enhance oral absorption of tacrolimus (FK506) with minimal use of oil,  surfactant, and cosurfactant.",Non-OADS,/arxiv_data1/oa_pdf/68/09/ijn-11-1109.PMC4807944.pdf
"Keywords:  tacrolimus, supersaturation, precipitation inhibitor, Soluplus, microemulsion, oral  bioavailability Introduction Tacrolimus (FK506), a macrolide immunosuppressant, has been prescribed as a first-line  therapeutic agent to prevent organ rejection after liver, heart, kidney, and bone marrow  transplantation.1,2 The calcineurin inhibitor exhibits superior immunosuppressive activity to  cyclosporine A, providing long-term survival in patients after transplantation.3,4 However,  oral FK506 therapy has been deterred by poor and variable intestinal absorption, predomi - nantly caused by its low aqueous solubility (1–2 μg/mL) and extensive metabolism in the  gastrointestinal (GI) tract.5,6 The oral bioavailability (BA) of the marketed product (Prograf;  Astellas Pharma, Inc., Tokyo, Japan), a solid dispersion system with cellulose derivatives,  was only 21% in patients with large intra- and interindividual variation (4%–89%).7 Several pharmaceutical technologies have been explored to boost dissolution and/ or oral absorption of potent calcineurin inhibitors, including oily solution,8 cyclo - dextrin complex,9 polymeric micelle,10 and a self-emulsifying drug delivery system  (SEDDS).11 SEDDS is an isotropic blend of oils, surfactants, and/or cosolvents, which  rapidly forms oil-in-water emulsions upon contact with aqueous medium under gentle correspondence: Myung Joo Kang college of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  cheonan, chungnam 330-714, Korea Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lee et al Running head recto: Increased oral absorption of FK506 by supersaturable system DOI: http://dx.doi.org/10.2147/IJN.S102991",Non-OADS,/arxiv_data1/oa_pdf/68/09/ijn-11-1109.PMC4807944.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/68/09/ijn-11-1109.PMC4807944.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/09/ijn-11-1109.PMC4807944.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 339–344Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  339OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9863 7Development and validation of a predictive model  of failed stepping-down of inhaled corticosteroids  in adult asthmatics Akira Yamasaki1 Katsuyuki T omita2 Kazuhiro Kato3 Kouji Fukutani3 hiroyuki sano4 Yuji T ohda4 eiji shimizu1 1Division of Medical Oncology and  Molecular respirology, Department  of Multidisciplinary internal Medicine,   Faculty of Medicine, T ottori University,   T ottori, 2Department of respiratory  Medicine, Y onago Medical centre,   T ottori, 3Department of respiratory  Medicine, sanin rosai hospital,   T ottori, 4Department of respiratory  Medicine and Allergology, Faculty of  Medicine, Kinki University, Osaka,   JapanBackground:  Asthma guidelines suggest stepping-down of inhaled corticosteroids (ICSs)  when asthma is stable.",Non-OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
"Keywords:  asthma, ICSs, stepping-down Introduction As the goal of asthma therapy is to maintain long-term control using the smallest  amount of medication possible, current asthma guidelines recommend consideration  of stepping-down therapy if asthma remains well controlled for at 3 months to reach  a minimum effective dose.1,2 To our knowledge, based on the data from a systematic  review, asthma exacerbations were statistically no more likely among individuals who  reduced inhaled corticosteroids (ICSs) compared to those who maintained their ICS  dose.3 In addition, it has been reported that stepping-down asthma medication is fre - quently successful, almost 60%–70%.4,5correspondence: Akira Yamasaki Division of Medical Oncology and  Molecular respirology, Department  of Multidisciplinary internal Medicine,  Tottori University, 36-1 nishi-cho,  Yonago 683-8504, Tottori, Japan Tel +81 859 38 6537 Fax +81 859 38 6539 email yamasaki@grape.med.tottori-u.ac.j pJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y amasaki et al Running head recto: Score for predicting failure of stepping-down of ICSs DOI: http://dx.doi.org/10.2147/PPA.S98637",Non-OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
Available from: http://www.ginas - thma.org /.,Non-OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
"Available  from: http://www.goldcopd.or g. Accessed January 11, 2016.",OADS,/arxiv_data1/oa_pdf/19/b9/ppa-10-339.PMC4807945.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/81/ott-9-1715.PMC4807946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1715–1719OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1715Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9958 1The interleukin-18  gene promoter -607 a/c  polymorphism contributes to non-small-cell lung  cancer risk in a chinese population Y ouchao Jia1,2 aimin Zang2 shunchang Jiao1 sumei chen1 Fu Yan1 1Department of Medical Oncology,   general hospital of chinese P la,   Beijing, 2Department of Oncology,   affiliated hospital of hebei University,   hebei, People’s republic of chinaAbstract:  The purpose of the present study was to determine the relationship between  interleukin-18 (IL-18) -607 A/C polymorphism and the risk of non-small-cell lung cancer  (NSCLC) and its impact on the serum IL-18 level.",Non-OADS,/arxiv_data1/oa_pdf/7a/81/ott-9-1715.PMC4807946.pdf
"Interleukin-18 (IL-18), an 18-kDa cytokine, belongs to the interleukin-1 super - family.2 It has been reported that IL-18 has both anticancer and procancer effects on  lung cancer.3–5 IL-18 has pleiotropic efficacy in activating natural killer cell cytotoxic  effect and enhancing Th1 immune response, mainly by stimulating the expression of  interferon- γ and tumor necrosis factor- α and consequently causing the elimination of  tumor cells in vivo.6,7 It has been proposed that IL-18 modulates the immune system  for attacking cancer cells through the suppression of tumor growth and angiogenesis  in ovarian cancer, inhibition of breast cancer cell proliferation, potential invasion,  and enhancement of cytotoxic effects on colon carcinoma cells.8–10 Furthermore,  increased levels of IL-18 have been reported in head and neck squamous cell and  hepatocellular carcinoma; esophageal, gastric, ovarian, colon, skin cancer; and myeloid  leukemia cells.11–14correspondence: Youchao Jia Department of Medical Oncology,  general hospital of chinese Pla,  28 Fuxing road, Beijing 100853,  People’s republic of china  Tel/fax +86 31 2598 1172 email jiayouchao1235@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jia et al Running head recto: IL-18 polymorphism in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S99581",Non-OADS,/arxiv_data1/oa_pdf/7a/81/ott-9-1715.PMC4807946.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/81/ott-9-1715.PMC4807946.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/81/ott-9-1715.PMC4807946.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/83/ijn-11-1097.PMC4807947.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1097–1108International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1097OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10136 6Molecular magnetic resonance imaging of  activated hepatic stellate cells with ultrasmall  superparamagnetic iron oxide targeting integrin  αvβ3 for staging liver fibrosis in rat model caiyuan Zhang1,* huanhuan liu1,* Yanfen cui1,* Xiaoming li1 Zhongyang Zhang1 Y ong Zhang2 Dengbin Wang1 1Department of radiology, Xinhua  hospital, shanghai Jiao T ong University  school of Medicine, 2Mr advanced  application and research center, ge  healthcare china, shanghai, People’s  Republic of China *These authors contributed equally to  this workPurpose:  To evaluate the expression level of integrin αvβ3 on activated hepatic stellate cells  (HSCs) at different stages of liver fibrosis induced by carbon tetrachloride (CCl4) in rat model  and the feasibility to stage liver fibrosis by using molecular magnetic resonance imaging (MRI)  with arginine-glycine-aspartic acid (RGD) peptide modified ultrasmall superparamagnetic iron  oxide nanoparticle (USPIO) specifically targeting integrin αvβ3.",Non-OADS,/arxiv_data1/oa_pdf/dc/83/ijn-11-1097.PMC4807947.pdf
"Keywords:  magnetic resonance imaging, ultrasmall superparamagnetic iron oxide, liver fibrosis,  hepatic stellate cell, integrin Introduction Liver fibrosis is the excessive healing response to chronic liver injury, including viral  hepatitis, alcoholic hepatitis, nonalcoholic steatohepatitis, autoimmune hepatitis, and  metabolic disease.1 It may subsequently progress to cirrhosis with consequence of  portal hypertension, hepatocellular carcinoma, and liver failure and was estimated to  affect 1%–2% of the world’s population.2–4 Recent research reported that liver fibrosis  is reversible and treatable at early stage.5,6 Meanwhile, bridging or higher fibrosis is an Correspondence: Dengbin Wang Department of radiology, Xinhua  hospital, shanghai Jiao Tong University  school of Medicine, 1665 Kongjiang  Road, Shanghai 200092, People’s Republic  of china Tel +86 21 2507 8999 ext 7030 email dbwang8@aliyun.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Molecular MRI for staging liver fibrosis DOI: http://dx.doi.org/10.2147/IJN.S101366",Non-OADS,/arxiv_data1/oa_pdf/dc/83/ijn-11-1097.PMC4807947.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/dc/83/ijn-11-1097.PMC4807947.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/83/ijn-11-1097.PMC4807947.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/32/opth-10-503.PMC4807948.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 503–510Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  503Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9372 5Corneal biomechanics in asymmetrical normal- tension glaucoma hazem helmy1 Mahmoud leila2 ahmed atef Zaki3 1Department of glaucoma and Optic  nerve Diseases, 2retina Department,   3Corneal Diseases Department,   research institute of Ophthalmology,   Cairo, egyptPurpose:  We aimed to assess corneal biomechanics using the ocular response analyzer in  patients with normal-tension glaucoma (NTG), and to evaluate the relationship between corneal  biomechanics and visual field loss.",Non-OADS,/arxiv_data1/oa_pdf/b0/32/opth-10-503.PMC4807948.pdf
"In addition, these studies mentioned that because Correspondence: Mahmoud leila 146 C, second Floor, Flat 8,  street 3, hadabet al-ahram, Khufu  entrance, Cairo-Fayoum Desert road,  giza 12572, egypt Tel +20 12 8664 4025 email mahmoudleila@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Helmy et al Running head recto: Corneal biomechanics in glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S93725",Non-OADS,/arxiv_data1/oa_pdf/b0/32/opth-10-503.PMC4807948.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/32/opth-10-503.PMC4807948.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/opth-10-503.PMC4807948.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 1697–1706OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1697Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9718 9Up-regulated expression of phospholipase c ,  β1 is associated with tumor cell proliferation  and poor prognosis in hepatocellular carcinoma Junxiang li1 Xuya Zhao1 Dazhi Wang1 Wei he1 shuai Zhang1 Wei cao1 Yu huang1 ling Wang1 shi Zhou1 Kaijian luo2 1Department of interventional  radiology, 2Department of Oncology,   guiZhou cancer hospital, cancer  hospital of guizhou Medical  University, guiyang, People’s republic  of chinaBackground:  Phospholipase C, β1 (PLCB1) plays critical roles in intracellular transduction  and regulating signal activation which are important to tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
"Thus, aiming to improve the  outcome of the patients with HCC, it is necessary to identify novel molecular targets,  which play key regulatory roles in tumor cell proliferation and metastasis.correspondence: Kaijian luo guiZhou cancer hospital, cancer  hospital of guizhou Medical University,  no 1 West Beijing road, guiyang  550004, People’s republic of china Tel +86 851 681 2999 email drkjluo@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Up-regulated expression of phospholipase C, β1 DOI: http://dx.doi.org/10.2147/OTT.S97189",Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
"Moreover, the mRNA level of PLCB1 was notably elevated  in liver cancer tissues of GSE14520 containing 221-patient  cohort according from the Gene Expression Omnibus (GEO)  (http://www.ncbi.nlm.nih.gov/ge o) (Figure 1C).",Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/9a/ott-9-1697.PMC4807949.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d7/38/ijn-11-1119.PMC4807950.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1119–1130International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1119OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10164 9Folic acid-targeted disulfide-based cross-linking  micelle for enhanced drug encapsulation stability  and site-specific drug delivery against tumors Yumin Zhang1,* Junhui Zhou2,* cuihong Yang1 Weiwei Wang3 liping chu1 Fan huang1 Qiang liu1 liandong Deng2 Deling Kong3 Jianfeng liu1 Jinjian liu1 1Tianjin Key Laboratory of  radiation Medicine and Molecular  Nuclear Medicine, Institute of  Radiation Medicine, Chinese Academy  of Medical Science and Peking  Union Medical college, 2Department  of Polymer Science and T echnology,   school of chemical engineering and  T echnology, Tianjin University, 3Tianjin  Key Laboratory of Biomaterial  Research, Institute of Biomedical  Engineering, Chinese Academy of  Medical Science and Peking Union  Medical college, Tianjin, People’s  Republic of China *These authors contributed equally  in this workAbstract:  Although the shortcomings of small molecular antitumor drugs were efficiently  improved by being entrapped into nanosized vehicles, premature drug release and insufficient  tumor targeting demand innovative approaches that boost the stability and tumor responsiveness  of drug-loaded nanocarriers.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/ijn-11-1119.PMC4807950.pdf
"238, Baidi road, Nankai district, Tianjin  300192, People’s Republic of China email lewis78@163.co m;  liujinjian2002@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Folic acid-targeted disulfide-based cross-linking micelle DOI: http://dx.doi.org/10.2147/IJN.S101649",Non-OADS,/arxiv_data1/oa_pdf/d7/38/ijn-11-1119.PMC4807950.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/ijn-11-1119.PMC4807950.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/38/ijn-11-1119.PMC4807950.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/imcrj-9-069.PMC4807951.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e2/81/imcrj-9-069.PMC4807951.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 69–72International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  69Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9384 9Gold shunt for refractory advanced low-tension  glaucoma with spared central acuity Ryan Le1 Neeru Gupta1–3 1Keenan Research Center, Li Ka shing  Knowledge Institute, st. Michael’s  Hospital, toronto, oN, Canada;   2ophthalmology and Vision sciences,   Glaucoma Unit, st. Michael’s Hospital,   University of toronto, toronto, oN,   Canada; 3Laboratory Medicine and  pathobiology, st. Michael’s Hospital,   University of toronto, toronto, oN,   Canada Correspondence: Neeru Gupta   st. Michael’s Hospital, 30 Bond street,  Cardinal Carter Wing, 8-072, toronto,  oN M5B 1W8 Canada   tel +1 416 864 5444   Fax +1 416 864 5208   email guptan@smh.c aAbstract:  The aim of this study is to report a case of gold shunt surgery for uncontrolled,  low-tension glaucoma with good central vision, after having a previously failed trabeculectomy  and tube shunt surgeries.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/imcrj-9-069.PMC4807951.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/imcrj-9-069.PMC4807951.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/imcrj-9-069.PMC4807951.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/8c/ott-9-1641.PMC4807953.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1641–1646OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1641Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8872 6Lipid-rich carcinoma of the breast that is strongly  positive for estrogen receptor: a case report and  literature review Takaaki Oba1 Mayu Ono1 asumi Iesato1 T oru Hanamura1 Takayuki Watanabe1 T okiko Ito1 T oshiharu Kanai1 Kazuma Maeno1 Ken-ichi Ito1 ayako Tateishi2 akihiko Y oshizawa2 Fumiyoshi Takayama3 1Division of Breast, endocrine and  respiratory surgery, Department of  surgery, shinshu University school  of Medicine, Matsumoto, Nagano,   2Department of Laboratory Medicine,   shinshu University Hospital, 3Imaging  Center, Ichinose Neurosurgical  Hospital, Matsumoto, JapanAbstract:  Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts  for ,1% of all breast malignancies.",Non-OADS,/arxiv_data1/oa_pdf/0b/8c/ott-9-1641.PMC4807953.pdf
"The patient had no past or family history Correspondence: Ken-ichi Ito Division of Breast, endocrine and  respiratory surgery, Department of  surgery, shinshu University school of  Medicine, 3-1-1 asahi, Matsumoto,  Nagano, Japan Tel +81 26 337 2657 Fax +81 26 337 2721 email kenito@shinshu-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Oba et al Running head recto: Lipid-rich carcinoma of the breast positive for estrogen receptor DOI: http://dx.doi.org/10.2147/OTT.S88726",Non-OADS,/arxiv_data1/oa_pdf/0b/8c/ott-9-1641.PMC4807953.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0b/8c/ott-9-1641.PMC4807953.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/8c/ott-9-1641.PMC4807953.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31478 - http://dx.doi.org/10.3402/pba.v6.31478 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"These lesions help explain the cardiac dysfunction and increased heart weight observed in the older-aged mice.Warren Ladiges 2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31478 - http://dx.doi.org/10.3402/pba.v6.31478",Non-OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"The occurrence of multiple histological lesions increases with increasing age as shown by a dramatic shift of the curve to the right in 32-month-old CB6F1 male mice compared with the respective 8-month-old mice.Pathology assessment in preclinical aging studies Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31478 - http://dx.doi.org/10.3402/pba.v6.31478 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"2013;3:22451, doi: http://dx.doi.org/10.3402/pba.v3i0.",OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"2015;5:28866, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"org/10.3402/pba.v5.28866Warren Ladiges 4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31478 - http://dx.doi.org/10.3402/pba.v6.31478",Non-OADS,/arxiv_data1/oa_pdf/35/e5/PBA-6-31478.PMC4808080.pdf
"http://tilastokeskus.fi/til/ksyyt2012/ksyyt_2012_2013-12-30_ laa_001_en.html  (24 September 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/af/51/kqv197.PMC4808246.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/e2/hnv072.PMC4808256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/hnv075.PMC4808257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/d9/hnv077.PMC4808259.pdf
Available at: http://www.usariem.army.mil/index.cfm/about/divisions/mpd/taihod.,OADS,/arxiv_data1/oa_pdf/4d/d9/hnv077.PMC4808259.pdf
http://www.med.navy.mil/sites/nhrc/Documents/EMED 14.,OADS,/arxiv_data1/oa_pdf/4d/d9/hnv077.PMC4808259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/63/hnv079.PMC4808260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/c7/hnv082.PMC4808261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/c4/hnv083.PMC4808262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/56/nihms709184.PMC4808301.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/4a/nihms736143.PMC4808407.pdf
"Main Results In the validation cohort, the overall direction of the associations between the STONE  predictors and ureteral stone were similar to that of the original study, but the strength of the  associations was attenuated; nonblack race was not significantly associated with ureteral  stone (Table E1, available online at http://www.annemergmed.com ).",OADS,/arxiv_data1/oa_pdf/8c/4a/nihms736143.PMC4808407.pdf
"Calibration of the STONE score was represented graphically by plotting observed versus  predicted outcomes (Figure E1, available online at http://www.annemergmed.com ).",OADS,/arxiv_data1/oa_pdf/8c/4a/nihms736143.PMC4808407.pdf
"A comparison of the receiver  operating characteristic curves can be found in Table E3 and Figure E2, available online at  http://www.annemergmed.com .",OADS,/arxiv_data1/oa_pdf/8c/4a/nihms736143.PMC4808407.pdf
"Developmental  Cognitive  Neuroscience  18  (2016)  57–69 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn The  extended trajectory of  hippocampal  development:  Implications for  early memory development and  disorder Rebecca  L.  Gómez∗,  Jamie  O.  Edgin The  University  Of  Arizona,  United  States a  r  t  i  c  l  e  i  n  f  o Article  history: Received  13 May 2015 Received in  revised  form  12  August  2015 Accepted  22 August  2015 Available online  25  September  2015 Keywords:Memory development HippocampusCortexSleepAtypical populationsa  b  s  t  r  a  c  t Hippocampus  has  an  extended  developmental  trajectory,  with  reﬁnements  occurring  in  the  trisynaptic circuit until  adolescence.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
http://dx.doi.org/10.1016/j.dcn.2015.08.009 1878-9293/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Neuron 61,  454–466,  http://dx.doi.org/10.1016/j.neuron.2009.01.007 .",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"56,  657–664,  http://dx.doi.org/10.1111/dmcn.12376 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"11, 114–126, http://dx.doi.org/10.1038/nrn2762 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Commun.,  http://dx.doi.org/10.1038/ ncomms7004 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Neuropsychologia  46,  2865–2868,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"30  (28),  9548–9556,  http://dx.doi.org/10.1523/jneurosci.3500-09.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"17,  670–674,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Neuron  81, 1165–1178, http://dx.doi.org/10.1016/j.neuron.2014.01.015 .",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"12,  1007–1012,  http://dx.doi.org/10.1111/j.1467-7687.2009.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"2 (7),  475–483,  http://dx.doi.org/10.1038/35081509 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"14  (3),  521–536,  http://dx.doi.org/10.1017/ S0954579402003073 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"9,  12–29,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"6,  260,  http://dx.doi.org/10.3389/fpsyg.2015.00260 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"82  (4),  1092–1105, http://dx.doi.org/10.1111/j.1467-8624.2011.01597.x .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"66  (1),  1–29,  http://dx.doi.org/10.1016/j.cogpsych.2012.",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"130,  79–91, http://dx.doi.org/10.1016/j.jecp.2014.09.013 .",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"18  (3),  404–419,  http://dx.doi.org/10.1111/desc.12225 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"8 (3),  80–85, http://dx.doi.org/10.1111/1467-8721.00019 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Memory  8  (4), 265–269, http://dx.doi.org/10.1080/096582100406810 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"22,  1622–1627,  http://dx.doi.org/10.1016/j.cub.2012.06.",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Hippocampus 24, 354–362, http://dx.doi.org/10.1002/hipo.22229 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"30,  14356–14360,  http://dx.doi.org/10.1523/ jneurosci.3028-10.2010 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Neuron  81, 12–34, http://dx.doi.org/10.1016/j.neuron.2013.12.025 .",OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"85, 429–436,  http://dx.doi.org/10.1111/cdev.12149 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"5,  184,  http://dx.doi.org/10.3389/ fpsyg.2014.00184 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Science  265,  676–679,  http://dx.doi.org/10.1126/ science.8036517 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"30,  553–566,  http://dx.doi.org/10.1037/ 0012-1649.30.4.553 .",Non-OADS,/arxiv_data1/oa_pdf/c9/09/main.PMC4808499.pdf
"Review J Vet Sci 2016, 17(1), 1-11 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.1 JVS Received 20 Jan. 2015, Revised 27 Jul.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/jvs-17-1.PMC4808633.pdf
"Original Article J Vet Sci 2016, 17(1), 103-109 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.103 JVS Received 20 Mar.",Non-OADS,/arxiv_data1/oa_pdf/c2/1d/jvs-17-103.PMC4808634.pdf
"Short Communication J Vet Sci 2016, 17(1), 111-113 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.111 JVS Received 6 May.",Non-OADS,/arxiv_data1/oa_pdf/70/36/jvs-17-111.PMC4808635.pdf
"Short Communication J Vet Sci 2016, 17(1), 115-117 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.115 JVS Received 2 Sep. 2014, Revised 22 May.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/jvs-17-115.PMC4808636.pdf
"Short Communication J Vet Sci 2016, 17(1), 119-122 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.119 JVS Received 27 Feb. 2015, Revised 16 Jun.",Non-OADS,/arxiv_data1/oa_pdf/fc/04/jvs-17-119.PMC4808637.pdf
"Case Report J Vet Sci 2016, 17(1), 123-126 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.123 JVS Received 16 Jan. 2015, Revised 27 May.",Non-OADS,/arxiv_data1/oa_pdf/63/7e/jvs-17-123.PMC4808638.pdf
"Original Article J Vet Sci 2016, 17(1), 13-20 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.13 JVS Received 20 Oct. 2014, Revised 12 Dec. 2014, Accepted 30 Dec. 2014 *Corresponding author: Tel: +82-2-880-1264; Fax: +82-2-871-1752; E-mail: ysyoon@snu.ac.kr Journal of Veterinary Science ㆍⓒ 2016 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/9f/d9/jvs-17-13.PMC4808639.pdf
"Original Article J Vet Sci 2016, 17(1), 21-26 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.21 JVS Received 3 Jun.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/jvs-17-21.PMC4808640.pdf
"Original Article J Vet Sci 2016, 17(1), 27-34 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.27 JVS Received 30 Mar.",Non-OADS,/arxiv_data1/oa_pdf/4c/ca/jvs-17-27.PMC4808641.pdf
"Original Article J Vet Sci 2016, 17(1), 35-44 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.35 JVS Received 17 Mar.",Non-OADS,/arxiv_data1/oa_pdf/25/69/jvs-17-35.PMC4808642.pdf
"Original Article J Vet Sci 2016, 17(1), 45-51 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.45 JVS Received 9 Mar.",Non-OADS,/arxiv_data1/oa_pdf/33/92/jvs-17-45.PMC4808643.pdf
"Original Article J Vet Sci 2016, 17(1), 53-61 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.53 JVS Received 13 Feb. 2015, Revised 16 Apr.",Non-OADS,/arxiv_data1/oa_pdf/33/9e/jvs-17-53.PMC4808644.pdf
"Original Article J Vet Sci 2016, 17(1), 63-70 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.63 JVS Received 25 Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/57/jvs-17-63.PMC4808645.pdf
"Original Article J Vet Sci 2016, 17(1), 71-78 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.71 JVS Received 30 Mar.",Non-OADS,/arxiv_data1/oa_pdf/19/c3/jvs-17-71.PMC4808646.pdf
"Original Article J Vet Sci 2016, 17(1), 79-87 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.79 JVS Received 17 Feb. 2015, Revised 27 Jun.",Non-OADS,/arxiv_data1/oa_pdf/cc/f6/jvs-17-79.PMC4808647.pdf
"Original Article J Vet Sci 2016, 17(1), 89-96 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.89 JVS Received 9 Mar.",Non-OADS,/arxiv_data1/oa_pdf/45/a8/jvs-17-89.PMC4808648.pdf
"Original Article J Vet Sci 2016, 17(1), 97-102 ㆍhttp://dx.doi.org/10.4142/jvs.2016.17.1.97 JVS Received 16 Jan. 2015, Revised 2 Jul.",Non-OADS,/arxiv_data1/oa_pdf/83/e7/jvs-17-97.PMC4808649.pdf
Editor: Kazuhiro Oiwa./C2112014 The Authors 0006-3495/14/12/2872/9 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.10.061 2872 Biophysical Journal Volume 107 December 2014 2872–2880,Non-OADS,/arxiv_data1/oa_pdf/47/d4/main.PMC4808650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/61/main.PMC4808679.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.01.002 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/61/main.PMC4808679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/b1/main.PMC4808694.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.014 153,OADS,/arxiv_data1/oa_pdf/01/b1/main.PMC4808694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/73/main.PMC4808695.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.002 160,OADS,/arxiv_data1/oa_pdf/cc/73/main.PMC4808695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/17/main.PMC4808696.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.007 147,OADS,/arxiv_data1/oa_pdf/b4/17/main.PMC4808696.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/15/main.PMC4808697.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.003 144,OADS,/arxiv_data1/oa_pdf/4d/15/main.PMC4808697.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC4808698.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.010 166,OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC4808698.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4808699.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.01.008 112,OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4808699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/67/main.PMC4808700.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.010 117,OADS,/arxiv_data1/oa_pdf/50/67/main.PMC4808700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/c1/main.PMC4808701.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.006 157,OADS,/arxiv_data1/oa_pdf/27/c1/main.PMC4808701.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/75/main.PMC4808702.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.007 109,OADS,/arxiv_data1/oa_pdf/88/75/main.PMC4808702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/26/main.PMC4808703.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.009 138,OADS,/arxiv_data1/oa_pdf/1f/26/main.PMC4808703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/30/main.PMC4808705.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.01.006 182,OADS,/arxiv_data1/oa_pdf/24/30/main.PMC4808705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/5e/main.PMC4808706.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.011 120,OADS,/arxiv_data1/oa_pdf/2d/5e/main.PMC4808706.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/41/main.PMC4808707.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.008 141,OADS,/arxiv_data1/oa_pdf/a0/41/main.PMC4808707.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/0d/main.PMC4808708.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.002 123,OADS,/arxiv_data1/oa_pdf/14/0d/main.PMC4808708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/78/main.PMC4808709.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.004 150,OADS,/arxiv_data1/oa_pdf/b6/78/main.PMC4808709.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/36/main.PMC4808710.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.012 129,OADS,/arxiv_data1/oa_pdf/f0/36/main.PMC4808710.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/84/main.PMC4808711.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.01.007 114,OADS,/arxiv_data1/oa_pdf/32/84/main.PMC4808711.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/6d/main.PMC4808712.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.02.013 136,OADS,/arxiv_data1/oa_pdf/c6/6d/main.PMC4808712.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/72/main.PMC4808713.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.005 132,OADS,/arxiv_data1/oa_pdf/7e/72/main.PMC4808713.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/22/main.PMC4808714.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.004 163,OADS,/arxiv_data1/oa_pdf/30/22/main.PMC4808714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/c3/main.PMC4808715.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.03.001 126,OADS,/arxiv_data1/oa_pdf/71/c3/main.PMC4808715.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/eb/main.PMC4808720.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.006 175,OADS,/arxiv_data1/oa_pdf/aa/eb/main.PMC4808720.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/8c/main.PMC4808721.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.005 196,OADS,/arxiv_data1/oa_pdf/9d/8c/main.PMC4808721.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4808723.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.007 178,OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4808723.pdf
J Oncol Pharm Pract .http://dx.doi.org/10.1177/1078155214531610 .,Non-OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4808723.pdf
http://dx.doi.org/10.1097/MJT.0000000000000024 .,Non-OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4808723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/c8/main.PMC4808724.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.05.005 225,OADS,/arxiv_data1/oa_pdf/6a/c8/main.PMC4808724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/eb/main.PMC4808726.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.05.008 234,OADS,/arxiv_data1/oa_pdf/23/eb/main.PMC4808726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/be/main.PMC4808727.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.013 188,OADS,/arxiv_data1/oa_pdf/01/be/main.PMC4808727.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/c1/main.PMC4808728.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.012 207,OADS,/arxiv_data1/oa_pdf/28/c1/main.PMC4808728.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/2e/main.PMC4808729.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.05.003 227,OADS,/arxiv_data1/oa_pdf/16/2e/main.PMC4808729.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/14/main.PMC4808730.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.004 169,OADS,/arxiv_data1/oa_pdf/44/14/main.PMC4808730.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/da/main.PMC4808731.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.014 212,OADS,/arxiv_data1/oa_pdf/4e/da/main.PMC4808731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/dd/main.PMC4808732.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.05.007 230,OADS,/arxiv_data1/oa_pdf/c5/dd/main.PMC4808732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/71/main.PMC4808733.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.017 215,OADS,/arxiv_data1/oa_pdf/06/71/main.PMC4808733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/34/main.PMC4808734.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.015 219,OADS,/arxiv_data1/oa_pdf/7c/34/main.PMC4808734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/4d/main.PMC4808735.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.010 203,OADS,/arxiv_data1/oa_pdf/71/4d/main.PMC4808735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/14/main.PMC4808736.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.001 191,OADS,/arxiv_data1/oa_pdf/34/14/main.PMC4808736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/98/main.PMC4808737.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.009 200,OADS,/arxiv_data1/oa_pdf/d2/98/main.PMC4808737.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/0d/main.PMC4808738.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.05.001 222,OADS,/arxiv_data1/oa_pdf/8e/0d/main.PMC4808738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"Statisticalanalyses were performed using 2-tailed Student’s t-test, and the p-value of B0.05 was considered to be statisti- cally significant.Isolation of biologically active and morphologically intact exosomes Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"*Differences between patients’ and NC’s #4 fractions.Isolation of biologically active and morphologically intact exosomes Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"AML /C30acute myeloid leukaemia; HNSCC /C30head and neck squamous cell carcinoma; NC /C30normal control; SEC /C30size exclusion chromatography.Isolation of biologically active and morphologically intact exosomes Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"Isolation of biologically active and morphologically intact exosomes Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1016/j.tcb.2015.01.004 2.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1083/jcb.201211138 3.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1096/fj.08-122184 4.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1007/s00018-014-1764-3 5.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.3324/ haematol.2010.039743 7.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
2015;6:203. doi: http://dx.doi.org/10.3389/ﬁmmu.2015.00203 8.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
2006; Chapter 3:Unit 3.22. doi: http://dx.doi.org/10.1002/0471143030.cb0322s30 9.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1007/978-1-4939-1158-5_7Chang-Sook Hong et al.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1016/j.ymeth.2015.02.019 11.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1182/blood-2013-02-482406 14.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/ 10.1016/j.jim.2014.06.007 15.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.4049/jimmunol.0900970 17.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
2014;5:160. doi:http://dx.doi.org/10.3389/ﬁmmu.2014.00160 18.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/ 10.1042/BST20120265 20.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1007/978-1-61779- 068-3_15 21.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/ 10.1016/j.ymeth.2012.01.002 23.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1097/ CCO.0b013e32835b7c81 25.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.1080/2162402X.2015.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
2015;4:27269. doi:http://dx.doi.org/10.3402/jev.v4.27269 28.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"2014;3:23430. doi: http://dx.doi.org/10.3402/jev.v3.23430 29. de Menezes-Neto A, Saez MJ, Lozano-Ramos I, Segui-Barber J, Martin-Jaular L, Ullate JM, et al.",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
2015;4:27378. doi: http://dx.doi.org/10.3402/jev.v4.27378 30.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
Sci Rep. 2015;5:10266. doi: http://dx.doi.org/10.1038/srep10266 32.,OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
doi: http://dx.doi.org/ 10.1371/journal.pone.0011469 35.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
J Natl Cancer Inst.2015;107:363. doi: http://dx.doi.org/10.1093/jnci/dju363 36.,Non-OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
"Sci Rep. 2015;5:7639. doi: http://dx.doi.org/10.1038/srep07639Isolation of biologically active and morphologically intact exosomes Citation: Journal of Extracellular Vesicles 2016, 5: 29289 - http://dx.doi.org/10.3402/jev.v5.29289 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/60/9d/JEV-5-29289.PMC4808740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/1b/main.PMC4808741.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.011 185,OADS,/arxiv_data1/oa_pdf/9f/1b/main.PMC4808741.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/38/main.PMC4808742.pdf
http://dx.doi.org/10.1016/j.jdcr.2015.04.003 172,OADS,/arxiv_data1/oa_pdf/db/38/main.PMC4808742.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Wang, W .",Non-OADS,/arxiv_data1/oa_pdf/59/99/srep20869.PMC4808833.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/59/99/srep20869.PMC4808833.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010869).,Non-OADS,/arxiv_data1/oa_pdf/77/fc/bmjopen-2015-010869.PMC4809071.pdf
"2011. http://www.blv.admin.ch/dokumentation/00327/05754/index.html?download=NHzLpZeg7t,lnp6I0NTU042l2Z6ln1ah2oZn4Z2qZpnO2Yuq2Z6gpJCFfX59g2ym162epYbg2c_JjKbNoKSn6A –&lang=it (accessed 17 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/77/fc/bmjopen-2015-010869.PMC4809071.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010304).,Non-OADS,/arxiv_data1/oa_pdf/05/23/bmjopen-2015-010304.PMC4809072.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009353).,Non-OADS,/arxiv_data1/oa_pdf/d3/b4/bmjopen-2015-009353.PMC4809075.pdf
4. http://www.ukbiobank.ac.uk5.,Non-OADS,/arxiv_data1/oa_pdf/01/48/bmjopen-2015-009161.PMC4809076.pdf
http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1002356.,OADS,/arxiv_data1/oa_pdf/01/48/bmjopen-2015-009161.PMC4809076.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010214).,Non-OADS,/arxiv_data1/oa_pdf/df/2c/bmjopen-2015-010214.PMC4809077.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/df/2c/bmjopen-2015-010214.PMC4809077.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010579).,Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
The source code of EHDVizand various prototypes developed using EHDViz areavailable in the public domain at http://ehdviz.dudleylab.org.,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"16As an example, several ongoing clinical trials make use of AppleResearchKit for evaluating patients with asthma, 17car- diovascular disease, diabetes and Parkinson ’s disease (see http://researchkit.org/), and some efforts imple-ment mHealth-based solutions to engage patients and visualise data (AppCore: https://github.com/ researchkit/AppCore).",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Information retrieval systems that integrate multiple data streams have been developed or suggested for particular applications, including anti-biotic clinical decision systems, 3recording events during surgical operations,21diabetic patient data collection programs,22text mining, concept extraction from clin- ical documentation using natural language processing19 and wearable devices using software application pro-gramming interfacing (API) services (eg, Human API;see: https://www.humanapi.co/) that allow communica- tion between health monitoring devices and provider databases using a secure, programmatic data accessprotocol.",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
Data cleaning and quality control steps including the removal of outliers were performed using reshape2 package (https://cran.r-project.org/web/packages/ reshape2/index.html).,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
EHDViz uses the packages ggplot2 (http://ggplot2.org) and gridExtra (https://cran.,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
We used theShiny server architecture (https://github.com/rstudio/ shiny-server) because it can be implemented over mul- tiple desktop and server environments and can be distrib-uted as suitable software modules.,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Data handling in EHDViz Various biomedical and healthcare data types, including disease and procedure indexes, clinical dictionaries and ontologies, namely the International StatisticalClassi ﬁcation of Diseases and Related Health Problems (ICD-9: http://www.who.int/classi ﬁcations/icd/en/) codes, are indexed in the current implementation todeﬁne speci ﬁc disease terms pertaining to patients as part of diagnoses.",OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
EHDViz can also parse and normalise medicationdata using National Drug Codes (NDCs) and RxNorm and use medication data as part of the data aggregation methods in EHDViz (NDC: http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm; RxNorm: https://www.nlm.nih.gov/research/umls/ rxnorm/).,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"r-project.org/web/packages/RODBC/index.html), Java Database Connectivity ( JDBC ) (RJDBC: https:// cran.r-project.org/web/packages/RJDBC/index.html), MySQL (RMySQL: https://cran.r-project.org/web/ packages/RMySQL/index.html) or modern, NoSQLdatabase systems such as MongoDB ( rmongodb : https:// cran.r-project.org/web/packages/rmongodb/index.html).",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
Various examples of input formats and sample ﬁles are provided at the URL: http://ehdviz.dudleylab.org/help.,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Dashboards discussed in this manuscript are implemen- ted on a web server with Nginx (http://nginx.org/) on a secure, cloud-based virtual private server running on Ubuntu .",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"RESULTS Availability: the source code of EHDViz and various clin- ical dashboard implementations are available from theURL: http://ehdviz.dudleylab.org/.Clinical dashboards developed using EHDViz Collaborative data visualisations, wellness trend predictors, risk estimation algorithms, proactive acuity status monitor-ing in a clinical setting and complex disease indicators are essential components of implementing data-driven preci- sion medicine.",OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
We also provide a demon- stration at http://ehdviz.dudleylab.org/providers/full that allows a keyword-based search and multiselection ofall 375 health features to make customised dashboards.,Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Real-time displays were also designed from the simulated data, demonstrated at http://ehdviz.dudleylab.org/providers/real-time.",OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Demonstrations of ICD-9-class-based feature selection are providedat the URL: http://ehdviz.dudleylab.org/visualizations/ Population_Management_ICD9/, and a real-time moni- toring dashboard implemented using EHDViz is pro-vided at the URL: http://ehdviz.dudleylab.org/ visualizations/Population_Management_RealTime/.",OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"CONCLUSIONS Owing to the implementation of the Affordable Care Act (http://www.hhs.gov/healthcare/about-the-law/index.html) and the emerging trend of hospitals to rebuilding healthcare operations as affordable care organization (ACO), there is a growing need for healthinformation technology (healthIT) solutions to be more agile and sustainable across different levels of hospitals and health systems.",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
The authors would also like to thank Harris Center for Precision Wellness (http://precisionwellness.org/) and Icahn Institute for Genomics andMultiscale Biology (http://icahn.mssm.edu/research/genomics) for infrastructure support.,Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
"Data sharing statement Source code and sample data are available on the companion website: http://ehdviz.dudleylab.org Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
http://www.ncbi.nlm.nih.gov/pubmed/7914312 (accessed 12 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10169554 (accessed 19 Mar 2015).,OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
http://apps.icahn.mssm.edu/asthma/ (accessed 1 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/5b/1d/bmjopen-2015-010579.PMC4809078.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010128).,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/bmjopen-2015-010128.PMC4809079.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006430).,Non-OADS,/arxiv_data1/oa_pdf/cb/80/bmjopen-2014-006430.PMC4809082.pdf
Luxembourg: Publications Office of the European Union 2014. http://eurofound.europa.eu/publications/report/2014/labour-market/mapping-youth-transitions-in-europe 7.,Non-OADS,/arxiv_data1/oa_pdf/cb/80/bmjopen-2014-006430.PMC4809082.pdf
Luxembourg: Publications Office of the European Union 2014. http://eurofound.europa.eu/observatories/emcc/comparative-information/young-people-and-temporary-employment-in-europe 8.,Non-OADS,/arxiv_data1/oa_pdf/cb/80/bmjopen-2014-006430.PMC4809082.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009118).,Non-OADS,/arxiv_data1/oa_pdf/be/64/bmjopen-2015-009118.PMC4809083.pdf
2013. http://www.ukessays.com/essays/psychology/treatment-of-obsessive-compulsive-disorder-psychology-essay.php?cref=1 23.,Non-OADS,/arxiv_data1/oa_pdf/be/64/bmjopen-2015-009118.PMC4809083.pdf
"Additionally, we useda members-only social network site (SNS) webpage (http://malaysia-navi.vivian.jp/sns/) for Japanese retir- ees who reside in Malaysia, to announce our FGD meet-ings, and recruitment was made by sending emails and messages to the retirees.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
https://www2.kent.edu/sociology/ resources/jaee/upload/retiring-in-a-foreign-land.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
http://camel.minpaku.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
2014. http://www.longstay.or.jp/product/booklist/ 8.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
http://prami.ibero.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
http://epub.uni-regensburg.de/1114/1/JPG-313-333_neu.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/bmjopen-2015-010668.PMC4809084.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010076).,Non-OADS,/arxiv_data1/oa_pdf/ea/14/bmjopen-2015-010076.PMC4809085.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/14/bmjopen-2015-010076.PMC4809085.pdf
Published: 18th April 2015. http://www.times.co.zm/?p=56464.,Non-OADS,/arxiv_data1/oa_pdf/ea/14/bmjopen-2015-010076.PMC4809085.pdf
Published: 1st July 2015. http://www.times.co.zm/?p=62589.,Non-OADS,/arxiv_data1/oa_pdf/ea/14/bmjopen-2015-010076.PMC4809085.pdf
https://www.zambia.co.zm/downloads/draft_constitution.pdf (accessed 3 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/ea/14/bmjopen-2015-010076.PMC4809085.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010915).,Non-OADS,/arxiv_data1/oa_pdf/ca/3b/bmjopen-2015-010915.PMC4809087.pdf
[Working Paper 08-096] 2008. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.461.6523&rep=rep1&type=pdf 10.,OADS,/arxiv_data1/oa_pdf/ca/3b/bmjopen-2015-010915.PMC4809087.pdf
"Boston, MA: Management Consulting Services, 2004. http://wikiciv.org.rs/images/5/5d/Sussman_(2004)_Building_Adaptive_Capacity.pdf 12.",Non-OADS,/arxiv_data1/oa_pdf/ca/3b/bmjopen-2015-010915.PMC4809087.pdf
"New Zealand: Resilient Organisations Programme, 2007. http://cpor.org/ro/ResilienceMgmtResearch(2007).pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/ca/3b/bmjopen-2015-010915.PMC4809087.pdf
Health Canada Drug Product Database Data Extract Files2015 2015.01.13. http://hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/dpd_bdpp_data_extract-eng.php 10.,OADS,/arxiv_data1/oa_pdf/57/14/bmjopen-2015-010861.PMC4809089.pdf
Alberta Health Claims Assessment Alberta Health Diagnostic Codes2015 2015.01.13. http://www.health.alberta.ca/documents/ Diagnostic-Code-ICD-9.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/57/14/bmjopen-2015-010861.PMC4809089.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008777).,Non-OADS,/arxiv_data1/oa_pdf/31/05/bmjopen-2015-008777.PMC4809091.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/31/05/bmjopen-2015-008777.PMC4809091.pdf
2011. http://www.rwjf.org/pr/product.jsp?id=72058.,Non-OADS,/arxiv_data1/oa_pdf/31/05/bmjopen-2015-008777.PMC4809091.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010472).,Non-OADS,/arxiv_data1/oa_pdf/0e/3d/bmjopen-2015-010472.PMC4809092.pdf
All entered data will be checked and cleaned (LWAHvB and V ABS) according to the quality handbook of the emgo+institute for health and careresearch (http://www.emgo.nl/kc).,OADS,/arxiv_data1/oa_pdf/0e/3d/bmjopen-2015-010472.PMC4809092.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/3d/bmjopen-2015-010472.PMC4809092.pdf
"Nürnberg, 2011. http://nbn-resolving.de/urn:nbn: de:0168-ssoar-259992 (accessed 6 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
2011. http://www.york.ac.uk/media/che/documents/papers/researchpapers/CHERP63_avoidable_mortality_what_it_means_and_how_it_is_measured.pdf (accessed 6 Jan2015).,Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
2011. http://www.oecd.org/els/health-systems/49105858.pdf (accessed 6 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
"55, OECD Publishing, 2011.http://dx.doi.org/10.1787/5kgj35f9f8s2-en (accessed 6 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
2014. http://www.gbe-bund.de 27.,Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
2014. http://www.gbe-bund.de 28.,Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
ZUMA Nachrichten 2000; 24:47. http://nbn-resolving.de/urn:nbn:de:0168-ssoar-208052 (accessed 14 Jan2016).,Non-OADS,/arxiv_data1/oa_pdf/75/fa/bmjopen-2015-007875.PMC4809093.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010249).,Non-OADS,/arxiv_data1/oa_pdf/59/43/bmjopen-2015-010249.PMC4809096.pdf
http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/59/43/bmjopen-2015-010249.PMC4809096.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010898).,Non-OADS,/arxiv_data1/oa_pdf/9e/ce/bmjopen-2015-010898.PMC4809100.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011159).,Non-OADS,/arxiv_data1/oa_pdf/78/26/bmjopen-2016-011159.PMC4809102.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/26/bmjopen-2016-011159.PMC4809102.pdf
OECD Health Statistics 2015. http://stats.oecd.org//Index.aspx?,Non-OADS,/arxiv_data1/oa_pdf/78/26/bmjopen-2016-011159.PMC4809102.pdf
http://www.bls.gov/oes/current/naics4_623100.htm-29-0000 (access 22 Sep 2015).,OADS,/arxiv_data1/oa_pdf/78/26/bmjopen-2016-011159.PMC4809102.pdf
https://www.zotero.org/ (accessed 12 Feb 2016).68.,Non-OADS,/arxiv_data1/oa_pdf/78/26/bmjopen-2016-011159.PMC4809102.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010754).,Non-OADS,/arxiv_data1/oa_pdf/09/06/bmjopen-2015-010754.PMC4809103.pdf
http://www.ninds.nih.gov/disorders/encephalitis_meningitis/detail_encephalitis_meningitis.htm (accessed 15 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/09/06/bmjopen-2015-010754.PMC4809103.pdf
2015. https://www.aamc.org/cim/specialty/list/us/339608/infectious_disease_-internal_medicine.html (accessed 19Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/09/06/bmjopen-2015-010754.PMC4809103.pdf
1999. http://www.encephalitis.info/files/5913/4012/7875/FS063V1.pdf (accessed 11 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/09/06/bmjopen-2015-010754.PMC4809103.pdf
National Drug Strategy Household Survey detailed report 2013 [10 Aug 2015].http://www.health.gov.au/internet/main/publishing.nsf/content/tobacco-kff 4.,Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
"The Tobacco Atlas, Smoking ’s death toll 2015. http://www.tobaccoatlas.org/topic/ smokings-death-toll/ 7.",Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
"Third Session of the Conference of the Parties to the WHO Framework Convention onTobacco Control ; Durban, South Africa, 17 –22 November 2008. http://www.who.int/fctc/guidelines/article_11.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
"Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and HealthPromotion, Office on Smoking and Health, 2012. http://www.cdc.gov/tobacco 44.",Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
Country and Lending Groups Data 2015. http://data.worldbank.org/about/country-and-lending-groups —Low_ income (accessed Jan 2016) 45.,Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
Public support for putting tobacco products in plain packaging 2011. http://www.ash.org.uk/files/documents/ASH_765.pdf54.,Non-OADS,/arxiv_data1/oa_pdf/97/eb/bmjopen-2015-010391.PMC4809104.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010295).,Non-OADS,/arxiv_data1/oa_pdf/8c/95/bmjopen-2015-010295.PMC4809105.pdf
Google scholar (http://scholar.google.com) and Baidu scholar (http://xueshu.baidu.com/); 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/95/bmjopen-2015-010295.PMC4809105.pdf
Clinical Trials.gov (http://www.clinical trails.gov) and Chinese Clinical Trial Registry (http://www.chictr.org/cn/); 3.,Non-OADS,/arxiv_data1/oa_pdf/8c/95/bmjopen-2015-010295.PMC4809105.pdf
We will create a Summary of Findingtable in http://www.guidelinedevelopment.org/.,Non-OADS,/arxiv_data1/oa_pdf/8c/95/bmjopen-2015-010295.PMC4809105.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/95/bmjopen-2015-010295.PMC4809105.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010989).,Non-OADS,/arxiv_data1/oa_pdf/b8/42/bmjopen-2015-010989.PMC4809106.pdf
2013. http://www.volgmed.ru/uploads/files/2014-12/35099-prilozhenie_1-3_k_informacionnomu_pismu_2.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/b8/42/bmjopen-2015-010989.PMC4809106.pdf
"Synthesis and analysis All statistical syntheses and analyses will be performedusing Review Manager Software (V .5.3, Cochrane Collaboration, http://tech.cochrane.org/RevMan) and STATA for Windows (V .14.0, STATA Corp., T exas, USA).If more than two studies are eligible for analysis in each study type, we will combine the studies for meta-analysis by study types.",OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
"Evaluation of the level of evidence The level of evidence will be evaluated with the GRADE (Grading of Recommendations Assessment,Development and Evaluation) system, using the GRADEpro program (V.3.6, GRADE working group, http://tech.cochrane.org/revman/gradepro).",OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
2012. http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/pancreatic-cancer-statistics 2.,Non-OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
Pancreatic Adenocarcinoma; Version 2.2015. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
http://dx.doi.org/10.1002/1097- 0142(19931001)72:7<2124::AID-CNCR2820720711>3.0.CO;2-C 18.,Non-OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
2008. http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Ch13_NRS.pdf 36.,OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_Quick Reference_5×7.pdf 38.,OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
"The Cochrane Collaboration, 2014. http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Data%20extraction%20form_all%20studies.docx 40.",OADS,/arxiv_data1/oa_pdf/f0/d4/bmjopen-2015-010491.PMC4809107.pdf
22. https://http://www.gov.uk/government/uploads/system/uploads/ attachment_data/file/469737/SFR41-2015_Text.pdf 2015.,Non-OADS,/arxiv_data1/oa_pdf/97/d2/bmjopen-2015-010788.PMC4809108.pdf
"Finally, we estimated the potential workload needed to comply with these clinical practiceguidelines for patients with 1 –6 chronic conditions.Identification of clinical practice guidelines We searched the National Guideline Clearinghouse (NGC) (http://www.guideline.gov) to identify the mostrecent clinical practice guidelines for hypertension, dia- betes, CHD, COPD, osteoarthritis, depression, smoking cessation, overweight, prevention services and immunisa-tion.",Non-OADS,/arxiv_data1/oa_pdf/19/d9/bmjopen-2015-010119.PMC4809109.pdf
2013. http://www.bls.gov/news.release/archives/ atus_06202013.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/19/d9/bmjopen-2015-010119.PMC4809109.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"J Pathol Inform 2016, 1:8  http://www.jpathinformatics.org/content/7/1/8these disadvantages in the traditional teaching method,  several health professions education programs that  use LM to train their students have adopted Virtual  microscopy (VM) in their educational curricula in recent  years.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"J Pathol Inform 2016, 1:8  http://www.jpathinformatics.org/content/7/1/8considered in analyzing the results; (d) one respondent  who answered, “No” to the first question, answered the  rest of the survey.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"J Pathol Inform 2016, 1:8  http://www.jpathinformatics.org/content/7/1/8it in the curricula.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"J Pathol Inform 2016, 1:8  http://www.jpathinformatics.org/content/7/1/8server space.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"J Pathol Inform 2016, 1:8  http://www.jpathinformatics.org/content/7/1/8sharing the most information possible collected in this  survey, the results were analyzed and reported accordingly.",OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
Available from: http://www.cytopathology.org/about‑cytotechnology.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/JPI-7-8.PMC4809110.pdf
"International Journal of Preventive Medicine 2016, 7:58 http://www.ijpvmjournal.net/content/7/1/58with the highest prevalence in Isfahan, of about   85.5 people/100,000.",Non-OADS,/arxiv_data1/oa_pdf/b5/38/IJPVM-7-58.PMC4809111.pdf
"International Journal of Preventive Medicine 2016, 7:58 http://www.ijpvmjournal.net/content/7/1/58place of residence, disease-related variables, and variables  affecting women of childbearing age such as early onset  of puberty, use of OCs prior to developing MS, age at  the first pregnancy, number of pregnancies prior to MS,  family history of MS, other autoimmune disease, and  history of a viral disease in childhood.",Non-OADS,/arxiv_data1/oa_pdf/b5/38/IJPVM-7-58.PMC4809111.pdf
"International Journal of Preventive Medicine 2016, 7:58 http://www.ijpvmjournal.net/content/7/1/58MS (OR = 0.780, CI = 0.676–0.899) that show an  inverse relationship regarding OR.",Non-OADS,/arxiv_data1/oa_pdf/b5/38/IJPVM-7-58.PMC4809111.pdf
"International Journal of Preventive Medicine 2016, 7:58 http://www.ijpvmjournal.net/content/7/1/58In this study, the relationship between the number  of pregnancies and MS was statistically significant by  logistic regression model (OR = 0.586, CI = 0.461– 0.745,), which means that the risk of MS decreased in  relation to a greater number of pregnancies.",Non-OADS,/arxiv_data1/oa_pdf/b5/38/IJPVM-7-58.PMC4809111.pdf
"International Journal of Preventive Medicine 2016, 7:58 http://www.ijpvmjournal.net/content/7/1/5811.",Non-OADS,/arxiv_data1/oa_pdf/b5/38/IJPVM-7-58.PMC4809111.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59bacterial overgrowth has been reported in 50% of these  patients.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59Circumference Measuring Tape (model 201; Seca GmbH  and Co, KG, Hamburg, Germany).",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59AST levels did not change within the intervention group  but were significantly increased in the placebo group.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59symbiotic can at least prevents progression of the disease  and a longer period of intervention with a higher dosage  of supplement in patients with elevated levels of liver  enzymes might show significant effects on these markers.In our study symbiotic supplementation resulted in  improvement of liver steatosis.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59in 2011 on 66 NAFLD patient showed that probiotic with  Fos and lifestyle modification (i.e.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:59 http://www.ijpvmjournal.net/content/7/1/59modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic  fatty liver disease model.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/IJPVM-7-59.PMC4809112.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42Early detection and prediction of risk of developing  the cardiovascular disease is a crucial factor in  slowing the growth of cardiovascular‑related mortality  across the world.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42Table 1: Demographic details of study participants with/without Framingham score Demographic All (n=598)  n (%)Participants with  Framingham score ( n=346)Participants without  Framingham score ( n=252)P Age 40-50 237 (39.7) 125 (36.1) 112 (46.5) 0.462 51-60 172 (28.8) 104 (30.1) 68 (27.0) 61-70 138 (23.1) 85 (24.6) 53 (21.0 71-80 38 (6.4) 24 (6.9) 14 (5.6) 81-90 10 (1.7) 5 (1.4) 5 (2.0) 91-100 2 (0.33) 2 (0.6) 0 101-110 1 (0.17) 1 (0.3) 0 Area Downtown 41 (6.9) 16 (39.0) 25 (61.0) <0.001 Inner city 154 (25.8) 130 (84.4) 24 (15.6) Outskirts of town 403 (67.4) 200 (49.6) 203 (50.4) Married 178 (29.8) 104 (30.1) 74 (29.4) 0.711 Single 72 (12.0) 47 (13.6) 25 (9.9) Stable union (living together) 284 (47.5) 159 (46.0) 125 (49.6) Divorced 43 (7.2) 24 (6.9) 19 (7.5) Widowed 21 (3.5) 12 (3.5) 9 (3.6) Skin Did not answer 2 (0.3) 2 (0.6) 0 <0.001 Brown 12 (2.0) 7 (2.0) 5 (2.0) White 85 (14.2) 45 (13.0) 40 (15.9) Dark 378 (63.2) 203 (58.7) 175 (69.4) Indian 86 (14.4) 73 (21.1) 13 (5.2) Black 35 (5.9) 16 (4.6) 19 (7.5) Number of children 0 51 (8.5) 27 (7.8) 24 (9.5) 0.190 1 52 (8.7) 27 (7.8) 25 (9.9) 2 81 (13.5) 43 (12.4) 38 (15.1) 3 87 (14.5) 47 (13.6) 40 (15.9) 4 104 (17.4) 57 (16.5) 47 (18.7) 5 58 (9.7) 34 (9.8) 24 (9.5) 6 52 (8.7) 32 (9.2) 20 (7.9) 7 113 (18.9) 79 (22.8) 34 (13.5) Religion Catholic 339 (56.7) 197 (56.9) 142 (56.3) 0.664 Evangelical 201 (33.6) 115 (33.2) 86 (34.1) Spiritualist 6 (1.0) 3 (0.9) 3 (1.2) Buddhist 3 (0.5) 3 (0.9) 0 (0.0) None 49 (8.2) 28 (8.1) 21 (8.3) Income Up to Rs.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42Physical examination A physical examination was conducted for each  participant, which included height, weight, abdominal  circumference, systolic and diastolic pressure, and pulse  rate.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42Associations between cardiovascular risk according  to the Framingham score and demographic, physical  and epidemiological factors were examined.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42r = 0.176) and abdominal circumference ( P = 0.003).",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:42 http://www.ijpvmjournal.net/content/7/1/42Conflicts of interest There are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
Available from: http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/IJPVM-7-42.PMC4809113.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44of good quality.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44products of conception; assisted vaginal delivery; blood  transfusions; surgery (caesarean section).",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44in accordance with the ethical standards laid down in the  1964 Declaration of Helsinki.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44Tables  4 and 5 show the reasons related by respondents  for avoiding referral as well as the suggestions by  respondents for improving referral.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44study in 1998, the 2003 and 2008 Nigerian National  Demographic Health Surveys and a study in Peru in  2006, that the met need for EOC is still low.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:44 http://www.ijpvmjournal.net/content/7/1/44ACKNOWLEDGEMENTS This work was part of a dissertation submitted to the National  Postgraduate Medical College of Nigeria in part fulfillment of  the requirements for the award of the Fellowship of the College  in Public Health.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
Available	 from:	http://llwww.care.,Non-OADS,/arxiv_data1/oa_pdf/bc/36/IJPVM-7-44.PMC4809114.pdf
"International Journal of Preventive Medicine 2016, 7:55 http://www.ijpvmjournal.net/content/7/1/55and specificity ranging from 60% to 98% and 54% to 90%,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/88/2f/IJPVM-7-55.PMC4809115.pdf
"International Journal of Preventive Medicine 2016, 7:55 http://www.ijpvmjournal.net/content/7/1/55Characteristics of nodules are summarized in Table  1.",Non-OADS,/arxiv_data1/oa_pdf/88/2f/IJPVM-7-55.PMC4809115.pdf
"International Journal of Preventive Medicine 2016, 7:55 http://www.ijpvmjournal.net/content/7/1/55Prevalence of thyroid nodules reported in 4–7% of the  general population while most of these nodules are  benign.",Non-OADS,/arxiv_data1/oa_pdf/88/2f/IJPVM-7-55.PMC4809115.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10is often performed using a ×100 oil‑immersion objective  lens.",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10lens and one using the ×100 objective lens.",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10microorganism details (e.g., “Yeast, possibly Cryptococcus   sp.” or “malaria”).",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10be inadequate most often with the ×40 WSI cases and  least often with the ×83 WSI cases [ Figure  5].",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10a sufficient amount of unbiased and diagnostically relevant  area is most easily accomplished by capturing a large area  of the slide and/or many representative areas, which WSI  is designed to do.",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"J Pathol Inform 2016, 1:10  http://www.jpathinformatics.org/content/7/1/10service and is beginning to explore the use of live  video human‑to‑human telemicroscopy for handling  teleconsults.",Non-OADS,/arxiv_data1/oa_pdf/ff/d8/JPI-7-10.PMC4809116.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/47controls To decrease heat strain.",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/4770% cotton).",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/47DISCUSSION The results showed that the difference between the mean  values of heart rate, oral temperature, skin temperature, and sweat rate of the participants with and without  cooling vest in this study have been affected by the  cooling vests and the difference has not relationship  with the climatic conditions.",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/47creates a cooling micro climate to absorb the metabolic  heat and prevent from the thermal exchange between  the user and the external environment.",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/47Bendkowska et al.",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:47 http://www.ijpvmjournal.net/content/7/1/47The effects of temperature gradient, mass and covering area.",Non-OADS,/arxiv_data1/oa_pdf/64/c8/IJPVM-7-47.PMC4809117.pdf
"International Journal of Preventive Medicine 2016, 7:53 http://www.ijpvmjournal.net/content/7/1/53REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/31/73/IJPVM-7-53.PMC4809118.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46and male depression were in the second and ninth  places  (in 2004), respectively, when these ranking were  determined in accordance with the disability‑adjusted  life year.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46Beck II depression questionnaire Beck II questionnaire comprised 21 items, which  considered physical, behavioral and cognitive symptoms  of the disease.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46RESULTS Out of 210 individuals, 198  patients finished this  study  [Figure  1].",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46DISCUSSION The results of this study showed that the treatment  approaches significantly decreased depressive symptom  intensity in rural areas.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46and exacerbation of depressive symptoms intensity.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/46Limitations We could not evaluate text messaging impacts during  the following period due to the cessation of the text  messages.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
Available from: https://www.ecouch.anu.edu.au/ecouch/ dep_launch.,Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
Available from: http://www.insomnia‑free.com/ chronic‑insomnia‑relief.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:46 http://www.ijpvmjournal.net/content/7/1/4632.",Non-OADS,/arxiv_data1/oa_pdf/2a/5b/IJPVM-7-46.PMC4809119.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57leading to insulin deficiency.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57A better understanding of the underlying mechanisms  may allow us to challenge the concept that the  accelerated cognitive decline in these individuals is an  irrevocable process.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57their axons into the fimbria.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57DISCUSSION Effects of diabetes on neuronal apoptosis Apoptosis, a morphologically distinct form of programmed  cell death, is an active, tightly regulated, metabolic, and  genetically encoded form of cell death, in which any harm  done to the organism by this process is minimized.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57of apoptotic regulators.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57also play an important role in amplifying the apoptotic  signaling from the death receptors, with receptor  recruited caspase 8 activating the pro‑apoptotic Bcl‑2  protein.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/57of type 1 diabetes on gray matter density as measured by voxel‑based  morphometry.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:57 http://www.ijpvmjournal.net/content/7/1/5785.",Non-OADS,/arxiv_data1/oa_pdf/7f/f8/IJPVM-7-57.PMC4809120.pdf
"International Journal of Preventive Medicine 2016, 7:60 http://www.ijpvmjournal.net/content/7/1/60nausea and vomiting, shortness of breath, tachypnea,  and hypertension 2 days after cesarean section.",Non-OADS,/arxiv_data1/oa_pdf/68/aa/IJPVM-7-60.PMC4809121.pdf
"International Journal of Preventive Medicine 2016, 7:60 http://www.ijpvmjournal.net/content/7/1/60CONCLUSIONS One of the rare but important causes of hypertension  in pregnancy is pheochromocytoma with high morbidity  and mortality of mother and fetus.",Non-OADS,/arxiv_data1/oa_pdf/68/aa/IJPVM-7-60.PMC4809121.pdf
"International Journal of Preventive Medicine 2016, 7:54 http://www.ijpvmjournal.net/content/7/1/54Received:  06 Oct 15 Accepted:  26 Jan 16   Published:  09 Mar 16 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/IJPVM-7-54.PMC4809122.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs355/ en/.,Non-OADS,/arxiv_data1/oa_pdf/98/ca/IJPVM-7-54.PMC4809122.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/11INTRODUCTION Centralization of cancer treatment in Denmark has  resulted in an increase in subspecialist pathologists at large  cancer center and a decrease at smaller local pathology  units.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/11and an internet connection that makes it possible  for pathologists to collaborate on the same physical  specimens by simultaneously viewing the same live  images.",OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/11find a sui table  time for consultation, and at the agreed  time, he or she would call the uropathologist over an  ordinary telephone line.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/113 + 4.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/11We found conclusively that preselection of one to four  slides based on the diagnostic question (e.g., presence  of cancer, tumor type, or difficulties in reaching a  Gleason score) was representative of a complete patient  case when assessed by conventional consultation where  the pathologist reviews all slides.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"J Pathol Inform 2016, 1:11  http://www.jpathinformatics.org/content/7/1/11whole slide imaging for primary diagnosis in surgical pathology.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/JPI-7-11.PMC4809123.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45• Strabismus • Refractive error: Anisometropia or high bilateral  refractive errors (isometropia) • Visual deprivation.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45disability prevention.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45• Hyperopia ≥+4.5 diopter in both eyes and hyperopia  difference ≥+1.5 diopter between eyes • Myopia ≥5 diopter in eyes or myopia difference ≥3  diopter between eyes.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45participants (52.6%) were female and 1529 participants  (47.4%) were male.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45Degree of amblyopic prevalence in children examined  by ophthalmologists was 109 children  (75.2%) which in  68 children  (62.4%) suffered amblyopia in one eye and  41 children  (37.6%) suffered amblyopia in two eyes.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45and the difference was not significant echoing the  results obtained in other researches done previously.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:45 http://www.ijpvmjournal.net/content/7/1/45children aged 6 through 71 months the baltimore pediatric eye disease study.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/IJPVM-7-45.PMC4809124.pdf
"International Journal of Preventive Medicine 2016, 7:41 http://www.ijpvmjournal.net/content/7/1/41INTRODUCTION Metabolic syndrome (MetS) is a complex disorder  resulting from the interaction of both genetic and  environmental factors.",Non-OADS,/arxiv_data1/oa_pdf/93/b9/IJPVM-7-41.PMC4809125.pdf
"International Journal of Preventive Medicine 2016, 7:41 http://www.ijpvmjournal.net/content/7/1/41Quantity and quality of the genomic DNA were assessed  by a spectrophotometer (Biochrom Ltd, UK) and agarose  gel electrophoresis, respectively.",Non-OADS,/arxiv_data1/oa_pdf/93/b9/IJPVM-7-41.PMC4809125.pdf
"International Journal of Preventive Medicine 2016, 7:41 http://www.ijpvmjournal.net/content/7/1/41by 1000 genomes project.",Non-OADS,/arxiv_data1/oa_pdf/93/b9/IJPVM-7-41.PMC4809125.pdf
"International Journal of Preventive Medicine 2016, 7:41 http://www.ijpvmjournal.net/content/7/1/41However, our preliminary results obtained from a small  population sample should be interpreted with caution  and will require confirmation in larger populations.",Non-OADS,/arxiv_data1/oa_pdf/93/b9/IJPVM-7-41.PMC4809125.pdf
"International Journal of Preventive Medicine 2016, 7:41 http://www.ijpvmjournal.net/content/7/1/41Pressure Education Program.",Non-OADS,/arxiv_data1/oa_pdf/93/b9/IJPVM-7-41.PMC4809125.pdf
"International Journal of Preventive Medicine 2016, 7:50 http://www.ijpvmjournal.net/content/7/1/50benefits of PA and good health, American College of  Sports Medicine recommended 30+ min of moderate PA  5 or more days/week or 20 min of vigorous PA 3 or more  days/week.",Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
"International Journal of Preventive Medicine 2016, 7:50 http://www.ijpvmjournal.net/content/7/1/50Research instrument Demographic attributes Age  (year), number of children, employment status,  marital status, and education level were evaluated in the  self‑administered questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
"International Journal of Preventive Medicine 2016, 7:50 http://www.ijpvmjournal.net/content/7/1/50validity of this scale were confirmed in this population.",Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
"International Journal of Preventive Medicine 2016, 7:50 http://www.ijpvmjournal.net/content/7/1/50PA MET  ‑  minutes per week could be found between  intervention and comparison worksite at posttest.",Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
"International Journal of Preventive Medicine 2016, 7:50 http://www.ijpvmjournal.net/content/7/1/50should be interpreted with caution because we do not  know whether the workday step counts were actually taken  at work or elsewhere.",Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
Available  from: http://www.hhs.gov.,Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
Available from: http://www.ipaq.ki.se.,Non-OADS,/arxiv_data1/oa_pdf/f3/3d/IJPVM-7-50.PMC4809126.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/52INTRODUCTION To achieve more effective cardiovascular disease (CVD)  prevention, the European Society of Cardiology (ESC)  strongly suggested the individual overall risk estimation  through risk scores.",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/52gender, were used; whereas, annual CVD death rates were  obtained from the WHO mortality database for 2002.",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/52and >14% risk of developing fatal CVD events during  the next 10‑years based on the baseline information)  according to the classification given by the ESC  SCORE.",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/52outcomes [Table 4].",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/52several prediction models have been developed for  the prevention of CVD,[23] but still, the set of risk  factors is, more or less, limited, so, several investigators  claim that the effort of risk prediction still needs more  attention.",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:52 http://www.ijpvmjournal.net/content/7/1/525.",Non-OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"Available from: http://www.who.int/whosis/mort/table1.cfm?path=whosis, mort, mort_table1&language=english.",OADS,/arxiv_data1/oa_pdf/5b/9f/IJPVM-7-52.PMC4809127.pdf
"International Journal of Preventive Medicine 2016, 7:43 http://www.ijpvmjournal.net/content/7/1/43on national reports, the prevalence of diabetes has been  raised during three decades in Iran and also a recent  national survey about HL has shown that majority  of people has inadequate knowledge.",Non-OADS,/arxiv_data1/oa_pdf/87/aa/IJPVM-7-43.PMC4809128.pdf
"International Journal of Preventive Medicine 2016, 7:43 http://www.ijpvmjournal.net/content/7/1/43and speak Persian language.",Non-OADS,/arxiv_data1/oa_pdf/87/aa/IJPVM-7-43.PMC4809128.pdf
"International Journal of Preventive Medicine 2016, 7:43 http://www.ijpvmjournal.net/content/7/1/437.",Non-OADS,/arxiv_data1/oa_pdf/87/aa/IJPVM-7-43.PMC4809128.pdf
"International Journal of Preventive Medicine 2016, 7:56 http://www.ijpvmjournal.net/content/7/1/56medical care is easier.",Non-OADS,/arxiv_data1/oa_pdf/09/36/IJPVM-7-56.PMC4809129.pdf
"International Journal of Preventive Medicine 2016, 7:56 http://www.ijpvmjournal.net/content/7/1/56plants.",Non-OADS,/arxiv_data1/oa_pdf/09/36/IJPVM-7-56.PMC4809129.pdf
URL: http://www.lmlcd.com/index.php/diabete/diabete‑au‑maroc.,Non-OADS,/arxiv_data1/oa_pdf/09/36/IJPVM-7-56.PMC4809129.pdf
"International Journal of Preventive Medicine 2016, 7:49 http://www.ijpvmjournal.net/content/7/1/49INTRODUCTION Pregnant women are at an increased risk of insulin  resistance, elevated inflammation, and oxidative stress, in  particular during the third trimester.",Non-OADS,/arxiv_data1/oa_pdf/18/27/IJPVM-7-49.PMC4809130.pdf
"International Journal of Preventive Medicine 2016, 7:49 http://www.ijpvmjournal.net/content/7/1/49Tehran, Iran, by enzymatic and high‑performance liquid  chromatography method.",Non-OADS,/arxiv_data1/oa_pdf/18/27/IJPVM-7-49.PMC4809130.pdf
